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ABSTRACT
Elucidating and Pharmacologically Targeting Secondary Injury Cascades following
Neural Injury
Brandon P. Lucke-Wold

3.4 million concussions occur each year in the United States. Recent evidence
suggests that some of these individuals are susceptible to neurodegenerative disease
development following traumatic brain injury. The unknown factor is how acute injury
contributes to this degenerative process. A prominent neurotrauma related
neurodegenerative disease is chronic traumatic encephalopathy (CTE). CTE is defined by
neurofibrillary tau tangles with a perivascular distribution and mood disturbances. In
order to elucidate the pathologic changes associated with CTE, it is imperative to utilize
adequate preclinical models. We have strategically developed and tested a clinically
relevant rodent blast model. The model reliably produces a CTE phenotype including
tauopathy, cell death, impulsivity, and cognitive decline. Using this validated model, we
investigated several important secondary injury cascades that link acute brain injury to
chronic neurodegenerative changes. More importantly, we pharmacologically targeted
these pathways and found improved pathologic and behavioral outcomes. In chapter 1,
we discuss the potential mechanisms linking acute injury to CTE in athletes and soldiers.
In chapter 2, we highlight the physics behind the compression wave produced by our
model and how this wave produces injury. In chapter 3, data is presented regarding the
CTE phenotype generated by our model following repetitive blast exposure in rodents.
Chapter 4 focuses on the role of blood brain barrier disruption and how targeting protein
kinase C activity with bryostatin reduces this disruption. In chapter 5, we look at the role
endoplasmic reticulum stress plays in human pathologic specimens from patients
diagnosed with CTE and in rodents following repeat blast. We found that
docosahexaenoic acid successfully targeted endoplasmic reticulum stress, reduced
tauopathy, and improved cognitive performance. In chapter 6, we looked at lipoic acid
and its role in reducing NADPH oxidative stress following repetitive neurotrauma. We
found that lipoic acid reduces impulsive-like behavior and decreased cell death. Finally,
in chapter 7 we discuss important strategies for improving preclinical models going
forward and what needs to be investigated to improve our understanding of CTE. In this
dissertation, we highlight important secondary injury cascades including blood brain
barrier disruption, protein kinase C activity, endoplasmic reticulum stress, and oxidative
stress that warrant further investigation for the development of novel treatment
approaches for CTE.
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Chapter One
Linking traumatic brain injury to chronic traumatic encephalopathy: Identification
of potential mechanisms leading to neurofibrillary tangle development
This work is published in J Neurotrauma. 2014 Jul 1;31(13):1129-38. doi:
10.1089/neu.2013.3303. Epub 2014 Apr 11. Review. PMID: 24499307
Lucke-Wold BP, Turner RC, Logsdon AF, Bailes JE, Huber JD, Rosen CL
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ABSTRACT
Significant attention has recently been drawn to the potential link between head
trauma and the development of neurodegenerative disease, namely chronic traumatic
encephalopathy (CTE).

The acute neurotrauma associated with sports related

concussions in athletes and blast induced traumatic brain injury in soldiers elevates the
risk for future development of chronic neurodegenerative diseases such as CTE. CTE is a
progressive disease distinguished by characteristic tau neurofibrillary tangles (NFTs) and
occasionally transactive response DNA binding protein 43 (TDP43) oligomers; both of
which have a predilection for perivascular and subcortical areas near reactive astrocytes
and microglia. The disease is currently only diagnosed post-mortem by neuropathologic
identification of NFTs. A recent workshop sponsored by National Institute of
Neurological Disorders and Stroke emphasized the need for pre-mortem diagnosis to
better understand disease pathophysiology and to develop targeted treatments. In order to
accomplish this objective, it is necessary to discover the mechanistic link between acute
neurotrauma and the development of chronic neurodegenerative and neuropsychiatric
disorders such as CTE. In this review we briefly summarize what is currently known
about CTE development and pathophysiology, and subsequently discuss injury-induced
pathways that warrant further investigation. Understanding the mechanistic link between
acute brain injury and chronic neurodegeneration will facilitate the development of
appropriate diagnostic and therapeutic options for CTE and other related disorders.
KEY WORDS: chronic traumatic encephalopathy, neurofibrillary tangles
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INTRODUCTION
Neurotrauma is one of the most common injuries in contact sports and military
conflicts (Goldstein et al 2012). Each year in the United States alone, over 1.7 million
traumatic brain injuries (TBIs) occur (Gavett et al 2011b). Many of these TBIs are related
to participation in contact sports, such as football and hockey, but a high rate of
neurotrauma has also been reported for civilian and military populations in war zones
(Stern et al 2011). In fact, the US Department of Defense labeled blast induced TBI
(bTBI) as the “signature injury” of the recent wars in Iraq and Afghanistan (Goldstein et
al 2012). The estimated annual cost of treatment for bTBI in the United States is 2.5
billion dollars (Shenton et al 2012). The enormous economic burden is due, in part, to the
progressive development of cognitive, motor, and psychiatric problems in blast-exposed
veterans and civilians (Peskind et al 2013). These clinical symptoms, emerging in former
athletes and soldiers alike, are often the first measurable signs for the development of a
chronic neurodegenerative disease such as chronic traumatic encephalopathy (CTE)
(Stern et al 2011). Clinical presentation of CTE has recently been divided into two
categories: young age of onset with primarily psychiatric and behavioral problems, and
old age of onset with primarily cognitive and motor deficits (Stern et al 2013). Increased
awareness about CTE has prompted widespread investigation into the progression and
pathophysiology of this disease (McKee et al 2009).
The two populations at greatest risk for development of CTE are professional
athletes and soldiers (Peskind et al 2013). It appears that individuals with one or two
copies of the apolipoprotein ε4 (APOε4) allele have poorer outcome following head
trauma and are at increased risk for developing CTE following TBI (Spillantini et al
3
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2011). Athletes exposed to subconcussive and concussive injury, as well as soldiers
exposed to even a single blast, can develop behavioral and psychiatric problems within a
single year following injury (Bailes et al 2013). An area in need of further investigation is
how acute neurotrauma relates to and/or causes chronic neurodegenerative diseases in
susceptible individuals. In this review, we examine tau-based CTE pathophysiology and
disease progression while discussing potential mechanistic pathways that may link acute
neurotrauma with chronic neurodegenerative disease development and NFT formation.
NEUROPATHOLOGICAL FINDINGS IN CTE
Post-mortem examination is currently the only widely-utilized and accepted
method by which CTE is diagnosed clinically, although in vivo approaches have been
identified and are currently under development for diagnosis and tracking pre-mortem
(Small et al 2013, Stern et al 2011). Common neuropathologic findings of CTE include
NFTS and transactive response DNA binding protein 43 (TDP43), as well as microglial
and astrocyte activation (Lakis et al 2013). Although the mechanistic link responsible for
these pathological outcomes is not fully known, the current understanding of the
pathologic progression will be discussed in the following paragraphs (Stern et al 2013).
NFTs
Normal tau binds to tubulin and stabilizes microtubule fibrils in neurons, thereby
facilitating neurite outgrowth. When tau becomes hyperphosphorylated it binds to other
normal tau proteins, which leads to aggregation (Iqbal et al 2013). Tau
hyperphosphorylation in the central nervous system (CNS) is common after TBI and
other brain injuries (Mannix et al 2013). TBI can cause normal tau to dissociate from
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tubulin; thereby, exposing multiple phosphorylation sites (Walker & Tesco 2013).
Hyperphosphorylated tau is no longer able to bind to tubulin and translocates from the
axon to the neuron soma (Iqbal et al 2013). A primary reason for this translocation is that
normal tau is soluble while hyperphosphorylated tau becomes insoluble thus favoring a
paired helical filament arrangement that is too large to function in axons (Mannix et al
2013).

The

paired

helical

arrangement

also

leads

to

poor

clearance

of

hyperphosphorylated tau from the neuron (Walker & Tesco 2013). Accumulation of
insoluble tau within neurons contributes to the development of tau oligomers (Cowan &
Mudher 2013). Tau oligomers are granular intracellular buildups of mutated tau, which
precede the development of NFTs (Walker & Tesco 2013). When tau phosphatases can
no longer dephosphorylate oligomers efficiently, NFTs grow and eventually mature
(Whittington et al 2013). NFT maturation involves the acetylation of the lysine residue
280 (Cowan & Mudher 2013). Once NFTs fully mature, they affect large projecting
neurons in a progressive hierarchical pattern (de Calignon et al 2012). NFTs can spread
to surrounding at-risk neurons through trans-synaptic propagation or extracellular
secretion as depicted in figure 1.1 (Le et al 2012). Propagation can occur by direct
seeding of tau oligomers into the lipid rafts of cell membranes thus increasing cell
permeability and allowing access for the spread of larger secreted NFTs (Whittington et
al 2013). After NFTs propagate, the post-translational modifications become finalized
and behavioral and motor symptoms begin to surface in patients (Walker & Tesco 2013).
A likely reason for the symptomatic changes is that NFTs cause neurons to become deinnervated, in part, due to decreased neurite outgrowth, which ultimately leads to
neuronal death (Cowan & Mudher 2013).
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TDP43
Wild-type TDP43 is a nuclear RNA/DNA binding protein that regulates the
transcription of thousands of genes (Hebron et al 2013). TDP43 is predominantly found
in large motor neurons throughout the CNS (Bandyopadhyay et al 2013). TBI causes an
up-regulation of Ca2+-permeable α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid (AMPA) receptors, which in turn lead to carboxy-terminal-cleaved TDP43
fragments (Yamashita et al 2012). These fragments translocate to the cytosol mediated in
part by the process of ubiquitination (Hebron et al 2013). The fragments form
intracellular aggregates that are representative of several neurodegenerative diseases
including: Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and
CTE (Bandyopadhyay et al 2013). Aggregates sequester RNA leading to pronounced
neurotoxicity (Yamashita et al 2012). One mechanism by which neurotoxicity occurs is
TDP43 aggregate induced misfolding of Cu/Zn superoxide dismutase (SOD1), which
predisposes surrounding cells to free-radical damage (Bandyopadhyay et al 2013).
Associated clinical symptoms of TDP43 pathology include cognitive and motor
impairment (Yamashita et al 2012). Cognitive impairment may take the form of apathy,
poor impulse control, and lack of overall executive judgment (McKee et al 2010). It has
yet to be determined exactly how TDP43 aggregates coincide and interact with NFTs to
produce the wide spectrum of clinical CTE presentation seen in patients (Le et al 2012).
Astrocyte activation
Astrocytes in a healthy brain provide a supporting role for neurons (Sirko et al
2013). If brain injury occurs, astrocytes become responsive by increasing expression of a
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microfilament known as glia fibrillary acidic protein (GFAP), while simultaneously
releasing cytokines that activate nearby neurons to increase nociceptive receptivity
(Wang et al 2009). Astrocytes also trigger self-renewing neurospheres that may help in
brain recovery (Sirko et al 2013). bTBI, in particular, causes increased astrocyte
activation and GFAP levels within 24 hours post-injury (Kochanek et al 2013). Peripheral
GFAP is absorbed and sequestered from the plasma immediately following bTBI leading
to an initial decrease in serum levels at 6 hours, but GFAP is subsequently increased by
augmented gene expression and changes in membrane permeability at 24 hours (Arun et
al 2013a). The process of astrocyte activation involves an increase in astrocyte size,
number, and motility that primarily occurs in the white matter following brain or spinal
injury (Wang et al 2009). The activation is most pronounced in the corpus callosum,
motor, and somatosensory cortex leading to symptoms of increased impulsive behavior
and cognitive dysfunction (Kochanek et al 2013). One mechanism by which astrocytes
are activated following brain injury is microglia-mediated crosstalk via pro-inflammatory
cytokines (Wang et al 2009). These immune cells release interleukin-1β and other
cytokines that act on toll-like receptors (TLRs) in astrocytes; thereby, inducing astrocytes
to release reactive oxygen species (ROS) (Ferreira et al 2013). ROS indirectly cause
excitotoxicity by decreasing the ability of astrocytes to uptake glutamate (Qureshi et al
2004). This excitotoxicity was shown to cause changes in exploratory behavior and
distinct motor deficits in mice exposed to cortical impact TBI (Madathil et al 2013).
Microglial activation
Microglia are ramified immune cells of the brain that are inactive in healthy
brains (Lai et al 2013). Following repetitive TBI, localized cell death activates microglia
7
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in the striatum and thalamus, which can be measured by the markers OX6 and CD68
(Acosta et al 2013). Activated microglia have a bushy appearance with thickened
processes and enlarged cell bodies (Lai et al 2013). Furthermore, the microglia foster the
spread of neuroinflammation (Hernandez-Ontiveros et al 2013). Short-term activation of
microglia is neuroprotective, while chronic activation is involved in neurodegeneration
(Acosta et al 2013). Chronic activation becomes more common in an aged brain
accounting in part for the progressive nature of neurodegenerative diseases (Kumar et al
2013). Glial tangles (GT), for example, are prominent in the frontal and temporal lobes of
CTE brains many years after initial injury (Stern et al 2011). A primary reason for the
persistence of microglia activation is due to diffuse traumatic axonal injury (dTAI)
(Smith 2013). dTAI can cause the up-regulation of surface antigens on microglia that
ultimately triggers the release of inflammatory cytokines (Hernandez-Ontiveros et al
2013). Sensorimotor behavioral deficits following dTAI have been reported, possibly as a
result of microglia induced inflammatory tissue damage (Smith 2013).
BACKGROUND ON TAU
Tau isoforms and tau mutations
The gene responsible for encoding tau is microtubule-associated protein tau
(mapt) on chromosome 17 (Rossi et al 2014). After tau is encoded, six isoforms can form
by various splicing of exons 2, 3, or 10 on the microtubule binding domain of pre-mRNA
(Avale et al 2013). The exon 10 splice-variant, hTau40, is the most important in
neurodegenerative disease development and is found specifically in the central nervous
system (Agarwal et al 2013). The isoforms consist of three (3R) or four (4R) tau repeats
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inserted at the carboxyl terminus (Takuma et al 2003). Ideally, the ratio between 3R and
4R isoforms in the brain is maintained at 1:1 (Sadik et al 2009b). When mutations occur
in the exon 10 splice-variant, the ratio is shifted to favor an increase in the 3R isoforms
(Agarwal et al 2013). Normally, apolipoprotein E in the brain helps catalyze the
proteolytic breakdown of mutated tau and restore the ideal 3R to 4R ratio, but the APOε4
allele produces an apolipoprotein that is ineffective in this reaction (Stern et al 2011).
When mutations persist, they play an important role in NFT development and the
activation of astrocytes (Spillantini et al 2011). The altered tau proteins have widespread
pathologic consequences (Le et al 2012).
Tau kinase overview
Tau has 79 potential binding sites, and phosphorylation of these sites plays an
important role in embryonic CNS development (Kanemaru et al 1992). 30 functional sites
on the normal tau protein can be phosphorylated in the adult brain as depicted in figure
1.2, but the amount of phosphorylation is kept to a minimum by tau phosphatases
(Billingsley & Kincaid 1997). In the adult brain, tau is regulated through multi-site
phosphorylation at serine/threonine residues by proline-kinases such as extracellular
signal-regulated kinases (ERK1/2), cycline-dependent kinase 5 (CDK5), and glycogen
synthase kinase 3-β (GSK3-β) (Tsujio et al 2000). Other non proline-kinases such as
protein kinase C (PKC), c-Jun kinase (JNK), Akt, and various tyrosine kinases play a
secondary role in tau phosphorylation (Zeng et al 2010). Following TBI, tau
hyperphosphorylation is increased due to an elevation in kinases compared to
phosphatases as depicted in figure 1.3, marking an initial pathologic change that indicates
future development of chronic neurodegeneration (Liu et al 2013). The key tau kinases
9
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are described in Table 1.1 and discussed in further detail with relation to changes caused
by TBI in the following paragraphs.
ERK1/2
ERK1/2 is dephosphorylated following a single mild TBI (Kuo et al 2013). The
dephosphorylated ERK1/2 triggers apoptosis via caspase3 activation (Zhao et al 2012).
Administration of estrone after TBI triggers ERK1/2 phosphorylation and pro-survival
(Gatson et al 2012). This hormone warrants further investigation in regards to its
potential role in ameliorating tau hyperphosphorylation. Estrone may initiate a
neuroprotective priming response that protects against subsequent injury (Gatson et al
2012). Other kinases, such as p70S6K and mitogen and stress activated protein kinase 1,
may also be involved in this neuroprotective process (Chen et al 2007, Li et al 2013b).
Facilitation of ERK1/2 via the compound PD90859 can additionally foster cell survival
after brain injury (Mori et al 2002). Besides mediating the complex balance between cell
survival and apoptosis, ERK1/2 plays another unique role by regulating the cytoskeleton
of activated astrocytes following TBI (Kramerov et al 2011). ERK1/2 is therefore
important not only for tau hyperphosphorylation but also in the process of reactive
astrogliosis.
CDK5
Following TBI, CDK5 acutely binds to its receptor and activates a pro-apoptotic
cascade (Li et al 2013a). Furthermore, CDK5 triggers cell-cycle activation and microglia
activation following controlled cortical impact TBI (Kabadi et al 2012a). The extent and
duration of microglia activation mediated by CDK5 requires further investigation. It is
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known that inhibition of CDK5 with the roscovitine derivative, CR8, promotes
neuroprotection and decreased apoptosis after controlled cortical impact (Kabadi et al
2012b). Additionally, roscovitine itself can improve cognitive and motor function in
Sprague Dawley rats after TBI (Hilton et al 2008). CDK5 inhibitors even improve
outcome when administered several hours to days after TBI (Johnson et al 2010a). How
these inhibitors alter the progression of tauopathies has yet to be investigated.
GSK3-β
Protein kinase B (PKB) and serum and glucocorticoid-regulated kinase (SGK) are
activated following TBI, which both subsequently phosphorylate GSK3-β (Shapira et al
2007, Wu et al 2013). GSK3-β activation via its phosphorylation has been linked to
apoptosis and tau hyperphosphorylation (Wang et al 2013b). Furthermore, GSK3-β upregulates NMDA receptors following brain injury causing an exacerbation of glutamate
excitotoxicity (Deng et al 2014). Inhibition of GSK3-β consequently reduces apoptosis
and the extent of excitotoxicity (Dash et al 2011). Humanin is a potential inhibitor of
GSK3-β that increases neuroprotection following brain injury, but further studies are still
needed to elucidate the mechanism of action (Wang et al 2013c). GSK3-β is also
functionally significant in microglial migration, translocation of monocytes across the
BBB, and inflammatory cascades following TBI (Lyman et al 2014). GSK3-β may
therefore be a key target in discovering the link between acute brain injury and chronic
neurodegeneration due to its primary roles in both microglia migration and tau
hyperphosphorylation.
PKC
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The five most common isoforms of PKC (α, δ, ε, ζ, η) play various supporting
roles as Ser/Thr kinases throughout multiple tissues in the body (Kim et al 2003).
Activation of specific PKC isoforms (α, δ, and ζ) is associated with perturbations in tight
junction proteins following brain injury, which ultimately leads to increased BBB
permeability (Combs et al 1998). The disruption in the BBB further increases PKC
activity thereby triggering the tau kinase, GSK3-β (Martin et al 2013). PKCη additionally
activates the pro-survival tau kinase, Akt, at several days post-injury (Cho 2011). After
hyperphosphorylation occurs, PKCα maintains the phosphorylation changes by inhibiting
tau phosphatases (Combs et al 1998). PKC prompts signal cascades that work in
conjunction with altered calcium homeostasis to propel the development of NFTs (Martin
et

al

2013).

Since

PKC

involvement

is

intimately

associated

with

tau

hyperphosphorylation and NFT formation, it seems reasonable to investigate the role of
selective PKC inhibitors/activators, such as bryostatin and balonol, in the prevention of
chronic tauopathies like CTE (Zohar et al 2011).
JNK
JNK is increased in damaged axons following TBI (Tran et al 2012). JNK activity
is also markedly increased in neurons and astrocytes of the hippocampus following TBI
(Otani et al 2002). JNK signaling can cause post-traumatic cellular damage within the
brain following injury (Tran et al 2012). JNK additionally may phosphorylate p53, which
enhances neuronal autophagy (Hong et al 2012). When JNK is inhibited, the extent of
abnormal tau hyperphospharylation is lessened (Tran et al 2012). Furthermore, glucagon
has been used to inhibit JNK signaling immediately after TBI causing a decrease in
intracranial cerebrovasodilation (Armstead et al 2012). Maintaining JNK signaling within
12
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a tightly controlled range is not only important for tau regulation but also for maintaining
blood flow to the brain following TBI (Armstead et al 2011).
Akt
Akt produces an interesting effect following brain injury by phosphorylating tau
at Ser212, but also inhibiting GSK3-β (Ksiezak-Reding et al 2003). GSK3-β activation
may therefore be necessary for initial tau hyperphosphorylation, but Akt activity
maintains hyperphosphorylation at later time points (Zeng et al 2010). By inhibiting
GSK3-β, it is thought that Akt triggers an anti-apoptotic pathway allowing for damaged
cells to survive and propogate NFTs (Ksiezak-Reding et al 2003). If Akt is inhibited, cell
death will occur (Farook et al 2013). Histone deacetylase inhibitors, such as Scriptaid,
prevent the dephosphorylation of Akt, and therefore increase the number of surviving
neurons after TBI (Wang et al 2013a). Akt regulation warrants further investigation to
tease out the level of activation that is necessary for maintaining neuroprotective
properties while avoiding the spread of NFTs.
Tau phosphatases
Two phosphatases, protein phosphatase 1 and 2A, are responsible for maintaining
tau in a non-hyperphosphorylated state (Billingsley & Kincaid 1997). If these two
phosphatases become dysfunctional or decreased, the hyperphosphorylated tau is quickly
ubiquitinated, which then predisposes the neuron to increased NFT formation (Lambrecht
et al 2013). TBI can cause a decrease in tau phosphatases (Kane et al 2012). In particular,
protein phosphatase 2A is decreased in the hippocampus for several weeks post-TBI,
which results in dysfunctional hippocampus plasticity (Bales et al 2010). Tau
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phosphatase activity must drop by half before NFTs will begin to develop (Lambrecht et
al 2013). Compounds that increase tau phosphatases, such as sodium selenate, may prove
promising in slowing the progression of tauopathies (Corcoran et al 2010).
DISCUSSION
Although the post-mortem pathology of CTE has been well described, the
mechanism by which acute TBI leads to initial tau hyperphosphorylation and the eventual
development of neurofibrillary tangles remains poorly understood. Since the term CTE
was only recently reintroduced into the medical literature in 2005, understanding disease
pathophysiology is in its infancy (Omalu et al 2005). Despite the link between TBI and
CTE being associational rather than mechanistic at this point, the growing prevalence of
this disease amongst soldiers, football players, wrestlers, and other athletes exposed to
head injuries increases the urgency for finding a causative mechanism, and furthermore
locating pharmacologic targets for treating this devastating disease. In the following
paragraphs, we discuss a few molecular pathways previously associated with other forms
of brain injury that warrant further investigation following TBI.
Endoplasmic reticulum stress
The endoplasmic reticulum (ER) is responsible for the correct folding and sorting
of proteins (Rubovitch et al 2011). Following brain injury, the ER becomes
dysfunctional, as evidenced by changes in bound intracellular calcium, leading to the
accumulation of unfolded proteins within the cell (Osada et al 2009). The increase in
unfolded proteins is known as the ER stress response (Cullinan & Diehl 2006). Ischemic
stroke and TBI can both cause acute activation of the ER stress response (Srinivasan &
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Sharma 2012). Three arms of the ER stress response (protein kinase-like ER kinase
(PERK), inositol requiring enzyme 1α (IRE1α), and activating transcription factor 6
(ATF6)) regulate the amount of pro-apoptotic activity following injury (Rubovitch et al
2011). All three arms affect the protein expression of C/EBP-homologous protein
(CHOP) (Osada et al 2009). CHOP is noteworthy for its ability to trigger apoptosis via
the activation of caspase12 (Srinivasan & Sharma 2012). If CHOP is maintained belowthreshold by the PERK arm, neuronal apoptosis does not occur (Cullinan & Diehl 2006).
When CHOP is pushed beyond threshold through activation of the IRE1α and ATF6
arms, neuronal apoptosis does occur, and tau hyperphosphorylation results from GSK3-β
(Hoozemans et al 2009). Furthermore, two downstream targets of the ATF6 arm of the
ER stress pathway are MAPK and JNK, which may subsequently be involved in tau
hyperphosphorylation as well (Krajewska et al 2011). In light of these findings, it may
prove beneficial to utilize a pharmacologic agent that attenuates the ER stress response in
a model of TBI. Salubrinal can increase activity of the neuroprotective PERK arm of the
ER stress response and inhibit the pro-apoptotic activity of the IRE1α arm of the ER
stress response (Gong et al 2012). Since GSK3-β and caspase12 are increased following
brain injury, it may also be worth investigating the GSK3-β peptide inhibitors, L803-mts
and TDZD-8, and the role they may play in preventing the development of NFTs
(Hoozemans et al 2009, King et al 2014).
Glutamate excitotoxicity
Glutamate excitotoxicity is triggered following brain injury and results in elevated
intracellular calcium, formation of reactive oxygen species, and mitochondrial failure
(Wagner & Zitelli 2013). Ischemia and other forms of brain injury can cause an increase
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in calcium that activates α-calcium/calmodulin protein kinase II, leading to memory
impairment via increased AMPA receptor activity in the hippocampus (Atkins et al
2006). The increased calcium also leads to intracellular accumulation in neuronal
mitochondria, making the organelle dysfunctional (Wagner & Zitelli 2013). Activated
microglia and astrocytes concurrently release interleukin-6, which triggers a further
increase in intracellular calcium within neurons and sensitizes N-Methyl D-aspartate
(NMDA) receptors (Ma et al 2013). Sensitized NMDA receptors promote auxiliary
excitotoxicity and foster the release of reactive oxygen species from the mitochondria,
which can eventually cause neuronal destruction (Qureshi et al 2004). Caspase3, a proapoptotic factor, is increased following glutamate induced mitochondria dysfunction
(Srinivasan & Sharma 2012). Caspase3 can cause tau cleavage and predisposes the
neuron to NFT development (Hoozemans et al 2009). To stem the tide of neuronal
destruction and progressive tau changes, it seems befitting to investigate compounds that
are known to decrease the amount of reactive oxygen species such as the NADPHoxidase inhibitor, apocynin (Ferreira et al 2013). Furthermore, targeting mitochondrial
dysfunction through p38 inhibitors may also prove beneficial following head trauma
(Huang et al 2013). By targeting key downstream pathways of glutamate excitotoxicity, it
may be possible to alleviate the potential progression to neurodegeneration.
Microglial and astrocyte regulators
Neurotrauma can result in a dynamic equilibrium between classically activated
(M1) and alternatively activated (M2) microglia (Acosta et al 2013). M1 microglia are
pro-inflammatory while M2 microglia are anti-inflammatory (Smith 2013). Targeting the
activation of M2 microglia immediately following injury may prove beneficial in
16

!
preventing neurodegeneration (Kuo et al 2008). Alternatively, acutely inhibiting M1
microglia with the noncompetitive cholinesterase inhibitor, donepezil, has also decreased
neuroinflammation and apoptosis after TBI (Hwang et al 2010). Similarly, neurotrauma
triggers two distinct responses, pro-survival or apoptosis, in activated astrocytes
depending on the extent and duration of injury (Kochanek et al 2013). If astrocyte
activation extends several days post-injury, it was found that nitration of tau occurs,
which may lead to a more rapid development of NFTs (Reyes et al 2008). Furthermore,
mutations in tau may be occurring in activated astrocytes, resulting in tau oligomers
being subsequently secreted into the extracellular milieu (de Calignon et al 2012). Future
studies are needed to characterize the time-course of astrocyte activation following TBI,
and more importantly at what point it is ideal to inhibit astrocyte activation.
CLINICAL RELEVANCE AND CONCLUSIONS
The Veterans Affairs Healthcare System reported that patients exposed to
repetitive blast waves have quantitative electroencephalogram changes that are
comparable to concussive injury (Tompkins et al 2013). Similarly, the detection of
repetitive concussions in athletes has increased significantly over the past 20 years (Small
et al 2013). The duration between injuries may account for why certain individuals
develop rapidly progressive neurodegeneration and increased phospho-tau expression
(Mannix et al 2013). The Department of Defense has recently invested 700 million
dollars into improving clinical diagnosis and care for the 266,810 bTBI patients who
were injured from 2001 onwards (Tompkins et al 2013). Likewise, the National Football
League has recently organized a new medical committee to investigate the issue of TBI,
and started a multi-prong approach for making football safer for the players (Ellenbogen
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et al 2010). Increased investigation into understanding the pathology of CTE will
hopefully aid in pre-mortem diagnosis as well as finding viable treatment options. The
pathways mentioned in this review (ER Stress, glutamate excitotoxicty, and microglia
and astrocyte modulation) appear promising in understanding the link between acute
bTBI and CTE development. Discovering the process of tau hypephosphorylation and
NFT development following TBI will likely provide a key for unlocking the unknown
mysteries of similar progressive neurodegenerative diseases.
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Figure 1.1: Traumatic Brain Injury can lead to diffuse traumatic axonal injury and blood
brain barrier disruption. Shearing of axons results in the disruption of tau binding to
tubulin. Subsequent hyperphosphorylation of tau leads to formation of tau oligomers in
the neuronal soma. Eventually, neurofibrillary tangles form and are secreted into the
extracellular milieu or spread to other neurons via trans-synaptic propagation. Concurrent
with axonal shearing, traumatic brain injury can cause a rapid blood pressure spike
resulting in blood brain barrier disruption. The disruption leads to an inflammatory
cascade as well as microglia and astrocyte activation. Microglia and astrocyte activation
in conjunction with tauopathy contribute to the pathology of chronic traumatic
encephalopathy.
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Figure 1.2: Tau is regulated by multiple biochemical processes including: nitration,
glycosylation, ubiquitination, acetylation, sumoylation, and phosphorylation. A. We
highlight some of the key regulation sites potentially involved in the pathophysiology of
chronic traumatic encephalopathy. B. Each site has a specific antibody of interest that can
be used to detect changes in intracellular/extracellular tau. C. Deglycosylation allows for
conversion of tau tangles into bundles of straight filaments, thus increasing the
accessibility of remaining tau located at microtubule edges. Glycosylation however
reduces phosphorylation of PKA, CDK5, and GSK3B decreasing formation of
neurofibrillary tangles. This example shows how post-translational modification of tau
can regulate tau phosphorylation and ultimately lead to the development of
neurofibrillary tangles, a hallmark of CTE.
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Figure 1.3: Neurofibrillary tangle formation involves an imbalance between tau kinase
and tau phosphatase activity. If tau kinase activity is increased and the phosphatase
activity is decreased, hyperphosphorylation persists and can result in the formation of
neurofibrillary tangles. Neurofibrillary tangles contribute to poor outcome by disrupting
axonal transport and eventually causing the hierarchical spread of neurodegeneration.
Neurodegeneration ultimately causes the classic symptoms seen in patients suspected of
having chronic traumatic encephalopathy.
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Table 1.1
Kinase Name:
ERK1/2

Site of Regulation:
Phosphorylation of

Physiological Role:
Important role in

Activated by TBI:
Yes (Kuo et al

threonine-x-tyrosine

growth factor

2013)

motif

signaling, cell
survival, and
apoptosis

CDK5

Binding to CDK

Plays a role in

Receptor 1 or CDK

neural development,

Receptor 2

pain signaling, and

Yes (Li et al 2013a)

sensory processing
GSK3-β

Requires priming

Implicated in

Yes (Shapira et al

kinase to

neuronal

2007)

phosphorylate a

development,

substrate prior to

glucose

phosphorylation at

homeostasis, and

tyrosine-216.

body pattern

Phosphorylation at

organization

serine-9, however,
hides the active site
PKC

3 categories based on

PKC activity is

binding at C-terminal: involved with
conventional requires

learning and

diacyl-glycerol and

memory, regulation
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calcium for

of transcription,

activation, novel

controlling cell

requires diacyl-

growth, and

glycerol, and atypical

mediating immune

does not require

responses

calcium or
diacylglycerol. Once
active, the receptors
for activated C-kinase
bind PKC and help
translocate it to the
plasma membrane
JNK

Diphosphorylation of

JNKs participate in

Yes (Tran et al

the threonine-proline-

multiple stress

2012)

tyrosine motif

cascades, the
inflammation
response, and
reactive oxygen
species formation

AKT

Akt binds to

Akt plays a role in

Yes (Ksiezak-

phosphatidylinositol

apoptosis, cellular

Reding et al 2003)

(3,4,5)-triphosphate

metabolism, and cell

on the cell membrane

migration
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and then is
phosphorylated at
threonine 308 by
phosphoinosotide
kinase 1

Table 1.1 Legend: Table 1.1 provides a list of tau kinases and the physiologic roles in
which they function. In addition, it highlights if the overall levels of these kinases are
altered by traumatic brain injury.
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Chapter Two
Elucidating the role of compression waves and impact duration for generating mild
traumatic brain injury in rats
Submitted to Brain Injury: accepted pending minor revisions.
Lucke-Wold BP, Phillips M, Turner RC, Logsdon AF, Smith KE, Huber JD, Rosen CL,
Regele JD
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ABSTRACT
1.7 million concussions occur each year in the United States. The mechanisms
linking acute injury to chronic deficits are poorly understood. Mild traumatic brain injury
has been described clinically in terms of acute functional deficits, but the underlying
histopathologic changes that occur are relatively unknown due to limited high-function
imaging modalities. In order to improve our understanding of acute injury mechanisms,
appropriately designed preclinical models must be utilized. The clinical relevance of
compression wave injury models revolves around the ability to produce consistent
histopathologic deficits. Repetitive mild traumatic brain injuries activate similar
neuroinflammatory cascades, cell death markers, and increases in amyloid precursor
protein in both humans and rodents. Humans however infrequently succumb to mild
traumatic brain injuries and therefore the intensity and magnitude of impacts must be
inferred. As accelerometers become more widely used in athletics, it is imperative that
the physical and mechanical properties of pre-clinical concussion models be determined.
This increased understanding could link the histopathologic deficits seen in rodents to
what might be happening in human brains following repetitive concussions. Advances in
mathematical and computer modeling can help characterize the wave properties
generated by the compression wave model. While this concept of linking duration and
intensity of impact to subsequent histopathologic deficits makes sense, numerical
modeling of compression waves has not been performed in this context. In this
collaborative interdisciplinary work, numerical simulations were performed to study the
creation of compression waves in our experimental model. This work was conducted in
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conjunction with a repetitive compression wave injury paradigm in rats in order to better
understand how the wave generation correlates with validated histopathologic deficits.
KEY WORDS: Finite Volume Modeling, Compression Wave, Traumatic Brain Injury,
Apoptosis, Pre-clinical Model
INTRODUCTION
It has been estimated that 1.7 to 3.4 million concussions occur each year in the
United States (McClure et al 2014). How mechanical forces cause brain injury and
initiate injury cascades is poorly elucidated. Therefore, a diagnosis of concussion is
primarily based on observable symptomatic changes (McCrea et al 2003). It is currently
unknown how many athletes and soldiers are at risk for developing chronic traumatic
encephalopathy (Bailes et al 2015). Chronic traumatic encephalopathy is a degenerative
tauopathy characterized by mood disorders and cognitive deficits (McKee et al 2009).
The biochemical mechanisms linking acute injury to behavioral deficits and the
development of neurodegeneration over time warrants further investigation (Lucke-Wold
et al 2014c). Banks and colleagues are conducting the first prospective cohort study to
determine the incidence of chronic traumatic encephalopathy in mixed martial arts
fighters (Banks et al 2014). Laboratory research can also provide important discoveries
for how acute injury contributes to tauopathy. Most importantly, laboratory studies allow
for a comparison of force dynamics to observed physiologic changes post-injury(Hua et
al 2015).
In order to improve our understanding of mild traumatic brain injury, it is
necessary to utilize pre-clinical models that produce relevant pathologic changes
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consistent with human brain injury. In previous papers, we have described acute
biochemical changes that occur within a rat’s brain following compression-wave injury.
These changes include blood brain barrier disruption, endoplasmic reticulum stress, and
oxidative stress (Logsdon et al 2014, Lucke-Wold et al 2014a, Lucke-Wold et al 2015a).
Recently, we discovered that these acute pathways are implicated in the development of
tauopathy, and contribute to long-term cognitive and behavioral deficits (Turner et al
2015). These deficits in humans can manifest as post-traumatic epilepsy, sleep
disturbances, and increased risk for suicide (Lucke-Wold et al 2015b, Lucke-Wold et al
2015c, Wasserman et al 2008). In this multidisciplinary project, we sought to delineate
the wave dynamics associated with our clinically relevant model and correlate the wave
properties to observed histopathologic changes within the rat’s brain post-injury.
Simulation and numerical modeling can be used to enhance our understanding of the
wave properties and impact force experienced by the rat. These properties are critical for
determining how mechanical injury causes lasting damage that ultimately leads to
behavior changes.
METHODS
Tabletop model
The model consists of steel driven and driver section with a mylar membrane
sandwiched in-between. The driven and driver section are screwed tight prior to rupturing
the membrane. The apparatus is securely attached to a table and the 0.005” membrane
was scored with a hand press prior to use. The intensity of the compression wave was
determined by a pressure gage attached to a regulator. Nitrogen gas was used to rupture
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the membrane. The pressure was allowed to build via a needle nose attachment and
regulator prior to rupture. The compression tube has a short driver section in order to
generate a short-duration wave. Piezoelectric sensors (Model 102AO5; PCB
Piezotronics) were placed in the reflected and two incident positions near the exit of the
shock tube to produce a linear configuration as shown in figure 2.1. To test for planarity,
the three sensors were placed at the edge of the tube. Data was recorded using a sensor
signal conditioner (482C Series; PCB Piezotronics) and a data acquisition board (DAQ
23GF; National Instruments). A computer program written with LabView version 12.0
(National Instruments) was used for analysis. The anesthetized rats head was placed at
the same position as sensor two. A polyvinyl tube to protect the thoracic cavity from
wave exposure protected the body.
Numerical approach
Numerical simulations are used to reconcile pressure profiles with the
experimental setup in order to characterize wave formation. The tube and the surrounding
air may generally be modeled by the compressible Navier-Stokes equations describing
fluid flow. The flow produces a shock wave and an expansion wave propagating into
stationary flow at atmospheric conditions. The timescales of both phenomena are small
relative to the timescale of the viscous/diffusive terms within the Navier-Stokes
equations. It follows that the boundary layers formed near the interior of the compression
tube will have a minimal influence on the flow. Thus, the non-viscous Euler equations
are used to simulate the compression waves generated from the tabletop compression
tube.
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The Euler equations listed in conservation form are:
𝜕𝑼𝜕𝑡+𝜕𝑭𝒙𝑼𝜕𝑥+𝜕𝑭𝒚𝑼𝜕𝑦=0.
where,
𝑼=𝜌𝜌𝑢𝜌𝑣𝜌𝑒𝑇, 𝑭𝒙=𝜌𝑢𝜌𝑢2+𝑝𝜌𝑢𝑣𝜌𝑒𝑇+𝑝𝑢, 𝑭𝒚=𝜌𝑣𝜌𝑢𝑣𝜌𝑣2+𝑝𝜌𝑒𝑇+𝑝 𝑣.
The conservative variables inside the vector 𝑼 represent density, 𝜌, x-momentum, 𝜌𝑢, ymomentum, 𝜌𝑣, and total energy, 𝜌𝑒𝑇. The total energy per unit mass may be defined as
the summation of the internal and kinetic energy:
𝑒𝑇=𝑝𝜌𝛾−1+12𝑢2+𝑣2.
An ideal gas equation of state 𝑃=𝜌𝑅𝑎𝑖𝑟𝑇 is used to close the system of equations.

The compression tube is modeled using an axisymmetric geometry, which
reduces computation time by solving for a three-dimensional flow field on a twodimensional domain. The computational domain illustrated in figure 2.2 shows the
compression tube with a large domain at the compression tube exit to capture the
propagation of the blast wave after it exits the tube. The surrounding fluid region is
chosen to be large enough to capture the transient evolution of the compression wave past
the sensor two location without experiencing any interactions with the domain boundaries
until much later.
The burst of the diaphragm is modeled by using a discontinuous initial condition
where the pressure is higher in the driver section and lower outside. The initial velocity is
zero and the initial temperature is 20°C everywhere. The initial conditions across the
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diaphragm are 110 psi in the driver section at atmospheric conditions, with 14.7 psi in the
driven section and the domain outside the tube.
The governing equations are solved numerically using Star-CCM+. The WeissSmith Precondition Roe’s Scheme (Weiss et al 1999) is used to discretize the physical
domain into cells, and the governing equations are solved with a finite volume scheme.
The scheme uses a multidimensional linear reconstruction to calculate the fluxes at each
cell edge. The reconstruction uses a Taylor series expansion at the cell face to retain
higher order accuracy. A multiple stage Runge-Kutta second order explicit scheme is
utilized for the time integration (Huang & Ayoub 2008). The time-step used in each
simulation is determined using the Courant-Freidrich-Lewis (CFL) number. The CFL
number is defined
𝐶𝐹𝐿=(𝑢+𝑐)𝛥𝑡𝛥𝑥,

where 𝑢 and 𝑐 are local fluid velocity. The maximum CFL inside the domain was used to
choose the time-step. The CFL number used for the simulations in this work is 0.5.
A range of grid spacing is used in this work and range from 0.3175 cm to 0.0595
cm. A grid sensitivity study is performed to ensure that the solution is not grid dependent.
Computing the 𝐿2 norm assesses grid sensitivity. The 𝐿2 error is typically calculated by
comparing the solution for the different mesh refinements to an exact solution. Since no
exact solution is available, the solution with the finest mesh is used as an exact solution.
The 𝐿2 error may be represented as,
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𝐿2=∫𝑃𝑀𝑒𝑠ℎ−𝑃𝐸𝑥𝑎𝑐𝑡2 𝑑𝑥0.5
The 𝐿2 error value represents the error over an entire domain with individual
contributions from each cell.
Animals
The Institutional Animal Care and Use Committee at West Virginia University
approved all experiments involving animals. The experiments were conducted in
accordance with the Guide for the Care and Use of Laboratory Animals. Sixteen (16)
young-adult male Sprague dawley rats (Hilltop Lab Animals, Inc.) were used for
immunohistochemistry (IHC). The rats were divided into two groups: repeat injury (6
compression waves every other day over 2 weeks) and anesthetized (4% isoflurane with
2% maintenance) control. Repeat injury exposure was performed with the 0.005”
membrane according to the methods previously described (Turner et al 2013). A power
analysis was conducted (DSS Research) with the equation n=1+[2C(s/d)2], where C is a
value dependent upon the a and b values chosen. For this study a=0.05 and b=0.2 for a
power of 1-b=0.8. C(0.05, 0.8)=7.85 (obtained from table). The number needed is based on
effect size and standard deviation, which was estimated from previous work. Rats were
housed with a 12h:12h light to dark cycle and food and water available ad libitum.
Immunohistochemistry
Animals were anesthetized as described above followed by decapitation. The
brain was removed and immediately flash frozen in isopentane and stored at -80°C.
Brains were sliced to a thickness of 20µm using a cryostat. Standard Hematoxylin and
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Eosin, Fluorojade B, Thioflavin, and DAB (Sigma Aldrich) staining protocols were
utilized to stain for cellular morphology and Amyloid precursor protein (APP) (Cell
Signaling).
Images were obtained from a blinded observer using a Zeiss Axio Imager 2 and
an Olympus MVX10 for brightfield and fluorescent imaging. For immunohistological
DAB stains, 100 total cells were counted in the stereologic selected region of interest
within the prefrontal cortex and determined to be either expressing or non-expressing.
The ratios between groups were compared using chi-squared analysis. For fluoroscent
stains, a blinded observer used image J quantification. The measurements were adjusted
for background giving corrected total cell fluorescence. The total cell fluorescence was
compared between groups.
Statistical analysis
Data were analyzed using GraphPad Prism version 4.0. An observer blinded to
experimental group did imaging quantification. A student’s t-test was used to compare
across control and repeat injury groups for fluorescent imaging. A χ2 analysis was used
for DAB staining. A p-value of <0.05 was considered statistically significant for all
studies.!
RESULTS
Compression wave formation
Figure 2.2 shows a sequence of pressure contours, which illustrate the formation
and propagation of a traditional blast wave. At t=0, the diaphragm separates the fluid
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inside the driver section from the fluid inside the driven section. The fluid inside the
driver section is at higher pressure than the atmospheric pressure in the driven section.
Once the diaphragm bursts, the t=0.1 ms frame shows that a shock wave moves to the left
and an expansion wave moves to the right. At t=0.3 ms the shock wave has exited the
tube and expands in all directions. The exit of the shock wave creates an expansion wave
that moves inside the shock tube. The induced flow from the shock wave as it propagates
to the left further away from the compression tube creates a low-pressure region behind
the shock wave. This region is where the pressure drops below atmospheric pressure.
A one-dimensional axis is selected down the center of the compression tube to
evaluate the error. The pressure values along the axis are compared between different
mesh refinements at a physical time of 1 ms. Figure 2.3 shows the 𝐿2 error as a function
of grid spacing on a log-log scale. The solution with the finest resolution is used as an
exact solution. Figure 2.3 also shows that the slope is 1.841, which indicates that the
solution is converging at a rate between first and second order accuracy. This
convergence rate is consistent with the scheme’s accuracy since the reconstruction step
makes the solution second order accurate everywhere except for discontinuities such as
shocks and contact discontinuities.
Figure 2.4 shows a contour plot of pressure on an x-t diagram using the solution
data located along the axis in the center of the compression tube. The green dashed lines
in figure 2.4 represent the analytical solution for an ideal one-dimensional compression
tube. Looking exclusively at the shock wave and the head of the expansion wave
propagation, both phenomena are represented relatively accurately compared to a purely
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1-D shock tube case. It may also be seen that the expansion wave reflects off the driver
wall at t=0.4 ms and begins propagating in the direction of the shock wave. The solid
blue lines represent the end of the compression tube and the initial diaphragm location.
When the shock exits the compression tube at t=0.149 ms an expansion wave is created
as the wave expands radially outward in all directions. The contour shows that the
pressure behind the transmitted compression wave decays with distance from the tube
exit. The red dashed lines represent the locations of each of the pressure transducers in
the experiment.
Pressure sensors
Pressure readings are obtained using pressure taps at specific locations within the
compression tube and at the location where the rat will be placed. Figure 2.1 provides the
geometry and location of each of the sensors from the experiment.!The pressures versus
time profiles were analyzed for each pressure sensor placed linearly. The waves were
mapped and quantified with MATLAB as previously published (Turner et al 2013).
Three transducers were then placed in the same plane at the edge of the tube. These three
transducers showed variation in the pressure histories, which suggests that non-planar
shock waves are produced. This non-planar wave behavior is likely caused by
inconsistent burst patterns of the diaphragm. The diaphragms are scored in similar
patterns with a press to improve the planarity of the wave. Since there is some planar
variability in pressure histories from case to case, an average pressure history is
calculated using 7 membrane ruptures. The averaged pressure histories are then readily
compared with the simulation results.
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Pressure profiles
The pressure profiles for each sensor are shown in figure 2.5 for both the
averaged experimental data and the numerical simulation. The pressure histories of the
experimental data were shifted to match time of peak pressure occurrence. The time shift
allows an average between pressure profiles and direct comparison between the averaged
experiment and the simulation.
The third sensor shows the same general trend between the experiment and the
simulation. The over-pressure does not reach the peak value observed in the simulation
and the rise time is finite. The lower peak pressure and more gradual pressure increase
indicate a wave that more closely resembles a strong compression wave. This is likely
due to incomplete or partial diaphragm rupture. However, since the pressure ratio across
the diaphragm is sufficiently large to create a shock (approximately 7.5), the wave
created inside of the tube from the diaphragm burst will still be regarded as a shock wave.
It can also be seen that the time scale of the pressure recovery matches between the
simulation and the experiment. This pressure recovery occurs from the shock exiting the
tube and the expansion wave travels inside.
The first sensor is near the exit of the tube and shows a similar behavior between
the experiment and the simulation. The peak of the simulation is almost twice the
magnitude of the experiment. Similar to the third sensor, the first sensor pressure
recovery timescale is consistent between the experiment and the simulation.
The second pressure sensor is oriented for the experiment as a reflected sensor
where the pressure transducer is pointed into the flow direction. The pressure tap is held
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within a large metal plate approximately 2 inches from the end of the shock tube. As can
be expected, the pressure trace for sensor two shows that the experiment and numerical
model are consistent on the arrival time of the blast wave at the transducer two location.
Beyond this time the two pressure histories deviate because the numerical simulation
does not model a reflecting plate. Instead, the numerical simulation measures what the
pressure profile would be in the absence of an object that alters the wave profile. In the
experiment, the pressure rises much higher and retains that high pressure for
approximately 1.5 ms. This higher pressure rise occurs because of the wave reflection
that occurs at sensor 2 from the wall plate. It should be noted that the reflection of the
wave alters the wave profile to make the wave duration much longer than an unobstructed
wave. This suggests that very different pressure histories may be recorded for the same
compression wave depending upon the pressure transducer placement and geometry.
Immunohistochemistry
Compression wave TBI can lead to long-term changes in the brain. Neurons are
acutely injured and can undergo apoptosis or survive with aggregated proteins. We show
nuclear fragmentation, pyknotic nuclei, blebbing, and chromatolysis in the contralateral
prefrontal cortex of repeat TBI animals compared to control animals (Figure 2.6 A-B). A
significant increase in amyloid precursor protein was also seen 72 hours post repeat TBI
(41/100) compared to controls (2/100) in the contralateral prefrontal cortex χ2 = 81,
p<0.001 (Figure 2.6 C-D). In addition to apoptosis, damaged tissue can degenerate over
time. Fluorojade B was used to mark early signs of neurodegeneration. We found a
significant increase in the contralateral prefrontal cortex at 72 hours post repeat TBI
compared to controls t=8.96, p<0.001 (Figure 2.7 A-B). We also found a significant
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increase in fluorojade B in the contralateral hippocampus 72 hours post repeat TBI
compared to controls t=3.22, p<0.01 (Figure 2.7 C-D). The compression wave caused
significant

degeneration

in

the

contralateral

hemisphere

due

to

rapid

acceleration/deceleration forces. Finally, a significant increase in thioflavin staining was
seen in the prefrontal cortex following repetitive TBI 72 hours post-injury compared to
controls t=3.636, p<0.01 (Figure 2.7 E-F). Thioflavin marks increased tau
hyperphosphorylation and protein aggregation.
DISCUSSION
Panzer and colleagues recently urged for better understanding of pre-clinical TBI
models and how these models produce head injury (Panzer et al 2012). Gupta proposed
that the most clinically relevant understanding of TBI is to determine how compression
waves penetrate into tissue (Gupta & Przekwas 2013). The numerical simulations
contained in this work show that the tabletop model produces a pressure wave consistent
with a compression wave. The expansion wave is created after the shock wave exits the
shock tube and combines with the shock wave to produce the compression wave. The
simulation results correlated well with the model recordings for sensor one and sensor
three. The wave duration for the numerical simulation at the sensor two location was five
times shorter than that observed from the averaged pressure transducer history. This
suggests that obstacles in the flow can significantly alter incident wave profiles.
Compression waves such as these can cause rapid acceleration/deceleration contributing
to damage at density gradients within the brain (Boulet et al 2011). This type of injury
from compression waves is most frequently seen in clinics due to athletic concussions
and motor vehicle collisions (DeKosky et al 2013). In this multidisciplinary paper, we
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show that the tabletop model creates compression waves and that these waves cause
significant acceleration/deceleration injury measured with immunohistochemistry.
The acceleration/deceleration can cause shearing of vessels and axons (Su & Bell
2016). We observed significant increases in amyloid precursor protein and thioflavin
after repetitive TBI showing damage from axonal shearing and persistent neuronal injury.
Likewise H&E and fluorojade B staining revealed increased cell death and nuclear
damage consistent with compression wave penetration into tissue. The damage was
particularly pronounced at the white/grey junction within the cortex and within the
hippocampus. It is therefore representative of an impact producing substantial coup and
contra-coup effects due to the acceleration/deceleration of the skull over time (Ommaya
et al 1971). Readnower and colleagues observed substantial disruption of the blood brain
barrier on the ipsilateral hemisphere following blast exposure likely due to a longer
duration

compression

wave

(Readnower

et

al

2010).

Due

to

the

rapid

acceleration/deceleration seen with our model, we observe the disruption in the BBB on
the contralateral hemisphere where the brain collides acutely with the skull (Lucke-Wold
et al 2014a). The coup/contre-coup phenomenon is much more relevant to what is seen in
the clinical setting instead of models using a fixed skull (Sato et al 2014).
Going forward, the use of advanced animal imaging can help determine the extent
and progression of injury over time following exposure to repetitive compression waves
(Tompkins et al 2013). Functional magnetic resonance imaging would help detect some
of the more subtle differences produced by the injury that is not as readily detected by
traditional assays. These changes could then be mapped in conjunction with advanced
simulation techniques. Finite element and finite volume modeling are needed to further
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map the waves progression through the skull and into the brain (Jean et al 2014).
Combining the computational modeling with in vivo injury data will continue to require
interdisciplinary collaboration (Ganpule et al 2013). The development of these
multidisciplinary

teams

is

necessary

to

address

the

complexities

of

acceleration/deceleration neurotrauma. By developing better understanding of pre-clinical
models, important injury factors relevant to the brain such as duration until degeneration,
number of impacts needed for cognitive decline, and the time scale of acute injury
cascades initiated post-injury can be determined. We provide evidence that compression
waves cause acceleration/deceleration injuries consistent with those seen clinically.
CONCLUSION
The use of numerical modeling provides a unique understanding of the wave
dynamics generated by our TBI model. The model reliably produces compression waves.
The wave is of sufficient duration and force to cause both acceleration/deceleration and
direct penetration. The injury profile outlined by immunohistochemistry confirms that
cell death, axonal shearing, and tau hyperphosphorylation occurs following repetitive
injury. These injury patterns may provide important clues for what is occurring in the
brains of athletes following repetitive injuries. The use of advanced imaging will improve
the ability to correlate between pre-clinical models and human pathology.
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Figure 2.1: Geometry of Sensor Layout. A two dimensional representation shows the
geometrical configuration of the problem.
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Figure 2.2: Contour Plot 2D Pressure. Domain pressure profile shown at different times
provides initial conditions and follows the shock and expansion wave development and
propagation.
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Figure 2.3: L2 Error. A log-log plot shows converging simulation results with increasing
grid resolution.
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Figure 2.4: x-t Diagram. An x-t pressure contour plot shows the evolution of the shock
and expansion waves after the diaphragm bursts.
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Figure 2.5: Pressure vs. Time by Sensor. A line plot provides a comparison between
experiment and simulation. The experiment uses pressure taps to measure gage pressure
while the simulation uses a point probe to measure static pressure.
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Figure 2.6: Acute Pathophysiology. H&E staining reveals nuclear enlargement and
fragmentation in the contralateral prefrontal cortex 72 hours post repetitive TBI. A
significant increase in APP was also observed χ2 = 81, p<0.001. Scale bar = 20µm.
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Figure 2.7: Neuronal Degeneration. A significant increase in fluorojade B was seen in
the contralateral prefrontal cortex and hippocampus 72 hours following repetitive TBI.
Thioflavin shows tau hyperphosphorylation and protein aggregation 72 hours following
repetitive TBI. **=p<0.01, ***p<0.001. Scale bar = 50µm.
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Chapter Three
The quest to model chronic traumatic encephalopathy: A multiple model & injury
paradigm experience
This work is published in Front Neurol. 2015 Oct 20;6:222. doi:
10.3389/fneur.2015.00222. eCollection 2015. PMID: 26539159
Turner RC, Lucke-Wold BP, Logsdon AF, Robson MJ, Dashnaw ML, Huang JH, Smith
KE, Huber JD, Rosen CL, Petraglia AL
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ABSTRACT
Chronic neurodegeneration following a history of neurotrauma is frequently
associated with neuropsychiatric and cognitive symptoms. In order to enhance
understanding about the underlying pathophysiology linking neurotrauma to
neurodegeneration, a multi-model pre-clinical approach must be established to account
for the different injury paradigms and pathophysiologic mechanisms. We investigated
the development of tau pathology and behavioral changes using a multi-model and multiinstitutional approach, comparing the pre-clinical results to tauopathy patterns seen in
post-mortem human samples from athletes diagnosed with chronic traumatic
encephalopathy (CTE). We utilized a scaled and validated blast-induced traumatic brain
injury model in rats and a modified pneumatic closed-head impact model in mice. Tau
hyperphosphorylation was evaluated by western blot and immunohistochemistry.
Elevated plus maze and Morris water maze were employed to measure impulsive-like
behavior and cognitive deficits respectively. Animals exposed to single blast (~50 PSI
reflected peak overpressure) exhibited elevated AT8 immunoreactivity in the
contralateral hippocampus at 1 month compared to controls (q = 3.96, p < 0.05). Animals
exposed to repeat blast (6 blasts over 2 weeks) had increased AT8 (q = 8.12, p < 0.001)
and AT270 (q = 4.03, p < 0.05) in the contralateral hippocampus at 1 month post-injury
compared to controls. In the modified controlled closed-head impact mouse model, no
significant difference in AT8 was seen at 7 days, however a significant elevation was
detected at 1 month following injury in the ipsilateral hippocampus compared to control
(q = 4.34, p < 0.05). Elevated plus maze data revealed that rats exposed to single blast (q
= 3.53, p < 0.05) and repeat blast (q = 4.21, p < 0.05) spent more time in seconds
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exploring the open arms compared to controls. Morris water maze testing revealed a
significant difference between groups in acquisition times on days 22-27. During the
probe trial, single blast (t = 6.44, p < 0.05) and repeat blast (t = 8.00, p < 0.05) rats spent
less time in seconds exploring where the platform had been located compared to controls.
This study provides a multi-model example of replicating tau and behavioral changes in
animals and provides a foundation for future investigation of CTE disease
pathophysiology and therapeutic development.
KEY WORDS: Chronic Traumatic Encephalopathy, Tauopathy, Animal Models,
Cognitive Performance, Perivascular Pathology
INTRODUCTION
Current limitations in understanding CTE pathophysiology are unlikely to be
addressed in a clinical population in the near future due to the challenges associated with
establishing long-term, prospective cohort studies in such a population. Preclinical
rodent models serve to fill this gap in knowledge for various disorders and could allow
for further investigation of the molecular mechanisms responsible for CTE, as well as
testing the potential of diagnostic and therapeutic approaches under development. Few
preclinical models of CTE have been proposed that sufficiently demonstrate both the
requisite tauopathy and behavioral changes attributed to CTE (Aungst et al 2014b, Bailes
et al 2014, Blaylock & Maroon 2011, Brody et al 2015, Creeley et al 2004, DeFord et al
2002, DeRoss et al 2002, Donovan et al 2014, Friess et al 2009, Fujita et al 2012,
Genovese et al 2013, Goldstein et al 2012, Hawkins et al 2013, Klemenhagen et al 2013,
Longhi et al 2005, Lucke-Wold et al 2014b, Mannix et al 2014, Mannix et al 2013,
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Mouzon et al 2012, Mouzon et al 2014, Petraglia et al 2014b, Petraglia et al 2014c,
Shitaka et al 2011, Turner et al 2012a, Uryu et al 2002).
The purpose of this paper is to present two preclinical models that successfully
reproduce some neuropathological and behavioral changes consistent with CTE-like
phenotypes, and discuss future directions for CTE animal modeling. Brody and
colleagues (Brody et al 2015) present several unanswered questions that we expand upon
in our accompanying review such as the role of 1) inter-injury interval, 2) number of
impacts, 3) impact severity, 4) age at time of impacts, 5) mechanism of impact, 6)
genetics, 7) gender, and 8) effect of environment on the likelihood and/or progression of
CTE development. We recently reported that endoplasmic reticulum stress might be a
contributing factor linking acute neurotrauma to behavioral deficits (Logsdon et al 2014).
The quest for elucidating CTE pathophysiology development is ongoing with the goal of
targeting specific injurious cascades a key priority in order to prevent the emergence of
clinical symptoms.
In this work we present novel models of neurotrauma-induced neurodegeneration
in both mice and rats following exposure to single or repetitive brain injury, respectively.
These models replicate both the tauopathy and some of the behavioral changes implicated
in CTE in the clinical population. We believe the blast model is particularly relevant
clinically due to utilization of a scaled, short-duration blast exposure. This is a striking
contrast to long-duration blasts utilized in numerous studies that may more closely
approximate an atomic blast than a blast from an improvised explosive device (Bass et al
2012, Panzer et al 2012, Panzer et al 2014a, Turner et al 2013). Park and colleagues show
that by having the animal outside of the tube, the wave is directed towards the skull
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causing neurologic injury without extensive lung injury (Park et al 2011). Extended
duration waves are generated when the tube has disproportionate length and volume
ratios for the driven and driver sections. When the animals are placed within a tube that
has not been scaled, the impulse exposure to the skull might not be representative of
human exposure (Cho et al 2013). The modified closed-head injury in unanesthetized
animals described previously by Petraglia and colleagues offers the benefit of injuring
awake animals, more closely replicating the clinical picture seen in athletes than most
other TBI models (Petraglia et al 2014b, Petraglia et al 2014c). Further studies are
required to address injury paradigms that do or do not contribute to CTE development but
utilization of these models appears promising in not only modeling CTE but also
identifying therapeutic targets based upon other recently published work by our groups
(Logsdon et al 2014, Lucke-Wold et al 2014a).
METHODS
Animals and human samples
All experiments involving animals were approved by either the Institutional
Animal Care and Use Committee of West Virginia University or that of the University of
Rochester and were performed based upon principles of the Guide for the Care and Use
of Laboratory Animals. Fifty-six (56) young-adult male rats (300-350 grams) were
acquired from Hilltop Laboratories (Scottdale, PA). All blast procedures were performed
at West Virginia University. Twelve (12) young-adult male C57BL/6J mice were
acquired from Jackson Laboratories (Bar Harbor, ME) and used for modified controlled
cortical impact at the University of Rochester. All animals were allowed to acclimate
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upon arrival for 1 week prior to any experimentation. At all times animals were provided
food and water ad libitum and maintained on a 12 hour light-dark cycle. Human samples
were from deceased professional athletes that were previously diagnosed with chronic
traumatic encephalopathy (Omalu et al 2010a). The tissue was collected from the
entorhinal cortices.
Experimental groups
Fifty-six (n = 56) rats were divided into three primary experimental groups for
behavior – anesthetized controls (n = 24), a single blast injury (n = 16), and repeat blast
injuries (n = 16). Each of these groups was sacrifed at 1 month following the final blast
or sham-injury and after undergoing functional assessment. Elevated-plus maze was done
at 7 days post-blast (n = 24; 8 controls, 8 single blast, and 8 repeat blast) and the Morris
water maze started at 21 days post-blast (n = 32; 16 controls, 8 single blast, and 8 repeat
blast). Following behavioral analysis, rats from the EPM group were divided into two
separate groups with one utilized for immunohistochemistry (n = 10; 4 controls, 3 single
blast, and 3 repeat blast) and the other for western blotting (n = 14; 4 controls, 5 single
blast, and 5 repeat blast). Twelve (12) mice were divided into three primary experimental
groups – anesthetized controls (n = 4), single injury with sacrifice at one week (n = 4),
and single injury with sacrifice at one month (n = 4). All mice were utilized for western
blotting techniques at time of sacrifice. An experimental schematic can be seen in figure
3.1.
Traumatic brain injury
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Briefly, all blast injuries administered to rats as part of this work were of
moderate intensity (~50 PSI peak reflected overpressure) as determined previously and
completed under isoflurane-based anesthesia (Logsdon et al 2014, Lucke-Wold et al
2014a, Turner et al 2013). Blast exposure occurred on the right side of the animal and
was only administered to the head and neck region. The rat was outside of the blast tube
and a rigid barrier protected the remainder of the animal. Blast waves were of a shortduration (~2 ms) to ensure clinical relevance based on elucidated scaling parameters
(Figure 3.2 A). The scaling parameters are based on impulse dynamic measurements,
which are more representative of human blast than closed models based on duration
(Needham et al 2015).
Mice were utilized in a manner previously described (Petraglia et al 2014b,
Petraglia et al 2014c). Briefly, mice were placed, unanesthetized, into a rodent restraint
bag/cone and immobilized on top of a foam bed of known spring constant. A helmet was
secured to the head using an elastic band, allowing for administration of a diffuse impact
through force distribution. The helmet is made of stainless steel and measures 3 mm in
thickness and 6 mm in diameter. Impacts were delivered using a modified controlled
cortical impact device that was adjusted to include an altered tip of vulcanized rubber
(Figure 3.2 B). The impact was zeroed so that it was directly perpendicular to the helmet
surface and orthogonal to the skull. The tip was driven 1 cm past zero point with a 100ms
impact.
Western blot
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Animals were anesthetized and sacrificed by rapid decapitation. Brains were
extracted and immediately placed in a lysate buffer with protease and phosphatase
inhibitors as described elsewhere (Logsdon et al 2014). Brains were dissected and tissue
flash frozen and stored at -80 °C prior to blotting. Hippocampal protein samples were
dissolved in 0.5 mL of 1% sodium dodecyl sulfate (SDS) prior to sonication and protein
assay. Pre-cast 10% 12-well gels (Life Technologies, Carlsbad, CA) were loaded with 30
µg of protein per well and run with 2X Lammeli buffer. Wet transfer was performed
using nitrocellulose membranes (Bio-Rad, Contra Costa, CA) at 60 volts for 2.5 hours.
Primary antibodies against AT8 (Pierce; Rockford, IL), AT270 (Pierce; Rockford, IL),
CP13 (kindly supplied by Dr. Peter Davies), and PHF-1 (kindly supplied by Dr. Peter
Davies) were utilized and detected utilizing the corresponding secondary. Membranes
were imaged using a LI-COR fluorescent scanner (LI-COR; Lincoln, NE) and images
converted to gray scale. Analysis was performed using background subtraction (Odyssey
Processing Software, LI-COR) and values normalized to β–actin levels, resulting in a
normalized intensity value.
Immunohistochemistry
For immunohistochemistry preparation, animals were anesthetized using
isoflurane and transcardially perfused with ice-cold physiologic saline followed by 10%
formalin for a total of 10 minutes. Brains were extracted and placed in fresh 10%
formalin for a minimum of 24 hours prior to blocking and subsequent paraffin
embedding. Sections were prepared in 6 µm thickness using a Leica RM2235 microtome
(Leica Microsystems, Wetzlar, Germany).

Staining was performed using standard

protocols used within the field and previously by our laboratory, using the antibodies
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described above as well as thioflavin for detecting neurofibrillary tangles (Goldstein et al
2012, McKee et al 2010, Stern et al 2013).
Behavioral assessments
Learning and memory was assessed using the Morris water maze. Spatial
acquisition trials began at Day 21 after the final blast exposure (in both single and repeat
injury paradigms). The pool utilized was ~180 cm in diameter and filled with water at
ambient temperatures (18-21 °C). A platform (10 cm x 10 cm) was submerged 2.5 cm
below the surface of the water. A series of objects was placed in the environment around
the pool to provide visual cues for the animal during trials. The training paradigm
(spatial acquisition) consisted of 6 days with a total of 4 trials occurring each day per
animal. Animals were placed into the maze from four different locations each day (4
trials) with a total of 2 minutes (maximum) allowed per trial. Upon finding the platform,
animals were allowed 15 seconds for acquisition to occur. If unsuccessful in finding the
platform, animals were placed on the platform at the conclusion of 2 minutes by the
investigator. On the probe trial day (platform removed), animals were placed in the maze
at a novel location and allowed to explore the maze for 1 minute. Data was acquired
using AnyMaze™ video tracking software (Stoelting Co., Wood Dale, IL) throughout all
studies and allows for acquisition of latency, distance, and speed data to be analyzed
across maze regions/quadrants.
Impulsivity was determined, at 7 days after the final blast, as previously described
using an elevated-plus maze and measuring exploratory behavior (Johnson et al 2013,
Logsdon et al 2014, Mosienko et al 2012). The apparatus was placed at a height of 60 cm
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from the floor and consisted of two open and two closed arms, with open arms opposing
one another and intersecting perpendicularly with the opposed closed arms. Each arm
was 50 cm long by 10 cm wide. Open arms were surrounded by clear plastic edging ~1.5
cm high. Closed arms were encased with black walls 30 cm tall, creating a 3-sided and
comforting enclosure for the rodent. At the start of each 5-minute trial, animals were
placed in the middle of the intersecting arms facing an open arm prior to release.
Animals were allowed to explore the apparatus for the duration of the trial. AnyMaze™
software was utilized to record the animals’ position, distance traveled, and entry pattern
into various arms throughout the trial. An increased percentage of time spent in the open
arms was considered a sign of impulsive behavior (Johnson et al 2013, Logsdon et al
2014, Mosienko et al 2012).
Statistical analysis
An observer blinded to experimental condition performed all data acquisition.
One-way Analysis of Variance (ANOVA) was used for statistical analysis of all tests
except spatial acquisition trials of the Morris water maze and immunohistochemical
comparisons in which a two-way, repeated measures ANOVA and students t-test were
utilized, respectively. Bonferroni post-hoc comparison was used to determine differences
between experimental groups on two-way ANOVA with repeated measures for spatial
acquisition. For all other comparison’s, a Tukey’s post-hoc was utilized. Analysis was
completed using GraphPad Prism 5.0 (GraphPad Software, Inc.; La Jolla, CA). A p
<0.05 was considered statistically significant for all data analyzed.
RESULTS
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Neurotrauma induces tau hyperphosphorylation in both blast and closed-head injury
models
To elucidate the effect of neurotrauma on the development of CTE-like
neuropathology, animals were exposed to sham-injury, single-injury (either blast or
modified closed-head), or repeat-injury (blast). Animals were first assessed for tau
phosphorylation, using AT8 and AT270 antibodies, believed to be the initial precursor of
neurofibrillary tangle development. AT8 forms a single band in rats and a double band in
mice (Hawkins et al 2013). Conversely, AT270 forms a double band in rats, but only a
single band in mice (Green et al 2007). The number of bands is indicative of calpain
dependent phosphorylation, which is regulated uniquely between rats and mice (Medeiros
et al 2012). Increased phosphorylation of tau was observed after blast exposure and
modified closed-head injury but the location of the increase was model-dependent.
Specifically, tau phosphorylation was observed in the contralateral hemisphere in rats
exposed to repeat blast injury but only in the ipsilateral hemisphere, and only with the
AT8 antibody, in mice receiving a single modified closed-head injury.
In rats exposed to blast, no significant difference in tau phosphorylation was
observed in the ipsilateral hippocampus after blast injury for AT8 (Figure 3.3 A) or
AT270 (Figure 3.3 E). A significant difference was observed in AT8 (F2,11 = 16.64, p <
0.001) and AT270 (F2,9 = 4.37, p < 0.05) levels in the contralateral hippocampus of rats
exposed to blast injury. At one month following a single blast, a significant increase in
tau phosphorylation recognized by AT8 increase was measured compared to control (q =
3.96, p < 0.05) (Figure 3.3 B). A significant increase in phosphorylation detected by
AT8 was also observed after repeat blast (q = 8.12, p < 0.001) (Figure 3.3 B).
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In the modified closed-head injury model utilized on the mice, a significant
difference was observed in tau phosphorylation AT8 (F2,9 = 4.93, p < 0.05) in the
ipsilateral hippocampus. At one-month following injury, AT8 expression was elevated in
comparison to sham-injury (q = 4.34, p < 0.05) (Figure 3.3 C). No significant difference
was observed at 7-days post-injury on the ipsilateral side or between any groups or time
points on the contralateral side (Figure 3.3 D).
At one-month following repetitive blast exposure, a significant increase
phosphorylation recognized by the AT270 antibody was measured in the contralateral
hippocampus of rats compared to anesthetized control animals (q = 4.03, p < 0.05)
(Figure 3.3 F).

No significant differences were observed in tau phosphorylation

recognized by AT270 in either ipsilateral (Figure 3.3 G) or contralateral (Figure 3.3 H)
hippocampus of mice receiving modified closed-head injury.
Hyperphosphorylation of tau following neurotrauma occurs in perivascular brain
regions
Clinical case series documenting patients with CTE have demonstrated the
deposition of neurofibrillary tangles (NFTs), an end product of tau hyperphosphorylation,
in perivascular regions, which is a distinct difference from other tauopathies such as
Alzheimer’s disease (AD). Possible mechanisms leading to NFTs in perivascular regions
include the disruption of the blood-brain barrier (BBB), leading to punctate
microhemorrhages, red blood cell breakdown, oxidative stress, and finally, persistent
neuroinflammation. We observed a significant difference in tau hyperphosphorylation
within perivascular regions of the contralateral hippocampus in rats exposed to repeat
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blast in comparison to control when identified with both AT8 (t = 4.46, p < 0.001) and
AT270 (t = 11.47, p < 0.001) at 1-month post-injury (Figure 3.4). These findings were
consistent with prior reports of CTE in humans and from our collection of post-mortem
human samples with documented CTE.
Neurotrauma is associated with conformational changes in tau that are recognized
precursors of neurofibrillary tangle formation
Following hyperphosphorylation, tau is purported to undergo conformational
changes associated with subsequent insolubility and deposition/precipitation in the form
of neurofibrillary tangles.

Following neurotrauma in rats and mice, we found an

elevation in markers of conformational change of the tau molecule based on
immunoblotting with PHF-1 and CP13.

After blast exposure, markers of tau

conformational change were observed in the contralateral hemisphere of rats, while after
the impact procedure in mice, the markers were found ipsilaterally. No significant
differences in markers of tau conformation change were observed in the ipsilateral
hippocampus after blast injury for neurofibrillary precursor PHF-1 (Figure 3.5 A) or
CP13 (Figure 3.5 E).
A significant difference was observed in PHF-1 (F(2,11) = 7.92, p < 0.01) and CP13
(F(2,9) = 6.03, p < 0.05) levels in the contralateral hippocampus of rats exposed to blast
injury. At one month following a single blast, a significant increase in PHF expression
was measured compared to control (q = 4.76, p < 0.05) (Figure 3.5 B).
A significant difference was observed in PHF-1 (F(2,9) = 7.18, p < 0.05) levels in
the ipsilateral hippocampus of mice exposed to injury. At one month following modified
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impact, a significant increase in PHF-1 expression was measured compared to control (q
= 5.17, p < 0.05) (Figure 3.5 C). No significant differences were observed in PHF-1
expression in the contralateral hippocampus of mice exposed to cortical impact (Figure
3.5 D).
At one month after repetitive blast exposure, a significant increase in CP13
expression was measured in the contralateral hippocampus of rats compared to control (q
= 4.73, p < 0.05) (Figure 3.5 F). A significant difference was observed in CP13 (F(2,9) =
21.70, p < 0.001) levels in the ipsilateral hippocampus of mice exposed to injury. At one
month following impact, a significant increase in CP13 expression was measured
compared to control (q = 9.28, p < 0.001) (Figure 3.5 G). No significant differences were
observed in CP13 expression in the contralateral hippocampus of mice exposed to
cortical impact (Figure 3.5 H).
Similar findings were seen using immunohistochemistry when comparing repeatinjured animals to sham-injured animals at 1 month post-injury. Specifically, a significant
difference was seen on PHF-1 staining (t = 6.06, p < 0.001) and CP-13 staining (t = 3.88,
p < 0.01) (Figure 3.6). Again, the distribution of the staining was notable for being
perivascular in nature, a finding shared across the clinical specimens diagnosed with CTE
as seen in figure 3.7. We show that PHF, AT8, and a thioflavin stained neurofibrillary
tangle are increased perivascular in human CTE specimens. CP-13 is increased in a
perivascular distribution following repeat blast in a rat.
Neurotrauma produces cognitive impairments
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Cognitive deficits have long been associated with the neuropathological diagnosis
of CTE in the clinical population, particularly amongst the population diagnosed with
CTE at a later age in life. Similarly, cognitive impairments in both learning and memory
have been associated with neurotrauma but have not been presented in the context of a
corresponding tauopathy in both a single and repeat blast injury paradigm. In cohorts of
animals subjected to either sham-, single-, or repetitive-injury, spatial acquisition
(learning) was assessed 3 weeks after the injury in single-injury animals and the final
injury in repeat-injury paradigms (Days 21-27 post-injury). Blast injury exposure was
associated with worsened performance in the Morris water maze as evident by latency to
find the platform in seconds when analyzed using a two-way repeated measures
ANOVA. Post-hoc tests revealed significant differences between anesthetized controls
and single-injury animals during spatial acquisition on Days 22-24, and Day 26 (Day 21:
t = 1.38, p > 0.05; Day 22: t = 3.70, p < 0.01; Day 23: t = 4.12, p < 0.001; Day 24: t =
4.38, p < 0.001; Day 25: t = 2.17, p > 0.05; Day 26: t = 3.20, p < 0.01). Similarly, posthoc tests demonstrated a significant impairment in acquisition between anesthetized
controls and repetitively injured animals on Days 22-26 (Day 21: t = 0.66, p > 0.05; Day
22: t = 5.01, p < 0.001; Day 23: t = 4.16, p < 0.001; Day 24: t = 4.72, p < 0.001; Day 25: t
= 3.69, p < 0.01; Day 26: t = 3.76, p < 0.01). Notably, no differences were seen between
single- and repeat-injured animals during the course of acquisition trials, despite the
notable difference in tau pathology at this time presented earlier (Figure 3.8). The
differences in latency to platform between blast-injured animals and anesthetized control
animals is apparent as well based on visualization of the track plots recorded during data
acquisition (Figure 3.9). Clearly different swimming patterns emerge with blast-injured
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animals exhibiting what appears to be more thigmotaxis (circling around the outer edge
of the pool) than anesthetized control animals that reached statistical significance
between controls and repeat-injured animals on Day 23 (q = 3.58, p < 0.05), although this
data point did not reach significance on Days 21 and 26 based on automated
measurements generated using AnyMaze™ (Figure 3.8).
Memory, as measured during the probe test (time spent in area surrounding the
now-removed platform) conducted on Day 27, again demonstrated deficits in animals
subjected to blast-induced neurotrauma when analyzed using a one-way ANOVA (F2,29 =
20.01, p < 0.0001). Post-hoc tests showed significant differences between sham and
single injury animals (t = 6.44, p < 0.05) as well as between sham and repetitively injured
animals (t = 8.00, p < 0.05) but no difference between single injury and repeat injury
paradigms (Figure 3.8). These findings were confirmed visually using track plots
generated during data acquisition (Figure 3.9). Anesthetized control animals exhibit a
greater preponderance of pool crossings and swimming behavior within the region near
the platform in contrast to blast-injured animals (Figure 3.9).
Impulsivity is increased following neurotrauma
Clinically, impulsive behavior has been described extensively in those with a
history of repetitive neurotrauma and the context of CTE. To make an analogous
comparison between our animal model of blast-induced traumatic brain injury and
clinically reported symptoms, the elevated-plus maze was utilized to measure impulsivelike behaviors based upon the percentage of time spent in the open-arms of the maze.
Significant differences between groups were observed when analyzed using a one-way
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ANOVA (F2,32 = 5.03, p < 0.05). Post-hoc tests revealed a significant difference between
sham and single injury animals (q = 3.53, p < 0.05) as well as between sham and
repetitively injured animals (q = 4.21, p < 0.05). No difference was seen between single
and repeat injury paradigms with regards to percentage of time spent in the open arms of
the apparatus (Figure 3.10). While not statistically significant, a trend towards a greater
distance traveled in the open arms was observed with increasing levels of neurotrauma,
evidence consistent with the percentage of time spent in the open arms (Figure 3.10).
Conversely, a trend was also present regarding distance traveled in the closed arms with
animals subjected to neurotrauma traveling less distance (Figure 3.10). Post-hoc tests
revealed no statistical significance when comparing sham to single injury groups but
significance was reached when comparing sham to repetitively-injured animals (F2,33 =
3.06 ; q = 3.47, p < 0.05).
DISCUSSION
While the clinical literature has been inundated with reports of CTE in athletes
and soldiers alike, few experimental tools exist for investigating disease pathophysiology,
establishing diagnostic criteria, and discovering preventative or therapeutic agents. For
these reasons, preclinical models of CTE are highly desirable.

In this work we

demonstrate two preclinical models capable of generating some biochemical and
behavioral hallmarks of CTE, namely tauopathy and impulsive-like behavior.
Furthermore, this work illustrates the utility of two distinct models and injury paradigms,
namely blast exposure versus a more traditional modified closed-head injury, and repeat
versus single injury paradigms respectively. Likewise, the fact that this work was
completed in two different species and builds upon prior work by both West Virginia
65

!
University and the University of Rochester laboratories validates the use of both mice
and rats in the preclinical modeling of neurotrauma related neurodegeneration (Logsdon
et al 2014, Petraglia et al 2014b, Petraglia et al 2014c). The modified closed-head injury
represents a helmeted design with controlled placement of the impact likely accounting
for ipsilateral deficit. The tauopathy development period following modified controlled
impact was not previously elucidated therefore warranting the 7-day time point. Petraglia
and colleagues show that astrocyte activation and cell death occurs at 7 days post
modified controlled impact (Petraglia et al 2014c). We previously reported that tauopathy
following blast in rats does not develop until weeks after injury and is on the contralateral
side due to coup/contra-coup injuries (Lucke-Wold et al 2015d).
The potential utility of these, as well as other preclinical models of neurotrauma
related

neurodegeneration,

is

highly

promising

for

investigation

of

disease

pathophysiology, particularly as related to biochemical endpoints associated with CTE.
To fully develop a CTE model, transgenic rodents will be needed that include amyloid,
tau, and TDP43 pathology. The quest for elucidating the underlying mechanisms behind
CTE development is ongoing. In previous work, we have shown blast causes substantial
blood brain barrier disruption (Lucke-Wold et al 2014a), endoplasmic reticulum stress
activation (Logsdon et al 2014), and oxidative stress (Lucke-Wold et al 2015a).

We

show in this work the induction of hyperphosphorylated tau, conformational changes in
tau, and more advanced precursors of NFT formation with the usage of CP13 and PHF-1
antibodies. AT8 binds to serine 199 and 202 as well as threonine 205. AT270 binds to
threonine 181, PHF binds to serine 396 and 404, and CP13 binds to serine 202. Serine
396 and 202 are only exposed after tau undergoes conformational change (Lucke-Wold et

66

!
al 2014c). These changes are the ultimate result of tau hyperphosphorylation and protein
misfolding/aggregation,
kinase/phosphatase

and

system.

are

likely

Peclinical

related

to

modeling

dysregulation
of

of

neurotrauma

the

tau

related

neurodegeneration will allow for the elucidation of how and when these kinases and
phosphatases become dysregulated, and will allow for increased understanding of the
disease process. Additionally, these studies will provide targets for direct or indirect
therapeutic development.

Similarly, preclinical models may prove instrumental in

identification of diagnostic and prognostic tests for establishing a diagnosis of CTE and
tracking disease progression. There is a clinical need for a rapid, cheap, and reliable
diagnostic test to predict severity of CTE. Currently neuropathological examination
remains the gold standard for diagnosis with some studies purporting the use of PETbased imaging for diagnosis (Gandy & DeKosky 2014, Mitsis et al 2014, Small et al
2013). It is possible that development and validation of these techniques, and others such
as diffusion tensor imaging and magnetic resonance spectroscopy may be accelerated
through the application to preclinical models. The current limitation is that advanced
imaging is expensive, cumbersome, and requires expertise from subspecialty radiologists.
Despite this work illustrating what we believe represents a clear step forward in
the study of neurotrauma related neurodegeneration, it is clear that further study is
warranted. Pre-clinical models must be utilized to more fully characterize behavioral,
biochemical, imaging, and electrophysiological/functional changes associated with the
development of CTE.

Future studies will likely address the development of

behavioral/functional deficits in relation to biochemical changes temporally and assess
the chronicity of changes based on the number, severity, and inter-injury interval of
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neurotrauma-related events. The development of better transgenic models is critical as the
field moves forward. Performing studies such as these will allow for the questions raised
in our accompanying review be addressed. Specifically, what is the role of the 1) interinjury interval, 2) number of impacts, 3) impact severity, 4) age at time of impacts, 5)
mechanism of impact, 6) genetics, 7) gender, and 8) effect of environment on the
likelihood and/or progression of CTE development.
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Figure 3.1: Schematic showing experimental design and behavioral experiments. Time
of sacrifice for biochemical experiments is also shown.
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Figure 3.2: Schematic representation of the two injury models utilized within this work.
(A) Experimental setup utilized at West Virginia University for the study of blast-induced
neurotrauma. The shock tube consists of a high-pressure driver section (nitrogen gas
filled) and a low-pressure driven section (ambient air filled). When the membrane
dividing the chambers ruptures, the blast wave is formed and released, encountering the
rat from the right side of the cranium. (B) Depiction of the model utilized at the
University of Rochester in un-anesthetized mice. An electromagnetic impactor used in
CCI was modified with a rubber tip and a specially designed helmet was placed on the
mouse as previously described.
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Figure 3.3: Blast and closed-head injury models both induced tau hyperphosphorylation.
(A) Immunoblots show no significant difference in tau phosphorylation at serine sites
199/202 and threonine site 205 (AT8) at one month after single and repeat blast
exposures in the ipsilateral rat hippocampus. (B) A significant increase in AT8
expression was measured after single (*p<0.05 vs. CTRL) and repeat blast exposure
(***p<0.001 vs. CTRL) in the contralateral rat hippocampus. (C) AT8 expression was
significantly increased at one month after closed-head injury in the ipsilateral mouse
hippocampus (*p<0.05 vs. CTRL). (D) No significant differences were observed in AT8
expression in the contralateral mouse hippocampus. (E) Immunoblots show no
significant difference in tau phosphorylation at threonine site 181 (AT270) at one month
after single and repeat blast exposure in the ipsilateral rat hippocampus. (F) A significant
increase in AT270 expression was measured at one month after repeat blast exposure
(*p<0.05 vs. CTRL) in the contralateral rat hippocampus. (G) No significant differences
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were observed in AT270 expression in the ipsilateral mouse hippocampus, (H) or the
contralateral mouse hippocampus after closed-head injury. One-way ANOVA Tukey’s
post-hoc analysis (values represent mean ± s.e.m.; normalized to β–actin) (n=3-5).
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Figure 3.4: Tau hyperphosphorylation is seen in microfoci throughout the contralateral
superficial cortex. AT8 was significantly increased at 1 month post repetitive blast (t =
4.455, p < 0.001). AT270 was also significantly increased following repetitive blast (t =
11.47, p < 0.001). AT270 was increased in a circular distribution. Tau
hyperphosphorylation is an indicator of progressive pathology. Values were calculated
using a student’s t-test comparing the mean difference between groups.
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Figure 3.5: Blast and closed-head injury models both induce conformational changes in
tau proteins. (A) Immunoblots show no significant difference in markers of tau
conformational change at serine site 396/404 (PHF) at one month after single and repeat
blast exposure in the ipsilateral rat hippocampus. (B) A significant increase in PHF
expression was measured after single (*p<0.05 vs. CTRL) and repeat blast exposure
(*p<0.05 vs. CTRL) in the contralateral rat hippocampus. (C) PHF expression was
significantly increased at one month after closed-head injury in the ipsilateral mouse
hippocampus. (D) No significant differences were observed in PHF expression in the
contralateral mouse hippocampus. (E) Immunoblots show no significant difference in
markers of tau conformational change at serine site 202 (CP13) at one month after single
and repeat blast exposure in the ipsilateral rat hippocampus. (F) A significant increase in
CP13 expression was measured at one month after repeat blast exposure (*p<0.05 vs.
CTRL) in the contralateral rat hippocampus. (G) A significant increase in CP13
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expression was measured at one month after closed-head injury in the ipsilateral mouse
hippocampus (***p<0.001 vs. CTRL). (H) No significant differences were observed in
CP13 expression in the contralateral mouse hippocampus after closed-head injury. Oneway ANOVA Tukey’s post-hoc analysis (values represent mean ± s.e.m.; normalized to
β–actin) (n=3-5).
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Figure 3.6: Tau conformational markers were increased throughout the contralateral
superficial cortex. PHF was significantly increased at 1-month post repetitive blast (t =
6.055, p < 0.001). CP-13 staining was also significantly increased following repetitive
blast (t = 3.883, p < 0.01). CP-13 was increased in a perivascular distribution. Tau
conformational change is required for the formation of neurofibrillary tangles. Values
were calculated using a student’s t-test comparing the mean difference between groups.
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Figure 3.7: Tauopathy is seen in a perivascular distribution. PHF and AT8 were
increased adjacent to longitudinal microvessels in human patients diagnosed with chronic
traumatic encephalopathy. A neurofibrillary tangle stained with thioflavin was seen
adjacent to a cut vessel lumen in the brain of a retired professional football player.
Similarly, CP-13 was increased next to a cut vessel lumen in the contralateral cortex 1
month following repeat blast in the rat. Arrows indicate tauopathy while arrowheads
point out vessels.
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Figure 3.8: Blast-induced brain injury produces deficits in learning and memory in rats.
(A) Spatial acquisition trials conducted on Days 21-26 post-injury revealed deficits in
learning in single-injury animals on Days 22-24 and 26 in comparison to control.
Repeat-injury was associated with deficits on Days 22-26 in comparison to control. No
differences were seen between single- and repeat-injury paradigms. (B) The probe test
on Day 27 revealed a statistically significant difference in time spent near the prior
platform location between injured animals (single or repeat) and control animals. No
difference was seen between single- and repetitively-injured rats. (C) Animals exposed
to neurotrauma exhibited a trend towards increased thigmotaxis during spatial acquisition
procedures but this finding did not reach statistical significance.
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Figure 3.9: Track plots acquired across spatial acquisition and probe testing in rats. (AD) Track plots generated from anesthetized control animals on Day 21, Day 23, Day 26,
and during the probe test. (E-H) Track plots generated from single-injured animals on
Day 21, Day 23, Day 26, and during the probe test post-injury. (I-L) Track plots
generated from repetitively-injured animals on Day 21, Day 23, Day 26, and during the
probe test post-injury. Injured animals appear to spend more time exhibiting thigmotaxis
behaviors (circling edge of pool) on later days and in the probe trial fail to spend as much
time as the anesthetized control animals within the probe region and the direct area
surrounding the probe region.
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Figure 3.10: Blast-induced brain injury in rats produces an increase in impulsive
behavior based on the elevated-plus maze. (A) A significant difference (p<0.05 vs.
CTRL) was seen between anesthetized control animals and both single and repeat blasts
with regards to the percentage of time spent in the open arm of the elevated-plus maze.
No difference was measured between single and repeat-injury paradigms. (B) While not
reaching statistical significance, a trend towards greater distance traveled in open arms
was seen with neurotrauma, a finding consistent with the documented increase in time
spent in the open arms. (C) Animals subjected to neurotrauma appeared to travel less
distance in the closed arms of the maze, although this finding did not reach statistical
significance. (D) Track plot showing little exploration of the open arm by control
animals. (E) Track plot showing increased exploration of the open arms of the elevatedplus maze by single-injured animals. (F) Track plot showing increased exploration of the
open arms of the elevated-plus maze by repetitively injured animals.
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Chapter Four
Bryostatin-1 Restores Blood Brain Barrier Integrity following Blast-Induced
Traumatic Brain Injury
This work is published in Mol Neurobiol. 2015 Dec;52(3):1119-34. doi: 10.1007/s12035014-8902-7. Epub 2014 Oct 10. PMID: 25301233
Lucke-Wold BP, Logsdon AF, Smith KE, Turner RC, Alkon DL, Tan Z, Naser ZJ,
Knotts CM, Huber JD, Rosen CL
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ABSTRACT
Recent wars in Iraq and Afghanistan have accounted for an estimated 270,000
blast exposures amongst military personnel. Blast traumatic brain injury (TBI) is the
‘signature injury’ of modern warfare. Blood brain barrier (BBB) disruption following
blast TBI can lead to long-term and diffuse neuroinflammation. In this study, we
investigate for the first time the role of bryostatin-1, a specific protein kinase C (PKC)
modulator, in ameliorating BBB breakdown. 37 Sprague dawley rats were used for this
study. We utilized a clinically relevant and validated blast model to expose animals to
moderate blast exposure. Groups included: control, single blast exposure, and single blast
exposure + bryostatin-1. Bryostatin-1 was administered i.p. 2.5 mg/kg after blast
exposure. Evan’s blue, immunohistochemistry, and western blot analysis were performed
to assess injury. Evan’s blue binds to albumin and is a marker for BBB disruption. Single
blast exposure caused an increase in permeability compared to control (t=4.808, p<0.05),
and a reduction back towards control levels when bryostatin-1 was administered
(t=5.113, p<0.01). Three important PKC isozymes, PKC α, δ, and ε, were co-localized
primarily with endothelial cells but not astrocytes. Bryostatin-1 administration reduced
toxic PKCα levels back towards control levels (t=4.559, p<0.01), and increased the
neuroprotective isozyme PKCε (t=6.102, p<0.01). Bryostatin-1 caused a significant
increase in the tight junction proteins VE-cadherin, ZO-1, and occludin through
modulation of PKC activity. Bryostatin-1 ultimately decreased BBB breakdown
potentially due to modulation of PKC isozymes. Future work will examine the role of
bryostatin-1 in preventing chronic neurodegeneration following repetitive neurotrauma.
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INTRODUCTION
1.7 million Americans experience a traumatic brain injury (TBI) each year in the
United States (Kou & Vandevord 2014). Over 70% of those patients sustain some form
of disability following TBI (Schneider et al 2014). The mechanisms by which TBI
contributes to permanent homeostatic changes within the central nervous system (CNS)
remain poorly understood. Recent evidence implicates disruption of the blood brain
barrier (BBB) as an important indicator of brain injury (Puvenna et al 2014). Blast TBI,
in particular, contributes to a vascular pressure surge that challenges BBB integrity
(Simard et al 2014). Blast TBI also causes significant alterations in ZO-1, occludin, and
VE-cadherin, important tight junction proteins (Hue et al 2014). The disruption is not
universal across vasculature however, with scattered lesions spread across the brain at
specific microfoci (Yeoh et al 2013). Oxidative stress from damaged tissue causes
increased BBB permeability at these microfoci (Abdul-Muneer et al 2013). The resulting
BBB dysfunction contributes to inflammatory cascades and injury expansion (Perez-Polo
et al 2013). The increase in blast-induced BBB permeability is transient with a return of
tight junction function within 3 days, but the subsequent injury response is long-lasting
(Readnower et al 2010).
One possible reason for these long-lasting effects is changes in protein kinase C
(PKC) isozyme activity after injury. Some PKC isozymes, PKCα, β, and ε, translocate to
the plasma membrane within 3 hours after TBI and remain active for days (Muscella et al
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2008, Padmaperuma et al 1996, Yang et al 1993). PKCα activity has been linked to
neuronal apoptosis following TBI (Chen et al 2012), and is closely tied with glutamate
receptor signaling (Luo et al 2014b). PKCα and δ activity can cause an uncoupling of
NMDA receptors from spectrin mediated through sigma-1 receptor activation leading to
calcium oscillations (Geddes-Klein et al 2006, Giordano et al 2005, Roh et al 2010). The
calcium oscillations contribute to mitochondrial dysfunction and cell death (Pandya et al
2013). PKCα and δ can also hyperphosphorylate structural proteins such as tau and
TBI61 within the hippocampus following injury (Yang et al 1994). Interestingly, PKC
activity also decreases cerebral edema following TBI (Karasu et al 2010, Yang et al
1993). Three important isozymes play important roles in cerebral vasculature. PKCα
regulates ZO-1 and occludin tight junction proteins (Kim et al 2010). PKCδ activity
regulates vessel constriction and vascular tone (Kizub et al 2014). PKCε decreases vessel
tone and provides neuroprotection (Lin et al 2012). Despite these associations, the role of
specific PKC isozymes in BBB disruption following blast TBI has yet to be elucidated.
Although PKC activity has not been well studied in TBI, available evidence
suggests that PKC isozymes play an important role in neural injury. An 80% increase in
PKC activity was reported 3 hours after TBI and contributes to secondary neuronal injury
(Yang et al 1993). Compounds that modulate PKC isozymes therefore warrant further
investigation. The potent PKC modulator, bryostatin-1, has profound neuroprotective
effects in animal models of neural injury. The single study using bryostatin-1 for
treatment of mild TBI showed profound protection against learning and memory deficits
in mice by increasing the α-secretase, ADAM10 (Zohar et al 2011). Although PKC
modulation has not been extensively studied in TBI models, in an Alzheimer’s disease
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model it increased PKCε, which facilitated amyloid β plaque degradation by increasing
the enzyme neprilysin (Lim & Alkon 2014). It also enhanced gabaergic signaling
improving learning and memory through PKCα modulation and decreased synaptic loss
(Hongpaisan et al 2011, Xu et al 2014). Following ischemic stroke, bryostatin-1
modulated PKCα and ε to enhance survival and reduce edema in aged Sprague-Dawley
rats (Tan et al 2013). Although Alzheimer’s disease and stroke are vastly different than
TBI, they do share similar secondary mechanisms of injury, such as PKC and microglia
activation, that should be carefully investigated
Herein, we show for the first time that PKC isozymes are increased after blastinduced TBI, and are correlated with acute BBB breakdown and tight junction protein
changes. Using our clinically relevant and validated blast model (Turner et al 2013), we
observed statistically significant acute changes in BBB permeability 6 hours after single
blast exposure. Interestingly, the PKC modulator bryostatin-1 reduced BBB permeability,
decreased levels of the detrimental PKCα isozyme, and increased the beneficial PKCε
isozyme. The mechanism of bryostatin-1’s beneficial effects is closely linked to
regulation of tight junction proteins through specific modulation of PKC isozymes.
Occludin closely interacts with the scaffolding proteins ZO-1 and VE-Cadherin (Morrow
et al 2010), and our data show that bryostatin-1 significantly elevated levels of occludin,
VE-Cadherin, and ZO-1. Increasing the levels of tight junction proteins has been shown
to help maintain BBB integrity (Goncalves et al 2012). Modulation of PKC expression
may therefore be a promising treatment strategy for preventing BBB disruption following
acute neurotrauma.
METHODS
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Animals and treatments
Thirty-seven (37) young adult (300-350g) male Sprague Dawley rats (Hilltop Lab
Animals, Inc.) were used for this study. Animals were housed in pairs with 12h:12h dark
to light cycle and food available ad libitum. The Institutional Animal Care and Use
Committee of West Virginia University approved all procedures and experiments
involving animals. The experiments were performed in accordance with the Guide for the
Care and Use of Laboratory Animals. Ten (10) animals were used for Evan’s Blue (EB)
absorbance analysis. Eighteen (18) animals were used for immunohistochemisty (IHC)
staining and western blot analysis. Nine (9) animals were used for microvessel isolation
and subsequent western blot analysis (Fig. 1). Bryostatin-1 was administered by
intraperitoneal injection (2.5 mg/kg) (Tan et al 2013), 5 minutes after blast exposure for
all blast + bryostatin-1 groups. Bryostatin-1 was dissolved in vehicle (10% ethanol in
0.9% normal saline). Bryostatin-1 was obtained by Dr. Daniel Alkon from the National
Cancer Institute, National Institutes of Health, Bethesda, MD. The dose of bryostatin-1
was selected in accordance with animal protocols and according to a dose response curve
showing that bryostatin-1 enters the brain but is maintained well below the maximal
tolerated dose (Berkow et al 1993, Sun & Alkon 2006). Control animals were
anesthetized and injected with vehicle. Bryostatin-1 is a potent modulator of PKC
isozymes with selectivity for PKCα and ε (Sun et al 2014).
Blast exposure
The animal was oriented perpendicular to the blast apparatus, with the driver
section placed near the right side of the skull. A polyvinyl chloride shield protected the
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rest of the body. We utilized a membrane with 0.005 inch thickness to generate a blast
exposure with peak reflected overpressure of ~50 PSI, and peak incident overpressure of
~15 PSI (Figure 4.1 B-C). The exposure produced moderate blast injury as previously
characterized (Turner et al 2013). The primary extent of injury has been localized to the
left hemisphere due to coup and counter-coup acceleration/deceleration mechanisms
(Turner et al 2012b). Briefly, nitrogen gas builds pressure behind a clear polyester film
that subsequently ruptures to produce a blast wave. Piezoelectric sensors (Model
102AO5; PCB Piezotronics) were placed in the reflected and incident positions at the exit
of the shock tube and data was recorded with a data acquisition board (DAQ 23GF,
National Instruments) and sensor signal conditioner (482C Series; PCB Piezotronics).
LabView software version 12.0 (National Instruments) was used to reconstruct accurate
pressure recording graphs (Figure 4.1 D). The short driver section generates briefduration waves comparable to those seen from improvised explosive devices when scaled
properly for the rodents size based on principles previously highlighted by Bass and
colleagues (Bass et al 2012, Panzer et al 2014b).
Evan’s blue
Groups for Evan’s Blue (EB) included: control (n=3), single blast (n=4), and
single blast + bryostatin-1 (n=3). BBB permeability was assessed 6 hours after blast
exposure using EB as a tracer molecule. EB binds to albumin, and albumin will only
enter the brain if the BBB is compromised. Animals were anesthetized with inhaled 4%
isoflurane (Halocarbon) and maintained with 2% isoflurane before normal saline
containing EB (2%, 5ml/kg) (2% w/v in saline) was administered intravenously (femoral
vein) 30 minutes prior to perfusion. The rats were transaortally perfused with normal
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saline for 10 minutes. The brains were excised; meninges and ependymal organs
removed, hemispheres separated, and left prefrontal cortex sectioned. The prefrontal
cortex is one of the brain regions most susceptible to BBB disruption following injury
(Yen et al 2013). The left prefrontal cortex samples were then weighed, and
homogenized in 1 ml of 50% trichloroacetic acid (TCA). The resulting suspensions were
placed in 0.5mL aliquots. The aliquots were incubated for 24 hours at 37°, and
centrifuged at 10,000 x g for 10 minutes. The supernatant was collected and measured by
absorbance spectroscopy at 620 nm for EB determination. Calculations were based on
external standard readings (50µg/mL of EB dissolved in saline with 8 serial dilutions).
The extravasated dye in brain tissue was expressed as ng EB/mg of brain tissue.
Microvessel isolation
Rats were anesthetized with 4% isoflurane, decapitated, and the brain was
removed. The brain was placed in 10 mL of MVI Buffer two (6.02 g/L NaCl, 0.35 g/L
KCl, 0.37 g/L CaCl2, 0.16 g/L KH2PO4, 0.3 g/L MgSO4, and 3.57 g/L HEPES) with
protease inhibitor cocktail. The meninges and choroid plexus were removed and the
cerebral hemispheres were placed in a glass homogenization tube with 4 mL of MVI
Buffer one (6.02 g/L NaCl, 0.35 g/L KCl, 0.37 g/L CaCl2, 0.16 g/L KH2PO4, 0.3 g/L
MgSO4, 3.57 g/L HEPES, 2.1 g/L NaHCO3, 1.80 g/L Glucose, 0.11 g/L Na Pyruvate,
and 10 g/L Dextran (64 K)) and protease inhibitor cocktail. MVI one and two were pH
adjusted to 7.4. With a Teflon pestle, the tissue was homogenized and filtrate placed in a
16 mL tube with 4 mL of 26% dextran. The tubes were centrifuged at 5,800 x g for 10
min at 4°C. The supernatant was aspirated and the pellet was re-suspended in 5 mL of
MVI buffer two with protease inhibitor cocktail. The homogenate was filtered through
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100µm filter, and centrifuged at 5,800 x g for 5 min at 4°C. The supernatant was
decanted and microvessel pellet saved for western blot analysis.
Western blot
Western blot analysis was performed similar to work previously published by our
laboratory (Dinapoli et al 2010). Briefly, 24 hours after blast exposure, animals were
anesthetized with 4% isoflurane, brains were removed by decapitation, and the brains
were subsequently sectioned. Groups included: control, single blast, and single blast +
bryostatin-1. Protein samples from the left prefrontal cortex were dissolved in 0.5 mL hot
(85-95o C) 1% sodium docecyl sulfate (SDS), sonicated, and a Bicinchoninic Acid
(BCA) protein assay kit (Thermo Fisher Scientific, Rockfield, IL) was used to determine
protein concentration. The pre-stained standard SeeBlue® Plus2 (Life Technologies,
Carlsbad, CA) was used. 2X Lammeli buffer combined with 30 µg of protein was loaded
per well and run on a Bolt® Mini tank system (Life Technologies) with pre-cast Bolt®
Bis-Tris Plus 10% 12-well gels (Life Technologies). PVDF membranes (Bio-Rad, Contra
Costa, CA) were soaked in methanol and used for wet transfer (Bio-Rad) at 60 volts for
2.5 hours. Primary antibodies used were occludin rabbit 1:1000 (Life Technologies),
PKC α, δ, ε mouse 1:200 (Santa Cruz Biotechnology, Santa Cruz, CA), and VE-Cadherin
rabbit 1:1000 (Cell Signaling, Danvers, MA). Microvessel isolation tissue was used to
detect changes in PKC isozymes. LI-COR secondary antibodies IRDye® 800CW and
IRDye® 680RD (LI-COR, Lincoln, NE) were used with an Odyssey fluorescent scanner
at wavelengths 800 or 700, intensity 6.0, and 84 resolution with high image quality.
Images were analyzed after background subtraction, and normalized to β-actin to give
relative overall intensity.
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Immunohistochemistry
Experimental groups included control (n=3), single blast (n=3), and single blast +
bryostatin-1 (n=3). Rats were anesthetized with 4% isoflurane and transcardially perfused
with 0.9% saline followed by 4% paraformaldehyde at 24 hours after blast exposure. The
rats were decapitated, and brains were removed and stored in 4% paraformaldehyde until
processing. The tissue was sectioned and paraffin embedded. 6µm slices from the left
prefrontal cortex were cut with a Leica RM2235 microtome (Leica Microsystems,
Wetzlar, Germany) and mounted on slides. Slides were washed in xylene, 100% EtOH
and 95% EtOH for 5 minutes each in order to remove the paraffin, followed by
rehydration in dH2O for 5 minutes. Using 10% methanol and 10% H2O2 in Dulbecco’s
phosphate buffered saline (DPBS), slides were quenched for 15 minutes, followed by
three rinses in DPBS for 5 minutes each. The slides were then added to permeabilizing
solution (1.8% L-Lysine, 4% horse serum, and 0.2% Triton X-100 in DPBS) for 30
minutes. Slices were circumscribed and incubated overnight with a primary antibody and
4% horse serum. The next day slides were rinsed and incubated for 3-hours with a
fluorescent secondary antibody. A second set of primary and secondary antibodies were
used in the case of co-localization staining. Slides were then fixed with Permount
mounting media. Primary antibodies include: PKC α, δ, and ε mouse 1:500 (Santa Cruz
Biotechnology), Claudin-5 mouse 1:200 (Life Technologies), occludin rabbit 1:200 (Life
Technologies), VE-Cadherin rabbit 1:150 (Cell Signaling), ZO-1 Alexa Fluor® 488
mouse 1:200 (Life Technologies), Glial Fibrillary Acidic Protein (GFAP) mouse 1:150
(Cell Signaling), GFAP rabbit 1:500 (DAKO, Glostrup, Denmark), Neuronal/glia
proteoglycan 2 (NG-2) rabbit 1:500 (Santa Cruz Biotechnology) and Von Willebrand
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Factor (VWF) rabbit 1:200 (Sigma Aldrich, St. Louis, MO). Secondary antibodies
include Alexa Fluor 594 goat anti-mouse 1:1000 (Life Technologies), Alexa Fluor 594
goat anti-rabbit 1:500 (Life Technologies), Alexa Fluor 488 donkey anti-mouse 1:500
(Life Technologies), and Alexa 488 donkey anti-rabbit 1:1000 (Life Technologies). 20
cells per slide were randomly selected, outlined, and measured with ImageJ software
(NIH) by an observer blinded to experimental group. Density was adjusted per mean area
to give corrected total cell fluorescence normalized to background for claudin-5,
occludin, VE-Cadherin, ZO-1, and PKC α, δ, and ε. Co-localization was quantified with
the ImageJ plugin Just Another Co-localization plugin to give Pearson’s coefficient for
controls and overlap coefficient for treatment groups (Bolte & Cordelieres 2006). For
percentage of co-localization, an observer blinded to experimental group counted 100
cells and the ratio of positive cells to total cells was recorded. χ2 analyses was used to
compare between groups.
Statistical Analysis
Biochemical assay data were analyzed using GraphPad Prism 6.0 (GraphPad
Software, Inc., La Jolla, CA) by an observer blinded to experimental group. A one-way
ANOVA with Tukey’s post-hoc was used to compare across groups for EB absorbance,
western blot analysis, and IHC quantification. Overlap coefficient was calculated via the
ImageJ plugin with the following equation: k^2 = k1*k2 with all values adjusted to
threshold. Pearson’s coefficient was obtained for controls. χ2 analyses was used to
compare the percentages of positive co-localized cells between groups. P < 0.05 was
considered statistically significant for all data analyzed.
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RESULTS
Bryostatin-1 significantly modulates PKCα and ε but not PKCδ expression after blast
Bryostatin-1 has previously been shown to be neuroprotective following mild TBI
in a murine model by reducing β-secretase and β amyloid production (Zohar et al 2011).
Furthermore, our lab has published that bryostatin-1 decreases PKCα and increases
PKCε following neural injury in an aged-female Sprague-Dawley model (Tan et al 2013).
The role bryostatin-1 plays in regulating PKC activity at the neurovascular unit has yet to
be determined. We examined perivascular regions of the left prefrontal cortex using
quantitative IHC. A significant difference in PKCα was observed between groups
(F(2,24) = 7.743, p<0.01) 24 hours after injury. Post-hoc comparison revealed a
significant difference between control and single blast groups (t=5.043, p<0.01) and
between single blast and single blast + bryostatin-1 groups (t=4.559, p<0.01) (Figure 4.2
A-G). A significant difference in PKCδ was observed between groups (F(2,27) = 16.73,
p<0.001) 24 hours after injury. Post-hoc comparison revealed a significant difference
between control and single blast groups (t=8.049, p<0.001) and between control and
single blast + bryostatin-1 groups (t=5.292, p<0.01) (Figure 4.2 H-N). No significant
difference was seen between single blast and single blast + bryostatin-1, consistent with
the notion that bryostatin-1 negligibly alters PKCδ expression. A significant difference in
PKCε was observed between groups (F(2,27) = 14.73, p<0.001) 24 hours after injury.
Post-hoc comparison revealed a significant difference between control and single blast +
bryostatin-1 groups (t=7.509, p<0.001) and between single blast and single blast +
bryostatin-1 groups (t=5.133, p<0.01) (Figure 4.2 O-U). We also examined changes in
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PKC expression using western blot analysis. A significant difference between groups was
observed for PKCα (F(2,14) = 7.672, p<0.01). Post-hoc comparison revealed a
significant difference between control and single blast (t=4.576, p<0.05), and between
single blast and single blast + bryostatin-1 (t=5.113, p<0.01) (Figure 4.3 A). A significant
difference between groups was observed for PKCδ (F(2,6) = 13.25, p<0.01). Post-hoc
comparison revealed a significant difference between control and single blast (t=7.197,
p<0.01), and between control and single blast + bryostatin-1 (t=4.549, p<0.05) (Figure
4.3 B). A significant difference between groups was observed for PKCε (F(2,15) = 10.05,
p<0.01). Post-hoc comparison revealed a significant difference between control and
single blast (t=4.546, p<0.05), and between control and single blast + bryostatin-1
(t=6.102, p<0.01) (Figure 4.3 C).
Bryostatin-1 maintained BBB integrity following blast exposure
BBB integrity can be measured by EB extravasation into the brain parenchyma
(Abdul-Muneer et al 2013). EB binds to albumin, and albumin does not readily penetrate
an intact BBB. NG-2 is a pericyte proteoglycan that is increased during BBB disruption
and subsequent neovascularization (Girolamo et al 2013). Disruption of the BBB has
multiple effects including neuroinflammation and formation of reactive oxygen species
(Abdul-Muneer et al 2014). A significant difference between groups was observed for EB
extravasation 6 hours after blast exposure (F(2,7) = 7.38, p<0.05) for the left prefrontal
cortex (Figure 4.4 A). Post-hoc comparison was significant between control and single
blast (t=4.808, p<0.05) and between single blast and single blast + bryostatin-1 (t=4.347,
p<0.05). No significant difference was seen between control and single blast +
bryostatin-1. Bryostatin-1 successfully preserved the integrity of the BBB apparent on
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gross exam of the left hemisphere (Figure 4.4 B). A significant difference in NG-2 was
observed 24 hours after blast exposure (F(2,27) = 20.42, p<0.001) for the left prefrontal
cortex (Figure 4.4 C-H). Post-hoc comparison was significant between control and single
blast (t=5.504, p<0.01), and between single blast and single blast + bryostatin-1 (t=8.961,
p<0.001), but not between control and single blast + bryostatin-1.
PKC modulation alters tight junction proteins at the BBB
Activation of PKC isozymes is thought to play a crucial role in BBB disruption
(Shao & Bayraktutan 2014). PKCα, in particular, has been linked to redistribution of
tight junction proteins leading to increased vascular permeability (Stamatovic et al 2006).
PKCα is also known to activate sonic hedgehog protein leading to dysfunctional
synthesis of tight junction proteins (Guo et al 2012, Xia et al 2013). Alternatively,
increasing PKCε facilitates tight junction protein translocation from the nucleus to the
plasma membrane (Chamorro et al 2009). Gross examination of the neurovascular unit
(VWF co-localized with GFAP) revealed histological disruption of the BBB following
blast injury but maintenance of barrier integrity when bryostatin-1 was administered
following blast exposure (Figure 4.5 A-C). A significant difference between groups was
not observed for Claudin-5 (Figure 4.5 D-J) using fluorescent IHC. A significant
difference between groups was observed for VE-Cadherin (F(2,6) = 18.58, p<0.01) using
western blot. Post hoc comparison revealed a significant difference between control and
single blast (t=4.571, p<0.05), and between control and single blast + bryostatin-1
(t=8.616, p<0.01) (Figure 4.6 A). A significant difference between groups was observed
for occludin (F(2,6) = 49.02, p<0.001) using western blot. Post hoc comparison revealed
a significant difference between control and single blast (t=6.955, p<0.01), between
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control and single blast + bryostatin-1 (t=14, p<0.001), and between single blast and
single blast + bryostatin-1 (t=7.048, p<0.01) (Figure 4.6 B). A significant difference
between groups was observed for ZO-1 (F(2,26) = 35.68, p<0.001) using fluorescent
IHC. Post hoc comparison revealed a significant difference between control and single
blast + bryostatin-1 (t=11.45, p<0.001), and between single blast and single blast +
bryostatin-1 (t=8.553, p<0.001) (Figure 4.6 C-I). Additionally, a significant difference
between groups was observed for VE-Cadherin (F(2,27) = 5.9, p<0.05) using fluorescent
IHC. Post hoc comparison revealed a significant difference between control and single
blast (t=4.016, p<0.05), and between control and single blast + bryostatin-1 (t=4.375,
p<0.05) (Figure 4.7 A-G). A significant difference was also observed between groups for
occludin (F(2,27) = 79.88, p<0.001). Post hoc comparison revealed a significant
difference between control and single blast (t=8.304, p<0.001), between control and
single blast + bryostatin-1 (t=17.86, p<0.0001), and between single blast and single blast
+ bryostatin-1 (t=9.557, p<0.001) (Figure 4.7 H-N).
PKC α, δ, and ε are co-localized with endothelial cells but not astrocytes after blast
exposure
The neurovascular unit and the associated BBB consists of endothelial cells,
astrocytes, and pericytes that form a structural basement membrane (Amtul & Hepburn
2014). The unit acts as a consortium that dictates vascular constriction and dilation in
response to stimuli (Muoio et al 2014). The role of PKC isozymes in mediating changes
to vasculature tone following TBI has yet to be elucidated. We examined the extent of colocalization for PKCα, δ, and ε with endothelial cells (VWF) or astrocytes (GFAP) in the
left prefrontal cortex of control animals and single blast exposed animals 24 hours after
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injury. The Pearson’s coefficient for control animals for PKCα and VWF was r = 0.395
(Figure 4.8 A-F). The overlap coefficient for PKCα and VWF after single blast exposure
(threshold A=20, threshold B=14) was r = 0.954 with k1=0.734 and k2=1.238 (Figure 4.8
G-L). The Pearson’s coefficient for control animals for PKCα and GFAP was r = 0.351
(Figure 4.8 M-R). The overlap coefficient for PKCα and GFAP after single blast
exposure (threshold A=29, threshold B=22) was r = 0.379 with k1=0.768 and k2=0.187
(Figure 4.8 S-X). The Pearson’s coefficient for control animals for PKCδ and VWF was r
= 0.61 (Figure 4.9 A-F). The overlap coefficient for PKCδ and VWF after single blast
exposure (threshold A=34, threshold B=14) was r = 0.88 with k1=0.444 and k2=1.744
(Figure 4.9 G-L). The Pearson’s coefficient for control animals for PKCδ and GFAP was
r = 0.029 (Figure 4.9 M-R). The overlap coefficient for PKCδ and GFAP after single
blast exposure (threshold A=52, threshold B=20) was r = 0.449 with k1=0.227 and
k2=0.89 (Figure 4.9 S-X). The Pearson’s coefficient for control animals for PKCε and
VWF was r = 0.004 (Figure 4.10 A-F). The overlap coefficient for PKCε and VWF after
single blast exposure (threshold A=44, threshold B=23) was r = 0.978 with k1=0.765 and
k2=1.249 (Figure 4.10 G-L). The Pearson’s coefficient for control animals for PKCε and
GFAP was r = 0.133 (Figure 4.10 M-R). The overlap coefficient for PKCε and GFAP
after single blast exposure (threshold A=24, threshold B=22) was r = 0.394 with
k1=0.286 and k2=0.543 (Figure 4.10 S-X). We examined the percentage of positive cells
for PKCα co-localized with VWF in perivascular regions of the left prefrontal cortex 24
hours after injury (Supplementary Figure 1). The ratio of positively stained cells to total
cells for control was 18/100, for blast-exposed animals 57/100, and for blast exposed

96

!
animals treated with bryostatin-1 36/100. χ2=20.595 with two degrees of freedom and a
two-tailed P value equal to 0.0001.
DISCUSSION
Bryostatin-1 has been successfully used in numerous animal models of neural
injury including TBI, ischemic stroke, auditory neurodegeneration, and Alzheimer’s
disease, and is currently under investigation in clinical trials (Lallemend et al 2005, Sun
& Alkon 2014, Sun et al 2009, Zohar et al 2011). Recent findings have shown that
secondary injury mechanisms such as neuroinflammation, endoplasmic reticulum stress,
and PKC activity are conserved despite the type of injury (Hoozemans & Scheper 2012,
Lucke-Wold et al 2014d, Wu et al 2014). The timing of activity might vary but the
pathways are similar and theoretically targeted in a similar fashion. For example,
bryostatin-1 protects against loss of pre-synaptic synaptophysin and loss of post-synaptic
spinophylin following TBI in mice (Zohar et al 2011). In an aged-female SpragueDawley stroke model, bryostatin-1 improved survival and reduced ischemic damage (Tan
et al 2013). Likewise, bryostatin-1 decreased apoptosis and prevented deficits in
synaptogenesis in a global model of cerebral ischemia (Sun et al 2009, Sun et al 2008).
Despite the different injury models bryostatin-1 was a successful therapeutic because it
upregulates PKC activity early and downregulates activity when used at excess doses or
at chronic time points (Sun & Alkon 2013). At the dose used in this study, it is possible
that an early activation of PKCα is followed by a drastic downregulation observed at 24
hours. PKCε may also be increased not only due to upregulation but also from increased
synthesis (Hongpaisan et al 2011). Future studies will be required to look at PKC changes
at both earlier time points and also the beneficial effects of bryostatin-1 when
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administered at subacute time points. In Alzheimer’s disease early upregulation of PKC
activity enhances neuronal repair and decreases amyloid mediated degeneration while
maintaining long-term potentiation (Kim et al 2012a, Nelson & Alkon 2009). In addition,
bryostatin-1 facilitates neurite outgrowth, maintains cognitive function (Lallemend et al
2005), and enhances synaptic connectivity and spatial learning (Sun et al 2014). For
affective disorders bryostatin-1 downregulates ERK dependent PKC activity at late time
points, which can have beneficial effects for treating substance abuse, depression, and
aversive emotional memories (Mogha et al 2012, Sun & Alkon 2014). Similar molecular
PKC targets appear to be altered in TBI (Luo et al 2014b).The potential for bryostatin-1
as a treatment for TBI warrants further investigation. The necessity for different dosing
strategies as well as altering the timing of dosing must be carefully considered in a series
of future studies. Furthermore, specific activation of select isozymes will offer
compelling insight into their protective properties following TBI. In this study, we
examined how a single 2.5 mg/kg dose of bryostatin-1 affects BBB integrity acutely
following blast-induced TBI.
We found that a single moderate TBI significantly increased EB extravasation
into the left prefrontal cortex six hours after injury. Bryostatin-1 administration
ameliorated this disruption. A potential mechanism by which this occurs is through
regulation of PKCα and PKCε, which subsequently increases the tight junction proteins
VE-Cadherin, occludin, and ZO-1 at the BBB. It has been previously shown in an
ischemic stroke model that inhibiting PKCα increases the tight junction proteins ZO-1,
occludin, and VE-Cadherin (Yu et al 2012). PKCα has limited regulatory function for
claudin-5 accounting for the non-significant findings observed. Tight junction proteins
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overall are essential for maintaining limited and selective permeability into the brain
parenchyma and preventing neuroinflammation (Chodobski et al 2011). A switch to
PKCα activation following TBI has been shown to accelerate neuroinflammation (Dai et
al 2010). Our data show that bryostatin-1 decreased levels of PKCα when given after
blast. A separate isozyme, PKCδ, mediates vasoconstriction, but its role in tight junction
disruption is poorly understood (Novokhatska et al 2013). Our data show that bryostatin1 had a negligible effect on PKCδ levels. Another isozyme, PKCε is associated with
neuroprotection in various models of brain injury (Feng et al 2013). Bryostatin-1 was
previously shown to regulate tight junction proteins in vitro via modulation of PKCε
(Yoo et al 2003). PKCε is essential for exportation of zona occluden proteins to the site
of functional activity (Chamorro et al 2009). We found that bryostatin-1 significantly
elevated PKCε when administered after blast injury.
Increasing VE-Cadherin, occludin, and ZO-1 strengthens the BBB therefore
maintaining its integrity (Liu et al 2014a). Other therapeutic approaches for TBI such as
hyperbaric oxygen and sevoflurane were previously shown to significantly increase tight
junction protein expression (Chen et al 2014, Thal et al 2012). Our data provide
compelling evidence that bryostatin-1 also increases tight junction proteins leading to
maintenance of the BBB and decreased permeability after blast injury. Future work will
examine the functional capacity of these tight junction proteins as well as their efficient
means of trafficking (McCaffrey & Davis 2012). Utilizing in vitro modeling with
astrocyte and endothelial co-culture may represent an effective way to examine
functional capacity (Yang et al 2012). Designing an effective in vitro model of blast TBI
and BBB dynamics is an area requiring focused investigation (Arun et al 2013b, Effgen
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et al 2014). Another avenue requiring further investigation is how changes in PKC
function affect the gliovascular unit. Our data show that PKC changes were localized to
the endothelial cells not glia. What has yet to be discovered is how cytokines released
from endothelial cells may alter the surrounding gliovascular unit (Alves 2014). In order
to investigate this important area, specific PKC modulators such as (Alphatomega; HFKKQGSFAKKK-NH(2)) for PKCα and the PKCε peptide activator must be used in
future investigative studies (Kang et al 2008, Teng et al 2008). A malfunctioning
gliovascular unit can contribute to chronic neurodegeneration (Barzilai 2013).
An area of ongoing research is how the progression of acute BBB disruption leads
to chronic detrimental outcomes. Subtle changes can occur in a young developing brain
post TBI that often take years to manifest into symptoms (Adelson et al 2013).
Microbleeds from a disrupted BBB following TBI can cause long-term negative
outcomes such as glial scarring and white matter degeneration (Glushakova et al 2014,
Lucke-Wold et al 2014c, Wu et al 2012). These markers of injury have been associated
with mid-to-late life diseases such as chronic traumatic encephalopathy, autoimmune
encephalomyelitis, vascular dementia, and early onset Alzheimer’s disease (Marcelo &
Bix 2014, Stein et al 2014, Turner et al 2012a). Interestingly, stabilization of the BBB
through PKC modulation decreases chronic negative effects acutely (Lanz et al 2013). If
BBB disruption does occur, calcium imbalance triggers a host of downstream events.
Current understanding indicates that glia communicate with neurons through calcium
signaling, and calcium signaling is often disrupted following TBI (De Bock et al 2014).
Disrupted calcium signaling can lead to activation of endoplasmic reticulum stress and
mitochondrial dysfunction (Naviaux 2014). Long term outcomes include the formation of
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reactive oxygen species, amyloid pathology, and tau hyperphosphorylation (Eckert et al
2013). PKC isozymes are known tau kinases that are increased in neurodegenerative
disease (Kamat et al 2014). Long-term bryostatin-1 treatment has been shown to
modulate tau hyperphosphorylation in a murine model of dementia (Ekinci & Shea 1997,
Sun & Alkon 2014). A large prospective cohort study has recently shown that veterans
diagnosed with TBI have a 1.57 adjusted hazard ratio for the onset of dementia compared
to controls (Barnes et al 2014). Ongoing work will investigate the long-term role
bryostatin-1 treatment plays in preventing neurodegeneration following repetitive blast
exposure. Appropriate dosing strategies will be carefully developed for single and
repetitive injury. The effects of bryostatin-1 are likely two fold: protection of BBB
acutely and preservation of neuronal stability chronically. Timing and appropriate dosing
is a necessity to tease out the most appropriate protective treatment windows. PKC
modulation offers a promising therapeutic approach for preventing the chronic sequelae
associated with neurotrauma.
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Figure 4.1: Table showing the experimental techniques used for each time point.
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Figure 4.2: Bryostatin-1 decreases PKCα and increases PKCε 24 hours after blast
exposure. Our data show that bryostatin-1 has a profound effect after blast traumatic
brain injury using fluorescent IHC. Scale bar = 100µm in left prefrontal cortex. PKCα
control (A) with inlay (B) compared to single blast exposure (C) with inlay (D), and
single blast exposure + bryostatin-1 (E) with inlay (F) showed significant difference
between groups. Post hoc comparison between control and single blast (** p<0.01) and
between single blast and single blast + bryostatin-1 (## p<0.01) as depicted in bar graph
(G). PKCδ control (H) with inlay (I) compared to single blast exposure (J) with inlay
(K), and single blast exposure + bryostatin-1 (L) with inlay (M) showed significant
difference between groups. Post hoc comparison between control and single blast (***
p<0.001) and between control and single blast + bryostatin-1 (** p<0.01) as depicted in
bar graph (N). PKCε control (O) with inlay (P) compared to single blast exposure (Q)
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with inlay (R), and single blast exposure + bryostatin-1 (S) with inlay (T) showed a
significant difference between groups. Post hoc comparison between control and single
blast + bryostatin-1 (*** p<0.001) and between single blast and single blast + bryostatin1 (!! p<0.01) as depicted in bar graph (U).

105

!

Figure 4.3: Bryostatin-1 is a potent PKC modulator. It has been used to regulate PKC
activity in a time-specific manner for multiple neural injury models. Protein
concentrations were measured in the left prefrontal cortex 24 hours after blast expsoure
using western blot analysis. A significant difference between groups was observed for
PKCα. Post-hoc comparison between control and single blast (* p<0.05), and between
single blast and single blast + bryostatin-1 (## p<0.01) (A). A significant difference
between groups was observed for PKCδ. Post-hoc comparison between control and single
blast (** p<0.01), and control and single blast + bryostatin-1 (* p<0.05) (B). A
significant difference between groups was observed for PKCε. Post-hoc comparison
between control and single blast (* p<0.05), and between control and single blast +
bryostatin-1 (** p<0.01) (C). Bryostatin-1 significantly decreased PKCα levels and
increased PKCε levels when administered after blast exposure.
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Figure 4.4: Bryostatin-1 preserves BBB integrity. Evan’s blue binds to albumin and is a
widely used marker for detecting breaches in the BBB. NG-2 is a proteoglycan found in
pericytes that will be increased when the BBB is disrupted. Scale bar = 100µm in left
prefrontal cortex. A significant difference between groups was observed for EB
absorbance in the brain after femoral vein injection post-blast. Post-hoc comparison
revealed a significant difference between control and single blast (* p<0.05), and between
single blast and single blast + bryostatin-1 (# p<0.05) (A). Gross examination revealed
increased EB staining in the left hemisphere following blast exposure that was decreased
when bryostatin-1 was given following blast (B). A significant difference between groups
was observed for NG-2 IHC fluorescent staining (C-H). Post-hoc comparison revealed a
significant difference between control and single blast (** p<0.01), and between single
blast and single blast + bryostatin-1 (### p<0.001) (I).
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Figure 4.5: Vasculature disruption after blast exposure is independent of claudin-5
regulation. PKCα specifically regulates occludin, ZO-1, and VE-Cadherin, but not
claudin-5. Claudin-5 levels may therefore be independent of bryostatin-1 modulation.
Scale bar = 5µm in the left prefrontal cortex (A-C). Scale bar = 100µm in the left
prefrontal cortex (D-J). VWF (green) was co-localized with GFAP (red) to give a visual
representation of cerebral vasculature. Control vasculature in the left prefrontal cortex
was visibly intact (A). 24 hours after blast exposure left prefrontal cortex vasculature was
visibly disrupted as indicated by the sparse VWF staining (B). Bryostatin-1 preserved
vasculature integrity when administered after blast exposure (C). No significant
differences were observed between groups for claudin-5 using fluorescent IHC (D-J).
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Figure 4.6: Bryostatin-1 significantly increases tight junction proteins. Our data show
that bryostatin-1 significantly upregulated tight junction proteins leading to maintenance
of BBB integrity following blast TBI. Scale bar = 100µm in left prefrontal cortex. A
significant difference was observed between groups using western blot for VE-Cadherin
with post hoc comparison showing significance between control and single blast (*
p<0.05), and between control and single blast + bryostatin-1 (** p<0.01) 24 hours after
blast exposure (A). A significant difference was observed between groups using western
blot for occludin with post hoc comparison showing significance between control and
single blast (** p<0.01), between control and single blast + bryostatin-1 (*** p<0.001),
and between single blast and single blast + bryostatin-1 (## p<0.01) 24 hours after blast
exposure (B). A significant difference was observed between groups using fluorescent
IHC for ZO-1 with post hoc comparison showing significance between control and single
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blast + bryostatin-1 (*** p<0.001), and between single blast and single blast + bryostatin1 (### p<0.001) 24 hours after blast exposure (C).
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Figure 4.7: Tight junction protein expression was increased by bryostatin-1 at
vasculature. Tight junction protein return of function is necessary for restoration of BBB
integrity. Scale bar = 75µm in left prefrontal cortex. A significant difference was
observed between groups using fluorescent IHC for VE-Cadherin with post hoc
comparison showing significance between control and single blast (* p<0.05), and
between control and single blast + bryostatin-1 (* p<0.05) 24 hours after blast exposure
(A-G). A significant difference was observed between groups using fluorescent IHC for
occludin with post hoc comparison showing significance between control and single blast
(*** p<0.001), between control and single blast + bryostatin-1 (**** p<0.0001), and
between single blast and single blast + bryostatin-1 (### p<0.001) 24 hours after blast
exposure (H-N).
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Figure 4.8: PKCα co-localized with endothelial cells but not astrocytes. Both astrocytes
and endothelial cells are critical for maintenance of the BBB. PKCα activity within
endothelial cells plays an intimate role in regulating extracellular tight junction proteins.
Fluorescnt IHC red staining for PKCα, green staining for VWF (endothelial) or GFAP
(astocyte), and yellow is overlay. Scale bar = 20µm in left prefrontal cortex. PKCα (A)
with inlay (B) and VWF (C) with inlay (D) have a weak overlay with a Pearson’s
coefficient of r=0.395 seen in (E) with inlay (F) for control animals. PKCα (G) with
inlay (H) and VWF (I) with inlay (J) have a very strong overlay with an overlap
coefficient of r=0.954 seen in (K) with inlay (L) 24 hours post blast exposure. PKCα (M)
with inlay (N) and GFAP (O) with inlay (P) have a weak overlay with a Pearson’s
coefficient of r=0.351 seen in (Q) with inlay (R) for control animals. PKCα (S) with
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inlay (T) and GFAP (U) with inlay (V) have a weak overlay with an overlap coefficient
of r=0.379 seen in (W) with inlay (X) 24 hours post blast exposure.
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Figure 4.9: PKCδ co-localized with endothelial cells but not astrocytes. PKCδ plays an
important role in mediating vascular tone. Its role in regulation of tight junction proteins
is not completely understood. Fluorescent IHC red staining for PKCδ, green staining for
VWF (endothelial) or GFAP (astocyte), and yellow is overlay. Scale bar = 20µm in left
prefrontal cortex. PKCδ (A) with inlay (B) and VWF (C) with inlay (D) have a moderate
overlay with a Pearson’s coefficient of r=0.61 seen in (E) with inlay (F) for control
animals. PKCδ (G) with inlay (H) and VWF (I) with inlay (J) have a strong overlay with
an overlap coefficient of r=0.88 seen in (K) with inlay (L) 24 hours post blast exposure.
PKCδ (M) with inlay (N) and GFAP (O) with inlay (P) have a very weak overlay with a
Pearson’s coefficient of r=0.029 seen in (Q) with inlay (R) for control animals. PKCδ (S)
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with inlay (T) and GFAP (U) with inlay (V) have a moderate overlay with an overlap
coefficient of r=0.449 seen in (W) with inlay (X) 24 hours post blast exposure.
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Figure 4.10: PKCε co-localized with endothelial cells but not astrocytes. PKCε
contributes to neuroprotection when increased after brain injury. PKCε has been
associated with improved cognitive performance and decreased neurodegeneration.
Fluorescent IHC red staining for PKCε, green staining for VWF (endothelial) or GFAP
(astrocyte), and yellow is overlay. Scale bar = 20µm in left prefrontal cortex. PKCε (A)
with inlay (B) and VWF (C) with inlay (D) have a very weak overlay with a Pearson’s
coefficient of r=0.004 seen in (E) with inlay (F) for control animals. PKCε (G) with inlay
(H) and VWF (I) with inlay (J) have a strong overlay with an overlap coefficient of
r=0.978 seen in (K) with inlay (L) 24 hours post blast exposure. PKCε (M) with inlay
(N) and GFAP (O) with inlay (P) have a weak overlay with a Pearson’s coefficient of
r=0.133 seen in (Q) with inlay (R) for control animals. PKCε (S) with inlay (T) and
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GFAP (U) with inlay (V) have a weak overlay with an overlap coefficient of r=0.394
seen in (W) with inlay (X) 24 hours post blast exposure.
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Supplementary Figure 4.1: Blast exposed animals have greater number of cells colocalized with PKCα and VWF. Staining for groups: red=PKCα, green=VWF, and
yellow=overlay. Regions analyzed for ratio of positive cells to total cells. Representative
section for control group PKCα (A) with inlay (B), VWF (C) with inlay (D), and overlay
(E) with inlay (F). Representative section for single blast exposed group PKCα (G) with
inlay (H), VWF (I) with inlay (J), and overlay (K) with inlay (L). Representative section
for single blast + bryostatin-1 group PKCα (M) with inlay (N), VWF (O) with inlay (P),
and overlay (Q) with inlay (R).
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Chapter Five
Endoplasmic reticulum stress implicated in chronic traumatic encephalopathy
This work is published in J Neurosurg. 2016 Mar;124(3):687-702. doi:
10.3171/2015.3.JNS141802. Epub 2015 Sep 18. PMID: 26381255
Lucke-Wold BP, Turner RC, Logsdon AF, Nguyen L, Bailes JE, Lee JM, Robson MJ,
Omalu BI, Huber JD, Rosen CL
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ABSTRACT
Object: Chronic traumatic encephalopathy is a progressive neurodegenerative disease
characterized by neurofibrillary tau tangles following repetitive neurotrauma. The
underlying

mechanism

linking

traumatic

brain

injury

to

chronic

traumatic

encephalopathy has not been elucidated. We investigate the role of endoplasmic
reticulum stress as a link between acute neurotrauma and chronic neurodegeneration.
Methods: We used pharmacological, biochemical, and behavioral tools to assess the role
of endoplasmic reticulum stress in linking acute repetitive traumatic brain injury to the
development of chronic neurodegeneration. Data from our clinically relevant and
validated rodent blast model was compared to post-mortem human chronic traumatic
encephalopathy pathology from a National Football League player and World Wrestling
Entertainment wrestler.
Results: Our results demonstrate strong correlation of endoplasmic reticulum stress
activation with subsequent tau hyperphosphorylation. Various endoplasmic reticulum
stress markers were increased in human chronic traumatic encephalopathy specimens,
and the endoplasmic reticulum stress response was associated with an increase in the tau
kinase, glycogen synthase kinase three β. Docosahexaenoic acid, an endoplasmic
reticulum stress inhibitor, improved cognitive performance in our rat model 3 weeks after
repetitive blast exposure. Our data show that docosahexaenoic acid administration
substantially reduced tau hyperphosphorylation (t = 4.111, P < 0.05), improved cognition
(t = 6.532, P < 0.001), and inhibited endoplasmic reticulum stress activation (t = 5.631, P
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< 0.01), and for the first time that endoplasmic reticulum stress is involved in the
pathophysiology of chronic traumatic encephalopathy.
Conclusion: Docosahexaenoic acid therefore warrants further investigation as a potential
therapeutic for the prevention of chronic traumatic encephalopathy.
KEY WORDS: chronic traumatic encephalopathy, blast traumatic brain injury,
endoplasmic reticulum stress, hyperphosphorylated tau, docosahexaenoic acid
INTRODUCTION
Chronic traumatic encephalopathy (CTE) is a progressive tau-dependent
neurodegenerative disease associated with a history of concussive and/or subconcussive
injury in sports or from exposure to blast waves in military personnel (Stein et al 2014).
Several progressive neuropsychiatric symptoms such as impulsive behavior, depression,
loss of executive function, and cognitive decline have been reported with this progressive
tauopathy (McKee et al 2014). Alarmingly, the number of sports-related concussions has
risen to three-hundred-thousand per year in the United States, and the number of military
service personnel exposed to blast traumatic brain injury (TBI) during the recent wars in
Iraq and Afghanistan was estimated at two-hundred-seventy thousand (Noble &
Hesdorffer 2013, Sosa et al 2013). Although several case reports and case series have
examined the underlying pathology of CTE, few studies have looked at pathways that
link TBI to chronic neurodegeneration (McKee et al 2010, Omalu et al 2010a, Omalu et
al 2010b, Watanabe et al 2010). As such, the pathophysiology of CTE development
remains poorly understood and no viable therapeutics are under development due to the
lack of identified therapeutic targets (Yokobori et al 2013). To address this lack of
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understanding, we investigated one component of the pathophysiology linking acute
neurotrauma to chronic neurodegeneration.
We propose that the endoplasmic reticulum (ER) stress response may play an
important role in linking acute neurotrauma to chronic tau-dependent neurodegeneration
(Lucke-Wold et al 2014c). The ER stress response consists of three arms: protein kinase
RNA-like ER kinase (PERK), inositol requiring enzyme one α (IRE1α), and activating
transcription factor six (ATF6). The arms are activated when binding immunoglobulin
protein (BiP) dissociates from the ER membrane signaling an increase in unfolded
proteins (Kang et al 2013). While arm one (PERK) is generally neuroprotective, it can
elevate C/EBP homology protein (CHOP) above threshold at extended time points
leading to apoptosis (Hiramatsu et al 2014). Arm two (IRE1α) and arm three (ATF6)
likewise increase CHOP and trigger pro-apoptotic pathways (Shoulders et al 2013). Arm
two can also lead to the phosphorylation of c-Jun N-terminal kinase (JNK) (Zhu et al
2014). ER stress markers are acutely increased following TBI in rodent models (Larner et
al 2004). Recent findings have shown that ER stress increases following cortical
contusion in a rat model with changes in amyloid precursor protein and tau (Begum et al
2014). Weight-drop TBI has been shown to increase intracellular calcium and result in
the activation of the ER stress response in mice (Rubovitch et al 2011). Controlled
cortical impact also increases ER stress and triggers apoptosis in rats acutely after injury
(Farook et al 2013). While these studies demonstrate the role of ER stress in acute
pathophysiological events after TBI, how ER stress contributes to persistent
neurodegeneration remains unclear. Abisambra and colleagues have ascertained that tau
from neurofibrillary tangles perpetually activates the ER stress response (Abisambra et al
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2013). Conversely the ER stress pathway can activate tau kinases such as apoptosis signal
regulating kinase one, JNK, and glycogen synthase kinase three Beta (GSK3β) (Chen et
al 2011, Placido et al 2014, Song et al 2014). These important co-stimulatory interactions
connect ER stress in interplay with chronic neurodegenerative diseases. In addition,
phosphorylated-PERK has been co-localized with tau in diseases such as Alzheimer’s
disease and supranuclear palsy (Stutzbach et al 2013).
Herein, we provide compelling evidence that the ER stress response is not only
activated acutely following neurotrauma but is involved in the development and
progression of CTE-like findings in an animal model and post-mortem specimens
previously described as having CTE (Omalu et al 2010b). Furthermore, we show that the
development of CTE-like findings following repetitive concussive blast in rats is
prevented by administration of docosahexaenoic acid (DHA). DHA, an important
component of omega three fatty acids, has recently been shown to decrease ER stress by
lowering intracellular calcium (Begum et al 2014). Our data show that DHA
administration decreases tau kinases, tau hyperphosphorylation, and improves cognitive
performance 3 weeks after repetitive blast injury. Modulation of ER stress responses may
therefore represent a promising preventative and therapeutic strategy in the field of
neurotrauma.
METHODS
Animals and human samples
All experiments involving animals were approved by the Institutional Animal Care
and Use Committee of West Virginia University and were performed according to the
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principles of the Guide for the Care and Use of Laboratory Animals. Eighty-eight (88)
young-adult male rats (Hilltop Lab Animals, Inc.) were used for this study based on
power analysis calculations (DSS Research). We used twenty-four (24) rats for Morris
water maze behavioral testing, thirty-two (32) rats for immunohistochemistry (IHC)
staining, and thirty-two (32) rats for western blot analysis. Human sections from the
entorhinal cortex of a National Football League (NFL) player with diagnosed CTE,
World Wrestling Entertainment (WWE) wrestler with diagnosed CTE, and age-matched
(44-year-old male) control were used for immunohistochemical studies.
The case of the WWE wrestler was previously documented and published in 2010
(Omalu et al 2010b). Briefly, he was 40 years of age at the time of death. Death was ruled
a suicide with the manner of death by asphyxiation resulting from hanging. The patient
had a history of repetitive brain trauma that included a car collision and mild traumatic
brain injury at 6 years of age and at least fifteen self-reported concussions throughout his
career in wrestling. Prior to his death, he suffered from depression and memory loss. The
patient also had a history of presumed anabolic steroid use and suspected prescription
drug dependency (narcotics).
The case of the NFL player was previously documented and published in 2010
(Omalu et al 2010a). Briefly, he was 36 years of age at time of death. Death was the
result of a head on motor vehicle collision with a tanker truck. The patient had a history
of repetitive head trauma from 4 years of collegiate football and eight seasons in the
NFL. Prior to his death, he suffered from cognitive and neuropsychiatric symptoms. The
patient also had a history of parasuicidal behavior.
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Experimental groups, blast exposure, and drug treatments
Groups for 24-hour post-injury IHC study: control, single blast, and repeat blast.
Groups for 24-hour post- injury western blot study: control, single blast, single blast +
DHA, and DHA alone. Groups for 3-week post-injury western blot and IHC study:
control, repeat blast, and repeat blast + DHA. Groups for 3-week post-injury behavioral
study: control, repeat blast, and repeat blast + DHA. All groups receiving repeat blast
exposure had one blast administered every other day for two weeks (six total blasts).
DHA (Zone Labs Inc.) was delivered i.p. 16mg/kg 5 minutes following each blast
exposure for the DHA + repeat blast groups, and subsequently every other day until
Morris water maze testing (Begum et al 2014).
Blast exposure
A scaled moderate intensity blast wave(s) (~50.72 PSI peak reflected over
pressure) was released perpendicular to the right side of the animal’s head with a shield
of polyvinyl chloride protecting the body. Blast exposures were generated using a novel
shock tube described in our prior work (Turner et al 2013). The shock tube was designed
with a short driver section in order to generate a short-duration wave, a characteristic
deemed clinically relevant based on extensive work demonstrating scaling principles
associated with blast across species. The overpressure was recorded using piezoelectric
sensors (Model 102AO5; PCB Piezotronics) placed in the reflected and incident positions
at the exit of the shock tube. Data was then recorded using a sensor signal conditioner
(482C Series; PCB Piezotronics) and a data acquisition board (DAQ 23GF; National
Instruments). Data was then recorded on the computer using a customized program
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written with LabView version 12.0 (National Instruments). A representation of the
experimental setup can be seen in supplementary figure 5.1.
Biochemistry preparation
Animals used for western blot analysis were sacrificed by decapitation with a
sharpened guillotine after being anesthetized by inhalation of 4% isoflurane
(Halocarbon). For western blot, the brains were immediately placed in a lysate buffer
containing: (10 mM Tris, pH 7.4, 320 mM sucrose, 1% Triton X-100, 1% CHAPS and
0.025% NaN3) with phosphatase and protease inhibitors (1 mM EDTA, 1 mM EGTA, 50
mM sodium fluoride, 2 mM sodium orthovanadate, 0.1 mM ammonium molybdate, 0.2
mM phenylarsine oxide, and Roche Complete tablets) (Plattner et al 2006). Bilateral
dissections of cortex, hippocampus, striatum, and cerebellum were performed, and tissue
was subsequently flash frozen in liquid nitrogen and stored at -80o C for current and
future studies. Animals used for immunohistochemistry were anesthetized with 4%
isoflurane (Halocarbon) and transcardially perfused with ice-cold 0.9% saline followed
by 10% formalin for a total of 10 min. The brains were dissected and placed in 10%
formalin. Brains were block-sectioned into 4 coronal sections, paraffin-embedded, and
serially sliced with a Leica RM2235 microtome (Leica Microsystems, Wetzlar, Germany)
for immunofluorescent, diaminobenzadine, and hematoxylin and eosin staining.
Western blot
Western blot procedures were performed similar to previous work published by
our lab (Dinapoli et al 2010). Hippocampal protein samples were dissolved in 0.5 mL hot
(85-95o C) 1% sodium docecyl sulfate (SDS), sonicated, and assayed with a

126

!
Bicinchoninic Acid (BCA) protein assay kit (Thermo Fisher Scientific, Rockfield, IL). 30
µg of protein per well was run with 2X Lammeli buffer on pre-cast Bolt® Bis-Tris Plus
10% 12-well gels (Life Technologies, Carlsbad, CA) using a Bolt® Mini tank system
(Life Technologies). A SeeBlue® Plus2 pre-stained Standard (Life Technologies) was
used. Nitrocellulose membranes (Bio-Rad, Contra Costa, CA) were used for wet transfer
(Bio-Rad) at 60 volts for 2.5 hours. Imaging was conducted with a LI-COR fluorescent
scanner at wavelength 700 or 800, intensity 6.0, and resolution eighty-four. Images were
converted to gray scale and analyzed after background subtraction (Odyssey Processing
Software). Values were normalized to β-actin to give relative overall intensity.
The following primary antibodies were used: AT270, growth arrest and DNA
damage-inducible protein 34 (GADD34) (Thermo), BiP, CHOP, p-JNK (Cell Signaling),
p-GSK3β (Santa Cruz), and CP-13 (kindly gifted by Dr. Peter Davies, Albert Einstein
College of Medicine) all at a concentration of 1:1000. Anti-rabbit or anti-mouse IRDye
secondary antibodies (LI-COR) were used at a concentration of 1:2000. A β-actin rabbit
monoclonal antibody (Cell Signaling) was used as an endogenous control at a
concentration of 1:10,000. Imaging was conducted with a LI-COR fluorescent scanner
and analyzed after background subtraction (Odyssey Processing Software). Values were
normalized to β-actin to give relative overall intensity.
Immunohistochemistry
Qualitative and quantitative staining was completed for this paper that utilized
previously described techniques for hematoxylin and eosin, bright-field imaging with
diaminobenzadine (DAB), and fluorescent imaging (Robson et al 2014, Turner et al
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2013). Briefly, in order to remove paraffin, slides were washed for 5 minutes in xylene,
100% EtOH, and 95% EtOH followed by 5 minute rehydration in dH2O. The slides were
then quenched with 10% methanol and 10% H2O2 in Dulbecco’s phosphate buffered
saline (DPBS) for 15 minutes. After quenching, slides were rinsed two times in DPBS for
10 minutes each. The slides were then placed in permeabilizing solution (1.8% L-Lysine,
4% horse serum, and 0.2% Triton X-100 in DPBS) for 30 minutes. For fluorescent
staining, brain slices were circumscribed, incubated with primary antibody overnight
followed by a fluorescent secondary for three hours, and fixed with a coverslip. If
staining for co-localization, a second set of primary and secondary antibody was applied
prior to fixing the coverslip. For diaminobenzadine staining, primary antibody, secondary
antibody, strepavidin-HRP, and then DAB was applied before fixing with the coverslip.
The hematoxylin and eosin protocol consisted of dissolving off paraffin with 5 minute
washes in xylene, 100% EtOH, and 95% EtOH. The slides were then stained in Harris
Hematoxylin Solution for 2 minutes and 15 seconds. The slides were rinsed in running
tap water and then dipped in differentiating solution (0.25 mL concentrated HCl in 100
mL of 70% EtOH). The slides were rinsed again in running tap water and placed in
Scott’s Tap Water substitute (2g of NaHCO3 and 20 g MgSO4 in 1 L of tap water) for 1
minute. Slides were placed in 95% EtOH for 0.5 minutes and stained with Eosin Y
Solution for 0.5 minutes. The slides were dehydrated with 5-minute washes in 95%
EtOH, 100% EtOH, and xylene and then a coverslip was fixed with Permount.
Primary antibodies were CHOP, IRE1α, x-box binding protein one (XBP1),
phosphorylated eukaryotic initiation factor two alpha (p-eIF2α), p-PERK, ATF6 (Cell
Signaling), AT100, AT270, GSK3β (Thermo), and MCI, paired helical filament (PHF),
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and CP-13 (kindly gifted by Dr. Peter Davies, Albert Einstein College of Medicine).
Secondary antibodies for fluorescent imaging were Alexa Fluor 488 and 594 (Life
Technologies) tagged with the corresponding species to the primary antibody. Imaging
was done with a Zeiss Axio Imager two (Carl Zeiss Microscopy, Thϋringen, Germany).
For quantification of DAB staining, perivascular regions were randomly selected from
hippocampus region for rats and entorhinal cortex for humans. An observer blinded to
experimental group randomly selected 100 total cells. The number of positive cells was
reported as a fraction of total cells counted. For fluorescent staining, twenty cells per
slide (hippocampus rat) (entorhinal cortex human) were randomly selected by blinded
observer, outlined, and measured. Fluorescent density was compared to background
readings, corrected with ImageJ software, and quantified. Co-localization quantification
with the Just Another Co-localization plugin for ImageJ was used to determine overlap
coefficient or Pearson’s coefficient (Bolte & Cordelieres 2006). Overlap coefficient was
calculated using k^2 = k1*k2 with values adjusted to threshold.
Morris water maze
Animals were assessed beginning two weeks after final blast exposure. The pool
was ~180 cm in diameter with a 10 cm x 10 cm platform submerged 2.5 cm below water
(20°C). The training paradigm consisted of 6 days of spatial acquisition with a hidden
platform followed by a probe day where the platform was removed. On acquisition days,
rats were placed into the maze apparatus four times from different pre-determined
locations. The animals were allowed 2 minutes per trial to locate the platform. Timing
stopped once platform was found. If the animal did not find the platform, it was placed on
the platform for 15 seconds to facilitate acquisition before starting the next trial. On the
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probe day, animals were placed in the apparatus for 1 minute at a novel entrance point.
The time the animal spent exploring an area encompassing 300% of where the platform
had been was recorded. Any-maze video tracking software (Stoelting Co., Wood Dale,
IL) was used to record distance traveled as well as latency to reach platform for all
studies. Tracking plots for each animal were recorded (Supplementary Figure 5.2).
Statistical analysis
A blinded observer performed all quantification for IHC and western blot. Oneway Analysis of Variance (ANOVA) was used for IHC, western blot, and Morris water
maze. Bonferroni post-hoc comparison was used to determine differences between
groups. For DAB staining, a chi-square analysis was used to compare between groups.
For co-localization studies, Pearson’s coefficient was obtained for control sections.
Overlap coefficient was obtained for experimental groups to determine extent of samecell protein expression. Two-way ANOVA was used to determine time dependent
acquisition for Morris water maze learning trials. GraphPad Prism 5.0 (GraphPad
Software, Inc., La Jolla, CA) was used for statistical analysis. P < 0.05 was considered
statistically significant for all data analyzed.
RESULTS
Tau pathology is evident in blast-injured animals and human CTE
Key pathologic findings for CTE include tau hyperphosphorylation and neuritic
threads. The pathology is commonly located in subcortical and perivascular foci (McKee
et al 2013). DAB staining revealed increased tau markers, PHF and CP-13, after repeat
blast in perivascular areas adjacent to the hippocampus in Sprague Dawley rats 3 weeks
post-injury, but not in control or repeat blast + DHA animals (Figure 5.1 A-L). Ratio of
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positive PHF stained cells for control = 0/100, repeat blast = 18/100, and repeat blast +
DHA = 3/100. χ2 = 26.571 with 2 degrees of freedom and p<0.0001. Ratio of positive
CP-13 stained cells for control = 0/100, repeat blast 17/100, and repeat blast + DHA =
4/100. χ2 = 22.571 with 2 degrees of freedom and p<0.0001. In addition, hematoxylin and
eosin staining revealed heterogeneous appearance, chromatolysis, vacuolization, and
degenerating neurons 3 weeks post repetitive blast but not in control or repeat blast +
DHA animals (Figure 5.1 M-R). Likewise, DAB staining revealed increased MCI, PHF,
and CP-13 in the entorhinal cortex of human subjects exposed to repeated head trauma
(CTE diagnosis) as compared to age-matched control specimens without a history of head
trauma (Figure 5.2 A-R). Ratio of positive MCI stained cells for control = 2/100, NFL
23/100, and WWE 25/100. χ2 = 19.7 with 2 degrees of freedom and p<0.0001. Ratio of
positive PHF stained cells for control = 2/100, NFL 29/100, and WWE 32/100. χ2 = 26
with 2 degrees of freedom and p<0.0001. Ratio of positive CP-13 stained cells for control
= 2/100, NFL 27/100, and WWE 26/100. χ2 = 21.794 with 2 degrees of freedom and
p<0.0001. MCI, PHF, and CP-13 mark a progression in tauopathy. MCI is an altered
form of tau that appears after injury, whereas PHF (serine 396 and 404) is a precursor to
tau oligomers, and CP-13 marks pre-tangle tau at serine 202.
ER stress is increased in blast-injured animals and human CTE
The ER stress response is an important indicator for an injured cell with all three
arms of the response modulating cell survival. Acutely the ER stress response enhances
survival, but chronic activation triggers apoptosis (Hetz & Mollereau 2014). The ER
stress response has been implicated in both acute injuries, such as TBI, as well as chronic
neurodegenerative disease development, such as AD (Hoozemans & Scheper 2012). We
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examined all three arms of the ER stress pathway with IHC in both our animals exposed
to single and repeat blast injury and in human CTE samples. Arm one, represented by peIF2α, was increased 24 hours after blast injury in the Sprague Dawley rats (F(2,12) =
4.07, P < 0.05) (Figure 5.3 H-N). Post-hoc comparison was significant between control
vs. single blast injury (t = 2.852, P < 0.05). One-way ANOVA revealed no statistical
significance for arm two, represented by XBP1, 24 hours after single or repeat blast
injury in Sprague Dawley rats (Figure 5.3 O-U). The one-way ANOVA for arm three,
represented by ATF6, was statistically significant (F(2,12) = 4.8, P < 0.05) for blast
animals, and Bonferroni post-hoc comparison revealed a significant difference between
control and repeat blast groups (t = 2.710, P < 0.05) (Figure 5.3 M-R). p-eIF2α was
increased in the National Football League (NFL) and World Wrestling Entertainment
(WWE) CTE brains (F(2,12) = 13.08, P < 0.001) (Figure 5.4 H-N). Post-hoc comparison
was significant between control vs. NFL brain (t = 3.798, P < 0.01) and control vs. WWE
brain (t = 4.866, P < 0.001). XBP1 was also increased in the CTE brains (F(2,12) =
38.55, P < 0.001) (Figure 5.4 A-G). Post-hoc comparison was significant between control
vs. NFL brain (t = 8.647, P < 0.001) and control vs. WWE brain (t = 2.998, P < 0.05).
Furthermore, ATF6 was increased in the CTE brains (F(2,12) = 9.935, P < 0.01) (Figure
5.4 O-U). Post-hoc comparison was significant between control vs. NFL brain (t = 4.369,
P < 0.01) and control vs. WWE brain (t = 2.951, P < 0.05). CHOP was significantly
elevated in human CTE brains (F(2,12) = 24.17, P < 0.001) (Figure 5.5 A-G). Post-hoc
comparison was significant between control vs. NFL brain (t = 6.849 P < 0.001). CHOP
was also significantly elevated 24 hours after blast injury in Sprague Dawley rats (F(2,12)
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= 4.161, P < 0.05) (Figure 5.5 H-N). Post-hoc comparison was significant between
control vs. single blast injury (t = 2.875, P < 0.05).
ER stress is associated with tau hyperphosphorylation
Tau hyperphosphorylation is an important precursor for the development of CTE
(Mez et al 2013). Currently, the mechanism of CTE development is not known, but ER
stress offers to be a promising candidate based on prior work in neurotrauma showing an
acute elevation of ER stress and chronic elevation of ER stress in neurodegenerative
disease such as Alzheimer’s disease. We co-stained for ER stress activation, IRE1α, and
tau hyperphosphorylation, AT270, in human CTE brains as well as Sprague Dawley rats
exposed to blast injury (Figure 5.6). IRE1α was used to represent the second arm of ER
stress and has been co-localized with other tauopathies (Hoozemans & Scheper 2012).
Pearson’s coefficient for human control brain was low (r = 0.173), but overlap coefficient
was high for the NFL brain (r = 0.881, k1 = 0.548 and k2 = 1.416 with threshold A = 16
and B = 19) and the WWE brain (r = 0.881, k1 = 0.615 and k2 = 1.261 with threshold A
= 35 and B = 20). Similarly, Pearson’s coefficient for the Sprague Dawley control was
low (r = 0.068), but overlap coefficient was high for single blast (r = 0.931, k1 = 0.704
and k2 = 1.231 with threshold A = 16 and B = 14) and repeat blast (r = 0.887, k1 = 0.518
and k2 = 1.518 with threshold A = 21 and B = 15).
Tau kinase activity and hyperphosphorylation is increased with repetitive blast injury
GSK3β is activated by the ER stress response and contributes to chronic
neurodegeneration (Hoozemans & Scheper 2012). GSK3β is responsible for over one
third of all tau hyperphosphorylation and can lead to neuronal apoptosis (Yang et al
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2013). We propose that ER stress activates GSK3β in a biphasic manner both acutely and
chronically (Liu et al 2012). An initial spike in activity is seen acutely which resolves,
but over time GSK3β activity continually rises in conjunction with neurodegeneration.
GSK3β was co-stained with a marker for tau hyperphosphorylation, AT100, in human
CTE brains and Sprague Dawley rats exposed to blast injury (Figure 5.7). AT100 is a
marker of tau hyperphosphorylation at threonine 212 and serine 214, and GSK3β is
known to phosphorylate at those sites (Cavallini et al 2013). Pearson’s coefficient for
human control brain was low (r = 0.286), but overlap coefficient was high for the NFL
brain (r = 0.846, k1 = 1.44 and k2 = 0.497 at threshold A = 2 and B = 2) and WWE brain
(r = 0.904, k1 = 2.316 and k2 = 0.353 at threshold A = 2 and B = 2). Pearson’s coefficient
for Sprague Dawley control was low (r = 0.374), but overlap coefficient was high for
single blast (r = 0.934, k1 = 0.566 and k2 = 1.543 at threshold A = 6 and B = 6) and
repeat blast (r = 0.807, k1 = 0.566 and k2 = 1.543 at threshold A = 6 and B = 6).
Pharmacologic modulation of ER stress alters tau hyperphosphorylation
24 hours post-blast we examined protein expression changes from arms 1 and 2 of
the ER stress response for single blast injured animals with and without DHA. A
significant difference in GADD34 protein expression was seen (F(3,12) = 10.17, P <
0.01). Post hoc analysis revealed a significant difference between control and single blast
groups (t = 6.009, P < 0.01), between single blast and single blast + DHA groups (t =
5.92, P < 0.01), and between single blast and DHA only groups (t = 6.848, P < 0.01)
(Figure 5.8 A). A significant difference in p-JNK was seen (F(3,12) = 9.779, P < 0.01).
Post hoc analysis revealed a significant difference between control and single blast
groups (t = 6.221, P < 0.01), between single blast and single blast + DHA groups (t =
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6.634, P < 0.01), and between single blast and DHA only groups (t = 6.04, P < 0.01)
(Figure 5.8 B). In addition, we looked at BiP expression changes 3 weeks post repetitive
blast exposure, and how ER stress activation contributes to phosphorylation of tau
kinases. A significant difference in BiP expression was seen (F(2,6) = 8.445, P < 0.05).
Post hoc analysis revealed a significant difference between control and repeat blast
groups (t = 4.867, P < 0.05), and between repeat blast and repeat blast + DHA groups (t
= 5.185, P < 0.05) (Figure 5.9 A). A significant difference in phosphorylation of GSK3β
at tyrosine 216 was seen (F(2,6) = 31.73, P < 0.001). Post hoc analysis revealed a
significant difference between control and repeat blast groups (t = 10.31, P < 0.001), and
between repeat blast and repeat blast + DHA groups (t = 9.085, P < 0.01) (Figure 5.9 B).
All three arms of the ER stress response are known to increase CHOP (Hoozemans &
Scheper 2012). CHOP is an important protein linking ER stress to neurodegeneration via
the activation of tau kinases. A significant difference in CHOP protein expression
between groups was seen 24 hours after blast exposure (F(2,13) = 9.8, P < 0.01). Post hoc
analysis revealed a significant difference between control and single blast groups (t =
5.29, P < 0.05) and between single blast and single blast + DHA groups (t = 5.361, P <
0.01). DHA reduced CHOP back toward control levels (Figure 5.10 A). AT270 is a
marker of tau hyperphosphorylation at threonine 181. The threonine 181 residue is
commonly phosphorylated only when tau has translocated to the cell soma (Kester et al
2014). A significant difference in AT270 between groups was seen 3 weeks after repeat
blast exposure (F(2,9) = 6.451, P < 0.05) (Figure 5.10 B). Post hoc analysis revealed a
significant difference between control and repeat blast groups (t = 4.81, P < 0.05) and
between repeat blast and repeat blast + DHA groups (t = 4.111, P < 0.05). CP-13 signals

135

!
a change in tau hyperphosphorylation towards pre-tangle tau. A significant difference in
CP-13 was seen 3 weeks after repeat blast exposure (F(2,6) = 13.23, P < 0.01) (Figure
5.10 C). Post hoc analysis revealed a significant difference between control and repeat
blast groups (t = 5.778, P < 0.05) and between repeat blast and repeat blast + DHA
groups (t = 6.714, P < 0.05).
Repeat blast exposure induces CTE-like behavioral changes alleviated by DHA
administration
CTE can lead to cognitive deficits and dementia (Stein et al 2014). We sought to
reproduce CTE-like behavioral changes, in addition to the pathological changes described
above, using a clinically relevant blast model. Using Morris water maze, a hippocampaldependent cognitive performance test, we specifically evaluated changes post-blast in
order to determine potential deficits in memory acquisition and retention (Petraglia et al
2014a). In addition, we evaluated DHA, a proposed ER stress modulator, as a potential
preventative/therapeutic agent. We found DHA administration 5 minutes following each
blast and subsequent every other day administration attenuated learning deficits from
repeat blast exposure. A significant difference in learning across trial days (F(5,126) =
19.68, P < 0.001) and between groups (F(2,126) = 38.53, P < 0.001) was observed. Post
hoc analysis revealed a significant difference between control and repeat blast groups for
latency to platform on day two (t = 3.633, P < 0.01), day three (t = 3.455, P < 0.01), day
four (t = 4.057, P < 0.001), day five (t = 3.079, P < 0.01), and day six (t = 3.149, P <
0.01). A significant difference in latency to platform was also seen between repeat blast
and repeat blast + DHA groups on day two (t = 3.855, P < 0.001), day three (t = 3.918, P
< 0.001), day four (t = 4.415, P < 0.001), day five (t = 3.442, P < 0.01), and day six (t =
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3.283, P < 0.01) (Figure 5.10 D). The probe trial revealed a significant difference
between groups (F(2,21) = 16.17, P < 0.001) on time exploring an area 300% of where
the platform had been located prior (Figure 5.10 E). Post-hoc comparison revealed
significant difference between control and repeat blast groups in time spent exploring an
area 300% of platform (t = 7.331, P < 0.001) as well as between repeat blast and DHA +
repeat blast (t = 6.532, P < 0.001).
DISCUSSION

ER stress has recently been implicated in chronic neurodegeneration (Moreno et
al 2013). Tauopathies are the result of aggregated and mutated proteins that cause
immunoexcitotoxicity, and ER stress activation (Blaylock & Maroon 2011). The ER
responds to toxic buildup of proteins by shutting down protein synthesis and inhibiting
protein folding (Ron & Harding 2012). The ER stress response may accelerate tauopathy
by facilitating tau hyperphosphorylation and rapid tau aggregration that leads to
neurofibrillary tangles (Hoozemans & Scheper 2012). CTE is unique amongst
tauopathies in that its onset and progression is thought to be associated with repetitive
head injury (Aungst et al 2014a, Macdonald et al 2014). Currently, diagnostic and
treatment options are unavailable for this disease, although improving with the use of the
[18F]FDDNP PET imaging probe (Small et al 2013). The growing number of athletes
and soldiers experiencing CTE, characterized by symptoms of impulsivity, cognitive
decline, and depression, urges renewed focus into understanding disease mechanism and
disease progression (Turner et al 2012a). It has long been postulated that TBI leads to
chronic neurodegeneration (Miyauchi et al 2014, Nakagawa et al 2011, Smith et al 2012).
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Recent findings have confirmed that changes in tau, amyloid, and cognition can result
from neurotrauma (Dapul et al 2013, Omalu et al 2011a, Stern et al 2011). The
mechanisms underlying how these changes develop is currently unknown.
We show for the first time that ER stress is intimately associated with CTE in
human clinical post-mortem specimens and in the development of CTE-like pathology
and behavioral deficits in an animal model of repetitive neurotrauma. ER stress is acutely
triggered by rapid changes in intracellular calcium following brain injury (Kaufman &
Malhotra 2014). All three arms of the ER stress response were significantly elevated in
human CTE brains indicating that not only does neurotrauma lead to acute increases in
ER stress, but also that tau pathology likely contributes to persistent elevations in ER
stress during chronic neurodegeneration. CHOP, a downstream target of ER stress, was
increased in the NFL CTE brain but not in the WWE CTE brain. The WWE CTE case
had more severe neurofibrillary tangle pathology whereas the process of tau
hyperphosphorylation was ongoing in the NFL CTE brain. Therefore, CHOP may be
associated with active changes in the tau phosphorylation state. Begum and colleagues
have shown that p-eIF2α is increased 24 to 48 hours after TBI, but downstream
components of arm two of the ER stress response were not increased until 3 to 7 days
after injury (Begum et al 2014). These findings likely account for why we didn’t observe
a statistically significant increase in XBP1 following single and repeat blast exposure at
24 hours after injury. The other branch of arm 2, p-JNK, was however increased at 24
hours, but the expression was reduced when DHA was given. ATF6 was significantly
increased 24 hours following repeat blast indicating an appropriate cleavage from the
membrane due to an accumulation of unfolded proteins (Ye et al 2000). Future work will
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examine the effects of repeat blast on ER stress activation at subacute (3-7 day) time
points. The CHOP increase was not statistically significant for repeat blast vs. control
groups 24 hours post-injury. It is likely that CHOP will be increased after repeat blast
starting 3 days post-injury. The initial lack of change is likely due to inflammatory
preconditioning from the short interval between blast exposures.
Using our clinically relevant and validated blast model, we examined active
changes in tau following blast induced TBI, and correlated these changes with human
CTE pathology. The ER stress activated tau kinase, GSK3β, was significantly increased
after repetitive blast injury, and subsequent tau hyperphosphorylation was co-localized
within the same cells where ER stress activation was occurring. The activating
phosphorylation of GSK3β at tyrosine 216 was reduced by DHA administration. Future
work will focus on teasing out exactly how an increase in CHOP may activate GSK3β
and in which specific cell types these changes are occurring. Interestingly, ATF6 from
arm three of the ER stress pathway has been shown to significantly elevate Akt (Zhou et
al 2014). Since GSK3β triggers apoptosis, Akt is necessary in order to directly inhibit
GSK3β and promote cell survival. Neuronal survival is required for trans-synaptic tau
propagation (Pooler et al 2013). Akt is a well-known tau kinase that fosters the transsynaptic spread of tau tangles over time (Sadik et al 2009a). We plan to investigate these
interactions between Akt and GSK3β in follow up studies. It is likely that ATF6 is
continually activated at extended time points in the injury cascade compared to arm one
and two of the ER stress response, which would account for the initial increase we
observed in GSK3β following blast exposure.
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Many of the experimental drugs that target the ER stress response have high
affinity for a single arm of the pathway at upstream targets. While beneficial acutely,
these compounds fail to address the compensatory response of the remaining arms of the
ER stress response and subsequent crosstalk between the arms. The crosstalk is what
allows CHOP to be pushed above threshold and apoptosis and tau hyperphosphorylation
to ensue (Hetz & Mollereau 2014). The ER stress response is a cellular defense
mechanism. If protein folding can’t be restored quickly, the ER triggers the cell to
undergo apoptosis. Too much activation of any arm of the ER stress response can
accelerate this process and contribute to chronic neurodegeneration (Fonseca et al 2013).
DHA acutely inhibits all three arms of the ER stress response after injury by limiting the
intracellular calcium surge (Begum et al 2013). DHA reduced GADD34 and p-JNK
acutely, but also decreased BiP 3 weeks following repeat blast. By acting at a target step
above ER stress activation and BiP dissociation, DHA prevents the compensatory
reverberation from other arms of the ER stress pathway allowing little to no acute protein
regulation resulting from injury. In addition, DHA has recently been shown to readily
enter the brain and inhibit neurofibrillary tangle formation in a murine model of
Alzheimer’s disease (Freund Levi et al 2014, Lebbadi et al 2011). Linking these two
important properties of DHA is a topic of ongoing investigation.
CONCLUSION
Markers of ER stress were increased in both Sprague Dawley rat samples and
human CTE specimins. These markers were co-localized with tau pathology in
hippocampal neurons. Sprague Dawley rats showed similar pretangle tau changes
comparable to human CTE 3 weeks post repetitive blast. Most importantly, we show that
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the omega-3 derivative, DHA, reduced ER stress mediated CHOP expression, GADD34
expression, and p-JNK at 24 hours and additionally reduced tau hyperphosphorylation,
BiP dissociation, and phosphorylation of GSK3β at three weeks post-injury. DHA also
decreased cognitive decline measured by Morris Water Maze when given 5 minutes after
each blast exposure. DHA appears to have pharmacotherapeutic potential as a
preventative treatment against the development of CTE and may be a promising
treatment for various other forms of neurotrauma (Hasadsri et al 2013).
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Figure 5.1: Robust tau changes 3 weeks post repetitive blast exposure. Non-transgenic
rodents do not develop neurofibrillary tau tangles. Tau hyperphosphorylation can occur
after traumatic neurotrauma however indicating acute changes similar to human
pathology. Abbreviations: CTRL = control, and DHA = docosahexaenoic acid. In the
Sprague Dawley rodent model, DAB staining revealed that PHFs were present in
perivascular regions of the hippocampus for repeat blast animals (18/100) (C) 20x, scale
bar 100µm, and inlay (D) 63x, but not in control (0/100) (A) 20x, scale bar 100µm, and
inlay (B) 63x and reduced in DHA + repeat blast animals (3/100) (E) 20x, scale bar
100µm, and inlay (F) 63x. Similarly, CP-13 was increased in repeat blast animals
(17/100) (I) 20x, scale bar 100µm, and inlay (J) 63x, but not in control (0/100) (G) 20x,
scale bar 100µm, and inlay (H) 63x and reduced in DHA + repeat blast animals (4/100)
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(K) 20x, scale bar 100µm, and inlay (L) 63x. In addition H&E staining revealed nuclear
chromatolysis, vacuolization, and degeneration after repeat blast (O) 20x, scale bar
100µm, and inlay (P) 63x, but not in control (M) 20x, scale bar 100µm, and inlay (N)
63x or repeat blast + DHA groups (Q) 20x, scale bar 100µm, and inlay (R) 63x.
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Figure 5.2: Human CTE: characterized by distinct changes in tau hyperphosphorylation.
The level of phosphorylation is dependent on the structural organization of tau and
additionally on tau aggregation. PHFs are precursors to tau oligomers and indicate
intrasomatic accumulation of tau. Abbreviations: CTRL = control, NFL = National
Football League, WWE = World Wrestling Entertainment. DAB staining revealed that
PHFs were not present in the entorhinal cortex of an age matched control (2/100) (A)
20x, scale bar 100µm, and inlay (B) 63x, but were present in the entorhinal cortices of a
NFL player (29/100) (C) 20x, scale bar 100µm, and inlay (D) 63x and a WWE wrestler
(32/100) (E) 20x, scale bar 100µm, and inlay (F) 63x. CP-13 is a precursor for tau
neurofibrillary tangles with a balanced 3R:4R ratio. DAB staining revealed that CP-13
was not present in the entorhinal cortex of an age matched control (2/100) (G) 20x, scale
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bar 100µm, and inlay (H) 63x, but was present in the entorhinal cortices of a NFL player
(27/100) (I) 20x, scale bar 100µm, and inlay (J) 63x and WWE wrestler (26/100) (K)
20x, scale bar 100µm, and inlay (L) 63x. MCI detects a distinct mutated version of tau
that is present in neurodegenerative tauopathies. DAB staining revealed no MCI in the
entorhinal cortex of an age matched control (2/100) (M) 20x, scale bar 100µm, and inlay
(N) 63x, but MCI was present in the entorhinal cortices of a NFL player (23/100) (O)
20x, scale bar 100µm, and inlay (P) 63x and a WWE wrestler (25/100) (Q) 20x, scale bar
100µm, and inlay (R) 63x.
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Figure 5.3: ER stress as a defense mechanism. The ER stress response is a robust cellular
mechanism that can help protect the cell from injury or toxic insult and restore
homeostatic processes after injury. Arm 1 in particular provides vigorous neuroprotection
after trauma. While acute increases in intracellular calcium trigger a modest ER stress
response, the accumulation of unfolded proteins with time can enhance the vitality of the
cellular ER response incorporating the detrimental arms 2 and 3. Abbreviations: CTRL =
control, SB = single blast, and RB = repeat blast. XBP1, arm 2 of the ER stress response,
was not significantly elevated in single blast exposed animals (C) 20x, scale bar 75µm,
and inlay (D) 63x or in repeat blast exposed animals (E) 20x, scale bar 75µm, and inlay
(F) 63x compared with control (A) 20x, scale bar 75µm, and inlay (B) 63x as depicted in
the bar graph (G). P-eIF2α, arm 1 of the ER stress response, was significantly elevated in
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the single blast exposed animals (P < 0.05) (J) 20x, scale bar 75µm, and inlay (K) 63x
but not in the repeat blast exposed animals (L) 20x, scale bar 75µm, and inlay (M) 63x
compared with control (H) 20x, scale bar 75µm, and inlay (I) 63x as depicted in the bar
graph (N). ATF6, arm 3 of the ER stress response, was not significantly elevated in single
blast exposed animals (Q) 20x, scale bar 75µm, and inlay (R) 63x but was significantly
elevated in repeat blast exposed animals (P < 0.05) (S) 20x, scale bar 75µm, and inlay
(T) 63x compared with control (O) 20x, scale bar 75µm, and inlay (P) 63x as depicted in
the bar graph (U).
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Figure 5.4: Tauopathy implicated in the activation of the ER stress response. Since tau
tangles are accumulations of aggregated protein, the cell recognizes an intracellular
disturbance that triggers the release of calcium. The calcium rush is directly responsible
for ER stress activation as well as initiating the ER stress response. All three arms of the
ER stress cascade were increased in human CTE samples. XBP1, arm 2 of the ER stress
response, was significantly elevated in the NFL CTE brain (P < 0.001) (C) 20x, scale bar
75µm, and inlay (D) 63x and in the WWE CTE brain (P < 0.05) (E) 20x, scale bar 75µm,
and inlay (F) 63x compared with control (A) 20x, scale bar 75µm, and inlay (B) 63x as
depicted in the bar graph (G). P-eIF2α, arm 1 of the ER stress response, was significantly
elevated in the NFL CTE brain (P < 0.01) (J) 20x, scale bar 75µm, and inlay (K) 63x and
in the WWE CTE brain (P < 0.001) (L) 20x, scale bar 75µm, and inlay (M) 63x
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compared with control (H) 20x, scale bar 75µm, and inlay (I) 63x as depicted in the bar
graph (N). ATF6, arm 3 of the ER stress response, was significantly elevated in NFL
CTE brain (P < 0.01) (Q) 20x, scale bar 75µm, and inlay (R) 63x and in the WWE CTE
brain (P < 0.05) (S) 20x, scale bar 75µm, and inlay (T) 63x compared with control (O)
20x, scale bar 75µm, and inlay (P) 63x as depicted in the bar graph (U).
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Figure 5.5: CHOP: an important component of ER stress. A baseline level of CHOP is
necessary in order for a cell to return to homeostasis. If CHOP is pushed above threshold,
apoptosis and tau hyperphosphorylation can occur. CHOP was significantly elevated in
the NFL CTE brain (P < 0.001) (C) 20x, scale bar 75µm, and inlay (D) 63x but not in the
WWE CTE brain (E) 20x, scale bar 75µm, and inlay (F) 63x compared to control (A)
20x, scale bar 75µm, and inlay (B) 63x as depicted in the bar graph (G). CHOP was also
significantly elevated in single blast exposed animals (P < 0.05) (J) 20x, scale bar 75µm,
and inlay (K) 63x but not in repeat blast exposed animals (L) 20x, scale bar 75µm, and
inlay (M) 63x compared to control (H) 20x, scale bar 75µm, and inlay (I) 63x as depicted
in the bar graph (N).
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Figure 5.6: AT270 co-localized with IRE1α. AT270 is a marker for tau
hyperphosphorylation at threonine 181. Tau hyperphosphorylation occurs after tau has
dissociated from tubulin and transported from the axon to the soma. What is unknown is
if ER stress occurs in the same cells where tau hyperphosphorylation is present. We show
that IRE1α, marker of arm 2 of the ER stress response, has a strong overlap coefficient
with AT270 for NFL CTE brain (r = 0.846) and WWE brain (r = 0.904) compared to
weak Pearson’s coefficient for control (r = 0.286). Control has minimal AT270 (red) (A)
20x, scale bar 75µm, and inlay (B) 63x, IRE1α (green) (M) 20x, scale bar 75µm, and
inlay (N) 63x, and overlap (yellow) (Y) 20x, scale bar 75µm, and inlay (Z) 63x. NFL
CTE brain has apparent AT270 (red) (C) 20x, scale bar 75µm, and inlay (D) 63x, IRE1α
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(green) (O) 20x, scale bar 75µm, and inlay (P) 63x, and overlap (yellow) (Aa) 20x, scale
bar 75µm, and inlay (Bb) 63x. WWE CTE brain has apparent AT270 (red) (E) 20x, scale
bar 75µm, and inlay (F) 63x, IRE1α (green) (Q) 20x, scale bar 75µm, and inlay (R) 63x,
and overlap (yellow) (Cc) 20x, scale bar 75µm, and inlay (Dd) 63x. IRE1α also has
strong overlap coefficient with AT270 for single blast exposed animals (r = 0.934) and
repeat blast exposed animals (r = 0.807) compared to weak Pearson’s coefficient for
control (r = 0.374). Control has minimal AT270 (red) (G) 20x, scale bar 75µm, and inlay
(H) 63x, IRE1α (green) (S) 20x, scale bar 75µm, and inlay (T) 63x, and overlap (yellow)
(Ee) 20x, scale bar 75µm, and inlay (Ff) 63x. Single blast exposed animal has apparent
AT270 (red) (I) 20x, scale bar 75µm, and inlay (J) 63x, IRE1α (green) (U) 20x, scale bar
75µm, and inlay (V) 63x, and overlap (yellow) (Gg) 20x, scale bar 75µm, and inlay (Hh)
63x. Repeat blast exposed animal has apparent AT270 (red) (K) 20x, scale bar 75µm, and
inlay (L) 63x, IRE1α (green) (W) 20x, scale bar 75µm, and inlay (X) 63x, and overlap
(yellow) (Ii) 20x, scale bar 75µm, and inlay (Jj) 63x.
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Figure 5.7: AT100 is a marker of tau hyperphosphorylation at threonine 212 and serine
214. Tau is phosphorylated after injury by a select few kinases. GSK3β is by far the most
important of these kinases accounting for over 1/3 of all tau hyperphosphorylation. We
show that GSK3β has a strong overlap coefficient with AT100 for NFL CTE brain (r =
0.881) and WWE brain (r = 0.881) compared to weak Pearson’s coefficient for control (r
= 0.173). Control has minimal AT100 (red) (A) 20x, scale bar 75µm, and inlay (B) 63x,
GSK3β (green) (M) 20x, scale bar 75µm, and inlay (N) 63x, and overlap (yellow) (Y)
20x, scale bar 75µm, and inlay (Z) 63x. NFL CTE brain has apparent AT100 (red) (C)
20x, scale bar 75µm, and inlay (D) 63x, GSK3β (green) (O) 20x, scale bar 75µm, and
inlay (P) 63x, and overlap (yellow) (Aa) 20x, scale bar 75µm, and inlay (Bb) 63x. WWE

154

!
CTE brain has apparent AT100 (red) (E) 20x, scale bar 75µm, and inlay (F) 63x, GSK3β
(green) (Q) 20x, scale bar 75µm, and inlay (R) 63x, and overlap (yellow) (Cc) 20x, scale
bar 75µm, and inlay (Dd) 63x. GSK3β also has strong overlap coefficient with AT100
for single blast exposed animals (r = 0.931) and repeat blast exposed animals (r = 0.887)
compared to weak Pearson’s coefficient for control (r = 0.068). Control has minimal
AT100 (red) (G) 20x, scale bar 75µm, and inlay (H) 63x, GSK3β (green) (S) 20x, scale
bar 75µm, and inlay (T) 63x, and overlap (yellow) (Ee) 20x, scale bar 75µm, and inlay
(Ff) 63x. Single blast exposed animal has apparent AT100 (red) (I) 20x, scale bar 75µm,
and inlay (J) 63x, GSK3β (green) (U) 20x, scale bar 75µm, and inlay (V) 63x, and
overlap (yellow) (Gg) 20x, scale bar 75µm, and inlay (Hh) 63x. Repeat blast exposed
animal has apparent AT100 (red) (K) 20x, scale bar 75µm, and inlay (L) 63x, GSK3β
(green) (W) 20x, scale bar 75µm, and inlay (X) 63x, and overlap (yellow) (Ii) 20x, scale
bar 75µm, and inlay (Jj) 63x.
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Figure 5.8: DHA reduces acute ER stress markers. Arms 1 and 2 of the unfolded protein
response are increased acutely after injury. GADD34 is a downstream marker of the first
arm of the ER stress response and p-JNK is downstream of the second arm. A significant
difference between groups for the acute markers was observed 24 hours after blast
exposure. (A) The single blast group had increased expression of GADD34 compared to
control (** P < 0.01), compared to DHA + single blast group (## P < 0.01), and
compared to DHA alone group (!! P < 0.01). (B) The single blast group had increased
phosphorylation of JNK compared to control (** P < 0.01), compared to DHA + single
blast group (## P < 0.01), and compared to DHA alone group (!! P < 0.01).
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Figure 5.9: ER stress plays an important role in activation of tau kinases. Tau
hyperphosphorylation feeds back and activates the ER stress response by causing the
dissociation of BiP from the ER membrane. A significant difference between groups was
observed 3 weeks post repetitive blast exposure for BiP. (A) The repeat blast group had
increased levels of BiP compared to control (* P < 0.05), and compared to the repeat
blast + DHA group (# P < 0.05). Activation of the tau kinase GSK3β can lead to
increased tau pathology following TBI. A significant difference between groups was
reported for p-GSK3β. (B) The repeat blast group has increased phosphorylation of
GSK3β at tyrosine 216 compared to control (*** P < 0.001), and compared to the repeat
blast + DHA group (## P < 0.01).
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Figure 5.10: DHA decreases ER Stress and tau while preventing cognitive decline.
CHOP is a key downstream target of all three arms of the ER stress pathway. Among its
many roles, CHOP contributes to apoptosis, activation of tau kinases, and disruption of
the mitochondria. A significant difference between groups was observed 24 hours after
blast exposure. (A) The single blast group had a significant increase in CHOP (P < 0.01)
compared to control. The DHA + blast group had a significant reduction in CHOP (P <
0.01) compared to the single blast group only. AT270 is a marker of tau
hyperphosphorylation that symbolizes the transition phase for tauopathy development.
(B) Repeat blast increased AT270 compared with control (P < 0.05). DHA + repeat blast
significantly reduced AT270 (P < 0.05) compared with repeat blast only. (C) Repeat blast
increased CP-13 compared with control (P < 0.05). DHA + repeat blast significantly
reduced CP-13 (P < 0.05) compared with repeat blast only. Morris water maze is a test of
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cognitive performance and the ability to learn. The protocol used for this experiment
consisted of 6 learning trial days followed by a probe trial on day 7. For each learning
trial session, the animal was placed into the maze at 4 different start positions. Latency to
platform was measured from each start position for up to 2 minutes. If the animal did not
reach the platform in 2 minutes, they were placed on it for 15 seconds. On probe trial day
the platform was removed and the animal was put into the maze at a novel start position
and allowed to swim for 1 minute. Time spent in an area 300% of where the platform had
been was recorded. (D) A significant difference in learning across trial days (P < 0.001)
and between groups (P < 0.001) was observed. A significant difference between control
and repeat blast groups for latency to platform was observed on day 2 (t = 3.633, P <
0.01), day 3 (t = 3.455, P < 0.01), day 4 (t = 4.057, P < 0.001), day 5 (t = 3.079, P <
0.01), and day 6 (t = 3.149, P < 0.01). A significant difference in latency to platform was
also seen between repeat blast and repeat blast + DHA groups on day 2 (t = 3.855, P <
0.001), day 3 (t = 3.918, P < 0.001), day 4 (t = 4.415, P < 0.001), day 5 (t = 3.442, P <
0.01), and day 6 (t = 3.283, P < 0.01). (E) A significant difference between control and
repeat blast groups (P < 0.001) and between repeat blast and repeat blast + DHA groups
(P < 0.001) was seen on probe trial.

159

!

Supplementary Figure 5.1: Representative set-up of blast model. (A) blast model with
piezoelectric sensor and driver section. (B) polyvinyl tube that protects the animal’s body
from blast wave. (C) sensor signal conditioner. (D) graph showing peak overpressure
recorded from ~50 PSI blast wave.
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Supplementary Figure 5.2: Representative track plots for Morris water maze on probe
trial day. (A) track plot for control animal. (B) track plot for repeat blast animal. (C) track
plot for repeat blast + DHA animal.
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Chapter Six
Amelioration of NADPH-mediated stress reduces cell death following blast-induced
traumatic brain injury
This!work!is!published!in!Transl Res. 2015 Dec;166(6):509-528.e1. doi:
10.1016/j.trsl.2015.08.005. Epub 2015 Sep 8. PMID: 26414010
Lucke-Wold BP, Naser ZJ, Logsdon AF, Turner RC, Smith KE, Robson MJ, Bailes JE,
Lee JM, Rosen CL, Huber JD
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ABSTRACT
1.7 million traumatic brain injuries (TBIs) occur each year in the United States,
but available pharmacologic options for the treatment of acute neurotrauma are limited.
Oxidative stress is an important secondary mechanism of injury that can lead to neuronal
apoptosis and subsequent behavioral changes. Utilizing a clinically relevant and validated
rodent blast model, we investigated how NADPH oxidase expression and associated
oxidative stress contributes to cellular apoptosis following single and repeat blast injuries.
Nox4 forms a complex with p22phox following injury, forming free radicals at neuronal
membranes. Using immunohistochemical-staining methods, we found a visible increase
in Nox4 following single blast injury in Sprague Dawley rats. Interestingly, Nox4 was
also increased in post-mortem human samples obtained from athletes diagnosed with
chronic traumatic encephalopathy (CTE). Nox4 activity correlated with an increase in
superoxide formation. Alpha lipoic acid, an oxidative stress inhibitor, prevented the
development of superoxide acutely, and increased anti-apoptotic markers Bcl-2 (t =
3.079, p<0.05) and heme oxygenase 1 (t = 8.169, p<0.001) after single blast. Subacutely,
alpha lipoic acid treatment reduced pro-apoptotic markers Bax (t=4.483, p<0.05), caspase
12 (t=6.157, p<0.001), and caspase 3 (t=4.573, p<0.01) following repetitive blast, and
reduced tau hyperphosphorylation indicated by decreased CP-13 and PHF staining. Alpha
lipoic acid ameliorated impulsive-like behavior 7 days after repetitive blast injury
(t=3.573, p<0.05) compared to blast exposed animals without treatment. TBI can cause
debilitating symptoms, and psychiatric disorders. Oxidative stress is an ideal targets for
neuropharmacologic intervention, and alpha lipoic acid warrants further investigation as a
therapeutic for prevention of chronic neurodegeneration.
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INTRODUCTION
Traumatic brain injury (TBI) remains an immense public health burden in the
United States, and continues to be a leading cause of morbidity and mortality in
individuals under the age of 45-years-old (Bruns & Hauser 2003). Mild TBI can lead to
progressive motor, cognitive, and behavioral decline (Bramlett & Dietrich 2014). These
long-term outcomes result in enormous societal costs (Maas et al 2008). In particular,
blast-induced TBI has been classified as the ‘signature injury’ of the recent wars in Iraq
and Afghanistan. National and international emphasis has been placed on how acute
neurotrauma leads to chronic neurodegeneration over time. The progression depends on
both severity and number of exposures. In order to investigate the pathologic process that
contributes to neurodegeneration, scaled injury in animal models must be ideally utilized.
A blast wave injury has three primary effects: wave transport through tissue,
acceleration/deceleration causing axonal shearing, and disruption of the blood brain
barrier (BBB). Typically, the primary damage of TBI is followed by secondary injury,
which can develop at a later date. The initial insult can lead to major brain damage and
loss of functional outcome. Secondary injury, on the other hand, triggers a cascade of
biochemical events leading to neuroinflammation, brain edema, and delayed neuronal cell
death and neurodegeneration (Zhang et al 2012).
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Delayed neuronal cell death is carefully mediated through the process of
apoptosis. When the cell is damaged beyond repair, a signaling cascade is initiated, which
can lead to cell destruction. Many pathways contribute to apoptosis activation in the cell,
but one of the main methods is the development and propagation of free radical oxygen
species (ROS). The creation of ROS has been linked to the activation of NADPH
oxidase. In a non-injury state, NADPH oxidase participates in cellular host defense
through cytokine signaling, gene expression regulation, posttranslational processing of
protein, endoplasmic reticulum stress response, and tissue homeostasis (Gao et al 2012).
Only after injury or infection does the NADPH oxidase pathway contribute to ROS
formation. Inhibiting the NADPH oxidase, Nox2, with apocynin following TBI has
provided beneficial behavioral and histopathologic results (Loane et al 2013, Lu et al
2014). Lipoic acid is another readily available supplement that can inhibit the formation
of ROS, but does not cross mitochondrial membranes thereby targeting plasma
membrane NADPH activity (Gomes & Negrato 2014). Although the mechanism is not
fully known, alpha lipoic acid can reduce toxic free radicals and decrease NADPH
oxidase activity (Park et al 2014). We sought to investigate the effect of lipoic acid on the
less well-studied NADPH oxidase pathway, Nox4, which is found at neuronal plasma
membranes (Supplementary Fig. 1).
The Nox4 pathway can lead to the generation of the superoxide radical (O2−)
(Zhang et al 2012). The superoxide radical is produced when an oxygen molecule gains a
single electron from another substance. Excess O2− can form the toxic hydroxyl radical
(OH−) through interaction with hydrogen peroxide (H2O2). The hydroxyl radical can
eventually combine with nitric oxide to form peroxynitrite (ONO2−) (Zhang et al 2012).
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Peroxynitrite has devastating effects on cellular membranes. Historically, mitochondria
dysfunction has been postulated as the primary source of free radical species generation,
but recent evidence has shown that NADPH oxidase can also contribute to reactive
species development. NADPH oxidase is a composite membrane enzyme made up of
Nox and phox subunits that associate with a series of supporting proteins (Bedard &
Krause 2007, Sorce & Krause 2009). The Nox subunits come in one of five isoforms, and
each isoform is heavily concentrated in a specific organ. Nox4 is one of the isoforms
most heavily concentrated within the central nervous system. Nox4 is constitutively
active and produces large amount of superoxide following injury. Through interaction
with cellular components, Nox4 generates hydrogen peroxide and subsequently the
potent hydroxyl radical (Gao et al 2012). Nox4 has not been previously studied for its
role in ROS formation following blast injury, therefore opening an important avenue for
investigating a novel and potentially important therapeutic target.
Oxidative stress induction and the consequential damage that occurs as a result of
blast exposure is likely profound, but the full extent of injury has yet to be elucidated. In
this work, we investigate the effects of NADPH oxidase, specifically Nox4 activity, in
the progression towards apoptosis and tau hyperphosphorylation following a moderate
blast injury 24 hours after blast exposure and 2 weeks after repetitive blast exposure. We
selectively targeted the Nox4 response at the neuronal plasma membrane using the antioxidant alpha-lipoic acid. Alpha lipoic acid is a natural occurring compound found in
multiple cell types that acts as a co-factor in oxidative metabolism reactions (Wei et al
2015). It is thioctic acid with a disulfide bond, chirality, and a dithialone ring (Reljanovic
et al 1999). The bioavailability is 30% and it is metabolized to 5 metabolites by the liver,
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which are then cleared primarily by catabolism (Teichert et al 2005). It acts as a freeradical scavenger when administered peripherally and readily passes through the BBB
and neuronal membranes but not mitochondrial membranes (Ozbal et al 2015). In
particular, it has been shown to be a carbonyl scavenging compound following TBI (Hall
et al 2010). Supplementation in humans following TBI has provided reduction in adverse
symptoms (Curtis & Epstein 2014). It reduces susceptibility for seizures as well as
excitotoxicity (Meyerhoff et al 2004). We investigate its role in modulation of Nox4 for
the prevention of the chronic sequelae associated with neurotrauma.
MATERIALS AND METHODS
The paper conforms to all relevant guidelines for human and animal research.
Animals
All procedures involving live animals were approved by the Institutional Animal
Care and Use Committee of West Virginia University and were performed according to
the principles of the Guide for the Care and Use of Laboratory Animals (NIH). This work
used (40) forty 350 g male Sprague-Dawley rats acquired from Hilltop Lab Animals
(Hilltop Lab Animals, Inc.). The method used to calculate the number of animals needed
for a given study was determined using information from the book, Guidelines for the
Care and Use of Mammals in Neuroscience and Behavioral Research. The number of
animals was based on effect size, standard deviation, power, and significance. The
equation to be used to calculate sample size is: n=1+[2C(s/d)2], where C is a value
dependent upon the a and b values chosen. For our studies a=0.05 and b=0.2 for a power
of 1-b=0.8. C(0.05, 0.8)=7.85 (obtained from table). Effect size and standard deviation
expected are variable per assay and were calculated based on numbers from previous

167

!
work. Animals were acclimated for 1 week prior to experimental use and were housed
under 12-hour light/12-hour dark conditions with food and water available ad libitum.
Human brain sections
Post-mortem formalin fixed brain sections were obtained from the entorhinal
cortex of a retired professional football player and professional wrestler as well as an age
and sex matched control. Descriptions of the chronic traumatic encephalopathy (CTE)
cases have been previously described (Omalu et al 2010a, Omalu et al 2010b). Briefly,
the professional wrestler committed suicide at age 40. No atrophy or necrosis was
observed in the brain. Neurofibrillary tau tangles were frequently scattered, and he had
the apolipoprotein E3/E3 allele. The professional football player died from traumatic
injury at age 36. The brain was grossly intact with widely spread tauopathy. No other
neurodegenerative disease diagnostic features were found in either case. The age and sex
matched control did not have a known history of neurotrauma and no evidence of tau
pathology.
Blast exposure
Rats were exposed to traumatic brain injury via a moderate blast wave exposure
characterized previously by our lab (Turner et al 2013). Briefly, the animals were
anesthetized with 4% isoflurane prior to blast exposure. Animals were then oriented with
the long axis of the animal perpendicular to the blast front. The blast was delivered
perpendicular to the head with the wave encountering the right side of the head (directly)
before passing through the skull and exiting the left side (indirectly). The thorax and
abdomen were protected using rigid shielding. The design allows for acceleration and
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deceleration to occur freely because the head is not fixed, similar to battlefield exposure.
Animals were divided into the following groups for the 24 hour study: control (n=4),
lipoic acid only (n=4), moderate blast exposure only (n=4), and moderate blast exposure
along with lipoic acid treatment (n=4). Immediately following blast, the animals were
returned to a holding cage with a homeothermic heating blanket with rectal thermometer
to maintain body temperature at 37°C. Once reflexes were restored, animals were
returned to the home cage.
For repetitive blast exposure, animals received blast every other day for a total of
six blast exposures over a two-week period. The groups used for this study were control
(n=8), repeat blast (n=8), and repeat blast along with lipoic acid treatment (n=8). The
animals were exposed to the same intensity blast wave as the animals from the 24-hour
experimental group. Animals were returned to a holding cage for monitoring before
being placed in their home cage. Animals were anesthetized with 4% isoflurane before
every blast exposure. Animals were sacrificed 2 weeks after final blast exposure.
Alpha lipoic acid treatment(s)
Alpha lipoic acid was obtained from Sigma Aldrich. It was dissolved in sterile
saline solution with 10% ethanol (0.1 mL/10 g body weight) (Teknova, Fisher Scientific,
Pittsburgh, PA). For animals that were part of the drug treatment group, the animals were
administered 10 mg/kg alpha lipoic acid 5 minutes after each blast exposure via i.p.
injection. Animals receiving blast injury only or controls received an i.p. injection of
saline after each blast. Animals were closely monitored and upon full recovery were
returned to the home cage.
Elevated plus maze
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The EPM was elevated 60cm from the floor. The two open arms intersected
perpendicular to the two closed arms. Each arm was 50cm by 10cm. The closed arms
were encased by black wood siding 30cm tall on all exposed sides. Elevated plus maze
assessment was conducted 7 days after repetitive blast exposure according to procedures
outlined by Walf and Frye (Walf & Frye 2007). The rats were placed in the center of the
maze facing an open arm. Each animal was recorded for a total of 5 minutes with open
access to every arm. ANY-Maze Version 4.63 video tracking software (Stoelting Co.)
was used to record the number of entries into the open arm, time spent in the open arm,
and distance traveled in the open arm. The ANY-Maze software settings were as follows:
test duration 300 seconds and percentage of body to be considered in arm 90%.
Immunoblotting
Protein was isolated from each respective sample by sonication in 500 µL of hot
(85-95o C) 1% sodium docecyl sulfate (SDS) as previously described (O'Callaghan &
Sriram 2004). Samples were run using 50 µg of protein/well using Tris-Glycine 10% selfpoured 10-well gels in combination with 5X Lammeli sample buffer. Gels were run using
a mini-PROTEAN system (Bio-Rad) and transferred to polyvinylidene fluoride (PVDF)
membranes (Bio-Rad) using wet electrophoretic transfer cells (Bio-Rad). Primary
antibodies used were anti-Bcl-2 (rabbit) and anti-HO-1 (goat) at 1:200 (Santa Cruz
Biotechnology, Santa Cruz, CA). An HRP-conjugated β-actin rabbit monoclonal
antibody (Cell Signaling) was used as an endogenous control for all samples at a
concentration of 1:10,000. Molecular weight determination was conducted using
SeeBlue® Plus2 (Life Technologies, Carlsbad, CA). LI-COR secondary antibodies
IRDye® 800CW (goat anti-rabbit) and IRDye® 680RD (goat anti-mouse) (LI-COR,
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Lincoln, NE) were used with an Odyssey fluorescent scanner at wavelengths 800 or 700,
intensity 6.0, and 84 resolution with high image quality. Images were converted to gray
scale, analyzed after background subtraction, and normalized to β-actin to give relative
overall intensity.
Samples used for carbonyl detection were isolated and sonicated in 6% SDS.
Control samples were mixed with derivation control solution and treatment samples were
mixed with 1X DNPH solution. The samples were incubated for 15 minutes followed by
mixing with a neutralization solution. The samples were loaded 20µl per well and ran on
a 10% gel as outlined above. The primary antibody and standards were from an OxyBlot
Protein Oxidation Detection Kit (Millipore).
Reactive oxygen species detection
Brain tissue was harvested from each treatment group including control, single
blast, and single blast with lipoic acid and prepared in accordance to procedures outlined
in the ROS Detection kit manual. Briefly, tissue was homogenized and cells were
isolated by incubation in collagenase at 2mg/ml for approximately 30 minutes. Cells
were then separated by enzyme digestion and manual disruption with repeated pipetting.
Cells were strained through a 70nm nylon cell strainer followed by centrifugation at
400xg for 5 minutes. The pellet was then resuspended to a concentration of 0.5x1061.0x106 cells/ml in Dulbecco’s Modified Eagle Medium.
Total ROS and Superoxide were detected using a Total ROS/Superoxide
Detection kit (Enzo Life Sciences) according to manufacturer’s instructions for a
fluorescent microplate assay. In brief, 100µl of suspended cells were added to each well
of a dark walled 96 well plate with a clear bottom. The cells were incubated overnight at
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37°C in Dulbecco’s Modified Eagle Medium. Media was then removed the following
day and 100µl of ROS/Superoxide Detection Solution, prepared using kit reagents, was
added to each well and incubated in the dark for 60 minutes. Total concentrations of
ROS determined by a glutathione based reaction (green) and Superoxide determined by a
xanthine oxidase reaction (red/yellow) were detected at an excitation/emission of
488/520nm and 550/610nm respectively using a Biotek Synergy H1 Hybrid Reader. Data
was collected using Gen5 2.01 software.
Histological preparations
Animals were anesthetized as described above and perfused transcardially with
cold 0.9% saline followed by 10% formalin for a total of ten minutes. The brain was then
extracted and placed into fresh 10% formalin for a minimum of 24 h. After the fixation,
the brain was blocked into sections and paraffin embedded as previously described
(Turner et al 2012b). Briefly, tissues were processed using the Tissue-Tek Q4 170 VIP 5
automatic tissue process (Sakura Finetek) and embedded in paraffin using the Tissue-Tek
TEC 5 embedding system (Sakura Finetek). Tissues were sliced using a Leica RM2235
microtome (Leica Microsystems) and slices mounted on slides for staining. Standard
fluorescent and DAB staining protocols were utilized for staining for iron (Sigma
Aldrich), 8-hydroxy-2-deoxyguanosine, Nox4, p22phox, and Bax (Santa Cruz), caspase 3
and caspase 12 (Cell Signaling), and PHF, MC1, and CP-13 (Kind gift from Dr. Peter
Davies).
Images were acquired from the S1BF region of the cortex (10 slides per animal).
Imaging was performed using a Zeiss Axio Imager 2 for brightfield images and Zeiss
Axio Observer Z1 for fluorescent images shown. For fluorescent staining, 10 cells per
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slide were randomly selected, outlined, and measured with ImageJ software (NIH) by an
observer blinded to experimental group. Density was adjusted per mean area to give
corrected total cell fluorescence normalized to background. For DAB and iron staining,
an observer blinded to experimental group selected 100 random cells per slide and
recorded the ratio of positive cells to total cells.
Data analysis
Data was analyzed using GraphPad Prism 5.0 (GraphPad Software, La Jolla, CA).
A one-way ANOVA with Tukey’s post-hoc test for multiple comparisons was used for
Western blot, fluorescent IHC, and elevated plus maze. Tukey’s post-hoc multiple
comparisons test is a pair wised comparison between each group with every other group.
The graphs show the comparisons that were statistically significant. χ2 analyses were
used for DAB and iron staining. A p-value < 0.05 was considered statistically significant
for all data analyzed.
RESULTS
An increase is seen in intraparenchymal iron, Nox4 and p22phox after single blast
Iron staining revealed an increase in intracellular iron deposition (19/100) 24
hours following blast injury in the left prefrontal cortex compared to control (2/100)
(Figure 6.1 A). Free iron induces oxidative stress, which is toxic to neuronal plasma
membranes (Uranga et al 2009). Lipoic acid administered 5 minutes post-blast leads to
decreased intracellular accumulation of iron (11/100) compared to blast only animals
with a χ2=40.594, p<0.0001. Nox4 is found at plasma membranes and contributes to free
radical formation (Zhang et al 2009). Nox4 was visibly increased (29/100) 24 hours
following blast injury in the left prefrontal cortex compared to control (8/100) (Figure 6.1
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B). Lipoic acid visibly reduced Nox4 (12/100) when given 5 minutes post-blast with
χ2=29.079, p<0.0001. P22phox forms an activation complex with Nox4 to regulate
downstream genetic markers. P22phox was also visibly increased (23/100) 24 hours after
single blast in the left prefrontal cortex compared to control (6/100). Likewise, alpha
lipoic acid treatment 5 minutes post-blast decreased p22phox (13/100) with χ2=24.031,
p<0.0001. Therefore, iron-mediated toxicity possibly acting through Nox4 oxidative
stress is mitigated by alpha lipoic acid treatment.
Nox4 activity increases superoxide formation but not total ROS after single blast
The Nox4/P22phox complex can lead to the generation of superoxide. Superoxide
can damage the cell if not readily cleared. Blast only animals had a visible increase in
superoxide 24h post-blast compared to control (Figure 6.2 A). Lipoic acid administered 5
minutes post-blast visually decreased superoxide back to control levels. Fluorescent
intensity measurement revealed a significant difference between groups for superoxide
(F(2,15) = 30.93, p<0.001). Post-hoc comparison revealed that single blast exposure
significantly increased superoxide compared to control (q = 9.1, p<0.001), but lipoic acid
administered 5 minutes after single blast ameliorated this response (q = 10.09, p<0.001)
(Figure 6.2 B). No significant difference was seen between groups for total ROS (F(2,15)
= 3.568, p=0.054) lending credence to a NADPH specific response verse mitochondria
dependent response.
Lipoic acid prevents formation of oxidative stress byproducts
Previous studies have shown that byproducts of oxidative stress are significantly
increased following TBI (Cheng et al 2013). In particular, 8-hydroxy-2-deoxyguanosine
and carbonyls are elevated post-injury (Ferguson et al 2010). We found a significant
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difference between groups for 8-hydroxy-2-deoxyguanosine in the cortex 24 hours post
blast (F(2,27)=28.18, p<0.001) (Figure 6.3 A). Tukey’s post-hoc comparison showed a
significant difference between control and blast (q=10.53, p<0.001) and blast and blast +
lipoic acid (q=4.074, p<0.05). We found a significant difference between groups for
carbonyls (F(3,16)=10.63, p<0.001) (Figure 6.3 B). Tukey’s post-hoc comparison
showed a significant difference between control and blast (q=6.429, p<0.01), lipoic acid
and blast (q=4.226, p<0.05), and blast and blast + lipoic acid (q=7.302, p<0.001). Lipoic
acid significantly reduced oxidative stress byproducts.
A decrease in anti-apoptotic markers is seen 24 hours post-blast but lipoic acid restores
towards baseline
Western blot investigation showed significant changes to anti-apoptotic makers in
the left prefrontal cortex following a single blast exposure. Bcl-2 is an important antiapoptotic oncogene that provides neuroprotection when increased (Indharty 2013). A
significant difference was seen between groups 24 hours post-blast (F(3,12) = 4.637,
p<0.05). Post-hoc comparison revealed that single blast exposure significantly decreased
Bcl-2 compared to lipoic acid only (q = 3.079, p<0.05) (Figure 6.4 A). The multiple
comparisons between other groups showed no significant difference. Heme oxygenase 1
(HO-1) is an inducible enzyme that degrades toxic heme following oxidative stress.
Pharmacologic upregulation of HO-1 following TBI leads to improved neuronal survival
by preventing apoptosis (Ding et al 2014). A significant difference was seen between
groups for HO-1 24 hours post-blast (F(3,12) = 11.33, p<0.001). Post-hoc comparison
revealed that lipoic acid only increased the level of HO-1 expression when compared to
control (q = 4.826, p<0.05) (Figure 6.4 B). Post-hoc comparison also showed that the
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expression of HO-1 decreased significantly between the lipoic acid only and single blast
(q = 8.169, p<0.001) animals. The level of expression also increased significantly
between single blast and single blast treated with lipoic acid groups (q = 4.417, p<0.05)
back towards control levels. The overall increase in anti-apoptotic markers following
lipoic acid treatment suggests a protective mechanism limiting Nox4-induced oxidative
stress damage.
Mild changes in pro-apoptotic markers were seen 24 hours post-blast
Fluorescent immunohistochemistry of the left prefrontal cortex showed mild
changes of pro-apoptotic markers 24 hours following single blast exposure. Bax is the
pro-apoptotic regulator of Bcl-2 that is often increased following TBI (Ghadiri et al
2014). Not surprisingly, a significant difference between groups was seen for Bax
(F(2,27) = 3.604, p<0.05). Post-hoc comparison revealed a significant difference between
animals exposed to a single blast compared to control (q = 3.724, p<0.05) (Figure 6.5 A).
No other significant expression changes were seen between the other experimental
groups. Caspase 12 is a pro-apoptotic marker that can lead to the activation of caspase 3.
A significant difference was seen between groups (F(2,27) = 4.325, p<0.05). Post-hoc
comparison revealed a decrease in the expression of caspase 12 in animals exposed to a
single blast with alpha lipoic acid treatment compared to control (q = 4.056, p<0.05)
(Figure 6.5 B). No other changes in expression were seen between any other groups.
Caspase 3 is an important down stream regulator of apoptosis. If caspase 3 is active,
apoptosis will occur. No significant change in caspase 3 expression was seen between
experimental groups (F(2,33) =1.985, p = 0.1535 (Figure 6.5 C).
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No appreciable difference in anti-apoptotic markers were observed 2 weeks post repeat
blast
Repeat injury is a growing concern in the field of neurotrauma. Repetitive
concussions have been linked to CTE and other tauopathies (Lucke-Wold et al 2014c).
An area in need of further investigation is the development of treatment options to
prevent chronic neurodegeneration following acute TBI. We sought to investigate the
beneficial effects of lipoic acid administration given 5 minutes after each blast (6 blasts
total every other day for 2 weeks). Western blot analysis of the left prefrontal cortex was
performed to determine expression changes in anti-apoptotic markers two weeks after
repetitive blast exposure. No significant difference between groups was observed for Bcl2 (F(3,12) = 2.538, p = 0.1057) (Figure 6.6 A). Likewise, no significant difference was
observed between groups for HO-1 (F(3,12) = 0.2129, p = 0.8855) (Figure 6.6 B).
Expression of all markers was shown to remain consistent across all treatment groups.
The data support that no changes in anti-apoptotic markers were seen sub-acutely postrepeat injury.
Lipoic acid reduced pro-apoptotic markers 2 weeks post-repetitive blast
Apoptosis is an important indicator of neurodegeneration (Tajes et al 2014). We
examined three pro-apoptotic markers in the left prefrontal cortex two weeks following
repetitive blast. A significant difference was seen in the expression of Bax between
groups (F(2,27) = 7.93, p<0.01). Post hoc comparison showed an increase in Bax with
repetitive blast animals compared to control (q = 5.194, p<0.01), but the increase was
ameliorated when lipoic acid was given after each blast (q = 4.483, p<0.05) (Figure 6.7
A). No significant difference existed between the control and repetitive blast treated with
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alpha lipoic acid groups. A significant difference between groups was noted for caspase
12 (F(2,27) = 11.96, p<0.001). Post-hoc comparison revealed a significant increase in
expression between repetitive blast animals compared to control (q = 5.809, p<0.001),
but lipoic acid administration after each blast negated this response (q = 6.157, p<0.001)
(Figure 6.7 B). No significant difference existed between the control and repetitive blast
treated with alpha lipoic acid groups. A significant difference in caspase 3 expression was
noted between groups (F(2,27) = 12.6, p<0.001). Post-hoc comparison revealed a
significant increase in caspase 3 for animals exposed to repetitive blast compared to
control animals (q = 6.989, p<0.001), but repetitive blast animals treated with alpha lipoic
acid had a reduced response (q = 4.573, p<0.01) (Figure 6.7 C). Lipoic acid effectively
decreases expression of pro-apoptotic markers at subacute time points (2 weeks)
following repetitive blast.
NADPH oxidase markers and pro-apoptotic markers are increased in human CTE
samples
We examined the NADPH markers, Nox4 and p22phox, in human CTE samples
obtained from a professional football player and professional wrestler that were then
compared to an age and sex matched control. A visible increase in Nox4 was observed in
the football player (32/100) and wrestler (27/100) samples compared to control (6/100)
with χ2=26.527, p<0.0001 (Figure 6.8 A). Likewise, a visible increase in p22phox was
observed for the football player (17/100) and wrestler (24/100) samples compared to
control (3/100) with χ2=34.585, p<0.0001 (Figure 6.8 B). The visual evidence suggests
that concussive injuries lead to an increase in the expression of NADPH markers at
extended time points. This increase is likely associated with the production of free
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radicals that can lead to permanent tissue damage. The response to tissue damage in a
diseased brain is often impaired. A significant difference between groups was observed
for the anti-apoptotic marker Bcl-2 (F(2,27) = 23.8, p<0.001). Post hoc comparison was
significant between football player and control (q = 7.302, p<0.001), and between
wrestler and control (q = 9.255, p<0.001) (Figure 6.9 A). Neurofibrillary tangles have
been proposed to spread between intact cells. These cells must be able to avoid apoptosis
when injured. A significant difference was also seen between groups for the proapoptotic marker Bax (F(2,27) = 23.38, p<0.001). Post hoc comparison was significant
between football player and control (q = 5.424, p<0.01), between wrestler and control (q
= 4.221, p<0.05), and between football player and wrestler (q = 9.645, p<0.001) (Figure
6.9 B). The football player case was a less severe form of CTE indicating that apoptosis
may play a role in the early disease stages. The wrestler case had severe CTE pathology
and showed that apoptosis maybe less likely to play a role in late disease stages.
Tau pathology increased following repetitive blast in rodents and in human CTE
specimens
Following injury, tau becomes hyperphosphorylated and can undergo
conformational changes leading to neurofibrillary tangles. CP-13 is a marker of pretangle tau whereas MCI is a conformational configuration of tau seen primarily in
neurodegenerative disease. Paired helical filament is a dimerized form of tau that
precedes the formation of oligomers. A significant difference between groups was
observed for CP-13 in blast exposed animals (F(2,27) = 8.15, p<0.01). Post hoc
comparison showed a significant increase in CP-13 for the repeat blast group compared
to control (q = 5.54, p<0.01), but lipoic acid ameliorated this change when administered

179

!
post blast (q = 3.967, p<0.05) (Figure 6.10 A). A significant difference was not observed
between groups for MCI in blast exposed animals (F(2,27) = 2.492, p=0.1016) (Figure
6.10 B). A significant difference between groups was observed for PHF in blast exposed
animals (F(2,27) = 18.01, p<0.001). Post hoc comparison showed a significant increase in
PHF for the repeat blast group compared to control (q = 7.865, p<0.001), but lipoic acid
ameliorated this change when administered post blast (q = 6.703, p<0.001) (Figure 6.10
C). A significant difference was observed for CP-13 in human specimens (F(2,27) =
20.31, p<0.001). Post hoc comparison revealed a significant difference between the
football player and control (q = 6.406, p<0.001), and between the wrestler and control (q
= 8.695, p<0.001) (Figure 6.11 A). A significant difference was observed for MCI in
human specimens (F(2,27) = 24.41, p<0.001). Post hoc comparison revealed a significant
difference between the football player and control (q = 9.88, p<0.001), and between the
wrestler and control (q = 4.838, p<0.01) (Figure 6.11 B). A significant difference was
observed for PHF in human specimens (F(2,27) = 51.21, p<0.001). Post hoc comparison
revealed a significant difference between the football player and control (q = 10.58,
p<0.001), and between the wrestler and control (q = 13.64, p<0.001) (Figure 6.11 C).
Blast injury results in an increase of impulsivity-like behavior
Elevated plus maze has been used as a test for impulsivity (Kim et al 2012b).
Animals spending more time in the open arm exhibit decreased risk aversion. The closed
arms represent a darkened environment, which is a preference for nocturnal rodents. A
significant difference between groups was noted for time spent in the open arm at 7 days
post repetitive blast (F(2,21) = 4.327, p<0.05). Post-hoc comparison revealed that rats
exposed to repetitive blast exhibited an increase in impulsive-like behavior spending
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more time in the open arms compared to the control group (q = 3.632, p<0.05), and
repetitive blast + lipoic acid treatment group brought the exploratory behavior back
towards control levels (q = 3.573, p<0.05) (Figure 6.12 A). We wanted to test if animals
receiving repetitive blast were overly active by measuring total distance traveled.
Notably, no difference was observed between groups for overall distance traveled during
the 5-minute interval within the apparatus (F(2,21) = 0.3174, p = 0.7315) (Figure 6.12 B).
DISCUSSION
We show for the first time that alpha-lipoic acid reduced Nox4 and p22phox
following blast TBI. Alpha-lipoic acid acutely increased anti-apoptotic markers 24 hours
after injury. In addition, alpha-lipoic acid decreased pro-apoptotic markers both acutely
and sub-acutely following blast exposure as well as decreasing tau hyperphosphorylation.
Animals exposed to repeat blast exposure had increased impulsive-like behavior on
elevated plus maze (EPM) that was decreased when alpha-lipoic acid was administered
following blast. Alpha lipoic acid, a naturally available supplement, has been used in
previous neural injury studies for its role as an anti-oxidant and for decreasing
neuroinflammation (Rocamonde et al 2013, Rocamonde et al 2012, Toklu et al 2009). It
has recently been suggested that lipoic acid would be a promising therapeutic for TBI
treatment, but experimental preclinical studies are limited (Hall et al 2010). We
investigated for the first time the beneficial effects of alpha lipoic acid on NADPH
oxidative stress reduction following blast TBI. We hypothesize that alpha lipoid acid
reduces Nox4 complex formation with p22phox. Because lipoic acid does not cross the
mitochondrial membrane, we propose it acts peripherally at the neuronal membrane to
decrease superoxide formation, carbonyls, and 8-hydroxy-2-deoxyguanosine. The free
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radical damage is likely due to surrounding microglia activation and peripheral immune
infiltration.
The blast exposure set up used for this study has previously been shown to
produce substantial neural injury to the left cortex due to acceleration/deceleration
dynamics with little damage to the right cortex (Turner et al 2013). We provide
reasonable evidence that alpha lipoic acid reduces the NADPH oxidase Nox4 in the
contralateral left prefrontal cortex, and subsequently inhibits the Nox4 complex
formation with p22phox at 24 hours post-blast. Nox4 has been shown to peak near
contusion sites in humans 24-48 hours following TBI (Li et al 2014b). Nox4 is
predominately located in neurons and is mediated by specific inducible mRNA (Peng et
al 2013). The Nox4 pathway can produce toxic free radicals that may lead to cellular
apoptosis (Li et al 2014a). We observed a significant reduction in superoxide, carbonyls,
and 8-hydroxy-2-deoxyguanosine but not total ROS. Lipoic acid passes through the
neuronal membrane but not the mitochondrial membrane (Wada et al 1997). ROS
generated by mitochondria are not the primary target of lipoic acid. Preventing Nox4
activation may therefore have profound effects on reducing neural injury expansion and
oxidative stress byproducts over time at the plasma membrane. Inhibiting another
NADPH oxidase, Nox2, following TBI has already proved promising in previous studies
with apocynin (Choi et al 2012, Ferreira et al 2013). Continued investigations into the
Nox4 and Nox2 pathways and their relation to TBI are warranted.
Not surprisingly, lipoic acid treatment increased expression of the anti-apoptotic
markers, Bcl-2 and HO-1, 24 hours following single blast injury. Enhancing Bcl-2
activity following TBI has been shown to decrease apoptosis and improve cognitive
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performance (Leeds et al 2014). Likewise, increasing HO-1 activity facilitates the
degradation of toxic heme and prevents plasma membrane damage and the induction of
inflammatory cascades (Okubo et al 2013). HO-1 also has been shown to reduce toxic
iron mediated damage likely accounting for the decrease in free iron observed in the
lipoic acid treated group (Wagener et al 2013). HO-1 converts toxic iron protoporphyrin
into stable Fe(2+) that can be readily cleared from the brain (Gozzelino et al 2010). At
two weeks following repetitive blast (6 blasts over the time course of 2 weeks), lipoic
acid treatment decreased pro-apoptotic markers Bax, caspase 12, and caspase 3. Bax and
caspase 3 trigger rapid and sustained apoptosis following TBI (Ghadiri et al 2014). Bax
deactivates Bcl-2 while caspase 3 triggers the final common pathway of apoptosis.
Caspase 12 is readily increased when toxic free radicals damage the endoplasmic
reticulum (Liu et al 2014b). Caspase 12 can interact with pro-apoptotic factors released
from damaged mitochondria to facilitate activation of caspase 3 (Chen et al 2013).
Reducing pro-apoptotic markers following TBI can decrease neurodegeneration
(Supplementary Figure 6.1). We showed that lipoic acid reduced pathologic
conformational changes of tau following repetitive blast.
The link between apoptosis and subsequent tauopathy is likely due to chronic
neuroinflammation. A recent study suggests that peripheral immune cells enter the brain
via a caveolin dependent mechanism (Badaut et al 2015). Caveolin increases ICAM-1
binding affinity for leukocytes post-injury causing increased diapedesis across damaged
endothelial cells (Xu et al 2013). The peripheral immune cells that enter the brain release
cytokines that trigger a robust gliosis response (Freeman & Ting 2015). The
inflammatory storm can cause activation of NADPH oxidases, which further damage
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neurons and contribute to apoptosis (Ho et al 2015). Overtime nuclear factor kappa B is
translocated to the nucleus triggering a chronic state of inflammation (Ahmad et al 2013).
This chronic inflammation can contribute to the formation of tauopathy (Breunig et al
2013). By targeting NADPH oxidase activity, lipoic acid can be used to disrupt this
cycle. Further studies are warranted to investigate the long-term effects of targeting
NADPH activity on chronic neuroinflammation. We provide evidence that lipoic acid
improves behavior following multiple injuries.
A behavioral alteration often seen in soldiers exposed to blast injury is impulsivity
(James et al 2014). Impulsivity has been linked to brain degeneration and tauopathy in
human CTE (Stein et al 2014). Impulsivity and aggression can lead to personal
relationship and work problems (Booth-Kewley et al 2010). In severe cases, impulsivity
can lead to death due to unnecessary risk-taking behavior (Lopez-Castroman et al 2014).
A behavioral measure of impulsive-like behavior in rodents is the elevated plus maze
(Steimer & Driscoll 2003). Rats with impulsive tendencies spend increased time in the
open arms of the maze. We observed a significant increase in impulsive-like behavior
that was ameliorated by lipoic acid administration 7 days following repetitive blast
injury. Repetitive blast injury did not however increase overall mobility. The mechanism
behind lipoic acid’s beneficial effects is likely due to its anti-oxidant and anti-apoptotic
properties. Future research will examine how lipoic acid affects cognitive function and
apoptosis within the hippocampus. The current findings correlate well with the tauopathy
changes we report. By decreasing apoptosis, lipoic acid can potentially mitigate the
effects of tauopathy and prevent the chronic sequelae of associated neurodegenerative
symptoms.
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CTE is an important neurodegenerative disease of growing prevalence and
importance, yet the pathophysiology is still poorly understood. A lack of prospective
studies and post-mortem diagnosis limits investigation into disease progression and
treatment targets (Baugh et al 2014). The use of new PET scans with a radioligand, which
labels both amyloid and tau, is improving diagnostic capabilities for living individuals
but further work needs to be done (Small et al 2013). We present for the first time that the
Nox4/p22phox pathway may play an important role in CTE pathology. Human samples
from a professional football player and wrestler had increased levels of Nox4 and
p22phox in comparison to age and gender-matched controls. Additionally, the CTE
samples showed disrupted apoptotic signaling mechanisms and abundant tauopathy. Bcl2 was significantly increased in both the football player and wrestler samples. Pure
tauopathies, unlike amyloid β mediated Alzheimer’s disease, have decreased apoptosis in
late stages of the disease. Hyperphosphorylated tau increases Bcl-2 allowing for effective
transfer of neurofibrillary tangles between living cells (Wang et al 2010). Tauopathies
also often have reduced pro-apoptotic markers. We observed that while Bax was
increased in the football player brain, it was reduced in the more severely affected
wrestler brain. The wrestler brain had neurofibrillary tangles and neuropil threads
throughout the cortex, deep nuclei, and brain stem indicating the most advanced stage of
CTE (Omalu et al 2010b). As long as tau phosphatases are still active, tau
dephosphorylation can cause an increase in Bax and trigger apoptosis in injured cells (Liu
et al 2010). At some point during the progression of CTE, tau phosphatases may decrease
substantially and the levels of Bax are markedly reduced. Nox4 fits into the picture by
producing free radicals that can derange signaling pathways. These deranged pathways
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typically trigger apoptosis, but in neurodegenerative disease they lead to
hyperphosphorylation of tau and conformational changes (Giraldo et al 2014).
Hyperphosphorylated tau acts in a positive feedback loop ramping up oxidative stress
(Borza 2014).
Lipoic acid may therefore have multiple beneficial effects when used as a
treatment for neurotrauma. Acutely, lipoic acid could decrease apoptosis by limiting
oxidative stress. Chronically after CTE has developed, lipoic acid could target the
positive tau feedback loop limiting excess tau hyperphosphorylation and conformational
change thereby slowing the progression of CTE. Many studies remain to be done in order
to investigate the beneficial properties of lipoic acid at chronic time points. Continued
supplementation following injury will probably have the most successful results. In order
to advance towards clinical trial, it will be necessary to utilize models that are more
representative of human disease pathology. Approaches such as a transgenic animals or
the use of a species closely related to humans on the evolutionary tree will likely be
necessary. Additionally, scaling blast injury for these new species must be considered in
order to accurately represent human injury exposure. Clinical safety studies are
advancing for lipoic acid’s use in the treatment of other disorders (Kates et al 2014).
Considerations regarding lipoic’s acid use for neurotrauma must be focused upon blood
brain barrier transport, effective dosing, and appropriate timing of administration.
CONCLUSIONS
In summary, lipoic acid provided acute neuroprotection in our clinically relevant
and validated blast TBI model. It decreased Nox4 and p22phox while increasing antiapoptotic markers acutely. Subacutely it decreased pro-apoptotic markers, decreased tau
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conformational changes, and improved impulsive behavior. CTE samples from a football
player and wrestler also showed signs of increased Nox4 activity. The Nox4 pathway
produces hydrogen peroxide and superoxide radicals that damage mitochondria, cellular
DNA, proteins, and lipid membranes (Lobo et al 2010). Long-term consequences include
neurodegenerative disease, tauopathy, and neuropsychiatric changes. Considering the
limitations to diagnosis and the incomplete understanding of CTE pathophysiology, Nox4
mediated oxidative stress should be more closely investigated. Oxidative stress
contributes to an important interplay with tau hyperphosphorylation. Ongoing projects
conducted by our laboratory will investigate the Nox4 pathway as well as lipoic acid
modulation at extended time points. Lipoic acid is a widely used supplement that has
already begun to be evaluated in clinical trials for the treatment of other chronic
disorders. Lipoic acid might be a worthwhile treatment option for TBI as well and
potentially offers a break through for an injury paradigm that has limited treatment
options. The mechanism of lipoic acid neuroprotection are not fully known and must be
further investigated going forward.
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Figure 6.1: Increased intracellular iron and NADPH oxidase in the left prefrontal cortex
24 hours post-blast. Scale bar for whole images = 50µm. Scale bar for inlay images =
20µm. (A) The amount of intracellular iron accumulation increased 24 hours following
single blast (19/100) compared to control (2/100). When alpha lipoic acid was given 5
minutes post-blast the amount of intracellular iron decreased (11/100) compared to single
blast indicating preserved plasma membrane integrity. (B) DAB staining for Nox4 shows
an increase in expression in the left prefrontal cortex 24 hours following single blast
(29/100) compared to control (8/100). The increased level of Nox4 suggests an elevated
production of reactive oxygen species. Alpha lipoic acid treatment decreased Nox4 back
towards control levels (12/100). (C) DAB staining of p22phox, which forms an activation
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complex with Nox4, showed increased expression in single blast (23/100) compared to
control (6/100). Alpha lipoic acid treatment 5 minutes post-blast decreased p22phox
(13/100) back towards control levels.
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Figure 6.2: Lipoic acid reduces the generation of superoxide in the left prefrontal cortex
post-blast. The Nox4 pathway can lead to the generation of free radicals at the plasma
membrane. In particular, NADPH leads to generation of superoxide. This radical can
damage intracellular organelles, which contributes to apoptosis. (A) A visual
representation of superoxide staining shows an increase following single blast that is
reduced by lipoic acid administration post blast. (B) A significant increase in superoxide
between single blast and control groups was detected with fluorescent scanning at 24
hours post-blast (q = 9.01, p<0.001) but was ameliorated by lipoic acid administration (q
= 10.09, p<0.001). *** = p<0.001 SB vs. CTRL. ### = p<0.001 SB vs. LA + SB. No
significant changes were reported for total reactive oxygen species.
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Figure 6.3: Lipoic acid significantly reduces oxidative stress byproducts. 8-hydroxy-2deoxyguanosine and carbonyls have been showng to be increased following TBI. (A) a
significant increase in 8-hydroxy-2-deoxyguanosine was seen 24 hours post blast
compared to control (q=10.53, p<0.001). Lipoic acid administration prevented this
increase (q=4.074, p<0.05). (B) a significant increase in carbonyls was seen between
control and blast (q=6.429, p<0.01). Other significant comparisons were seen between
the lipoic acid and blast groups (q=4.226, p<0.05) and the blast group and blast + lipoic
acid group (q=7.302, p<0.001). *=significance between control and blast, !=significance
between lipoic acid and blast, and #=significance between blast and blast + lipoic acid.
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Figure 6.4: Anti-apoptotic markers from left prefrontal cortex 24 hours post-injury. (A)
A decrease in Bcl-2 expression was seen in single blast compared to lipoic acid only (q =
3.079, p<0.05). No significant difference is seen when comparing other experimental
groups. * p<0.05 LA vs. SB. (B) Significant differences were seen between groups when
probing for Heme Oxygenase 1 (HO-1). An increase in HO-1 was seen between control
compared to lipoic acid only (q = 4.826, p<0.05). A decrease was seen between lipoic
acid only and single blast (q = 8.169, p<0.001), and an increase was seen between single
blast compared to single blast treated with lipoic acid (q =4.417, p<0.05). No significant
difference was seen when comparing the other experimental groups. * p<0.05 CTRL vs.
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LA. ### p<0.001 LA vs. SB. ! p<0.05 SB vs. LA + SB. CTRL = control, LA = lipoic
acid, SB = single blast.
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Figure 6.5: Immunohistochemistry of pro-apoptotic markers in the left prefrontal cortex
at 24 hours post-blast. Scale bar = 100µm. (A) Bax expression is increased in animals
exposed to single blast compared to control (t=3.724, p<0.05). No change is seen
between the other groups. * p<0.05 CTRL vs. SB. (B) A decrease is seen in the
expression of caspase 12 in animals treated with alpha lipoic acid following blast
compared to control (t=4.056, p<0.05). No change is seen between other experimental
groups. * p<0.05 CTRL vs. SB + LA. (C) Caspase 3 expression shows no change
between experimental groups. CTRL = control, SB = single blast, LA = lipoic acid.
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Figure 6.6: Immunoblot of anti-apoptotic markers in the left prefrontal cortex 2 weeks
post repetitive blast exposure. Animals were exposed to 6 blasts total over the time
course of two weeks. No significant differences between groups were observed for (A)
Bcl-2 or (B) HO-1. CTRL = control, LA = lipoic acid, RB = repeat blast, LA + RB =
lipoic acid treatment 5 minutes post each blast, Bcl-2 = B-cell lymphoma 2, and HO-1 =
heme oxygenase 1.
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Figure 6.7: Immunohistochemistry of pro-apoptotic markers 2 weeks post repetitive blast
exposure. Scale bar = 100µm. (A) A significant increase in Bax expression is seen
between animals exposed to repetitive blast compared to control (t=5.194, p<0.01).
Lipoic acid treatment administered 5 minutes post each blast reduced Bax expression
back towards control levels compared to the repeat blast group (t=4.483, p<0.05). No
change is seen between the other groups. ** p<0.01 CTRL vs. RB. # p<0.05 RB vs. RB +
LA. (B) An increase in the expression of caspase 12 was seen for animals exposed to
repetitive blast compared to control (t=5.809, p<0.001). Alpha lipoic acid treatment
reduced caspase 12 levels back towards control compared to the repeat blast group
(t=6.157, p<0.001). No change is seen between the control and the repetitive blast with
alpha lipoic acid treatment groups. *** p<0.001 CTRL vs. RB. ### p<0.001 RB vs. RB
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+ LA. (C) An increase is seen in the expression of caspase 3 in the repetitive blast group
compared to the control group (t=6.989, p<0.001). A significant reduction was noted
when alpha lipoic acid was administered following blast compared to the repetitive blast
group (t=5.459, p<0.01). No change is seen between the control and repetitive blast
treated with lipoic acid groups. *** p<0.01 CTRL vs. RB. ## p<0.01 RB vs. RB + LA.
CTRL = control, RB = repeat blast, LA = lipoic acid.
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Figure 6.8: NADPH oxidase marker expression in human CTE samples. Samples
obtained from the cortex of a professional football player, professional wrestler, and age
and sex matched control. Scale bar for whole images = 50µm. Scale bar for inlay images
= 20µm. (A) Nox 4 staining shows increased expression in tissue of the football player
(32/100) and professional wrestler (27/100) when compared to control tissue (6/100). The
increase of Nox4 can lead to formation of reactive oxygen species that cause cellular
damage. (B) P22phox forms a complex with Nox4 that leads to increased NADPH
oxidase activity within the cell. An increase in the expression of p22phox was seen in the
samples from the football player (17/100) and wrestler (24/100) compared to control
tissue (3/100). The complex formation of these two components suggests subsequent free
radical formation.
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Figure 6.9: Pro-apoptotic marker expression in human CTE samples. Scale bar = 100µm.
(A) Bcl-2 is a protective protein that is increased in order to prevent cellular apoptosis. In
the human tissue, Bcl-2 expression is greater in football player tissue compared to control
(t=7.302, p<0.001). Bcl-2 expression is also significantly increased between wrestler
tissue compared to control (t=9.255, p<0.001). *** p<0.001 CTRL vs. football player and
CTRL vs. wrestler. The increase in Bcl-2 could be a mechanism by which neurons
survive to propogate tau. (B) Bax is known to initiate the cellular apoptosis process. A
significant difference was seen between the football player tissue sample and control
(t=5.424, p<0.01). A significant difference was also seen between the wrestler tissue
sample and control (t=4.221, p<0.05). A significant difference in Bax was also seen
between the football player sample and wrestler sample (t=9.645, p<0.001). ** p<0.01
CTRL vs. football player. * p<0.05 CTRL vs. wrestler. ### p<0.001 football player vs.
wrestler. The wrestler sample had more severe CTE pathology compared to the football
player sample indicating that apoptosis may play an important role in acute disease
progression but not as much of a role once it has fully developed. Tauopathy progression
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is reliant on this disrupted apoptotic signaling. CTRL = control, NFL = football player,
WWE = wrestler.
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Figure 6.10: Lipoic acid reduces pathologic conformational changes in tau two weeks
following repetitive blast exposure. Scale bare = 100µm. CP-13 marks a form of
pretangle tau and MCI is a unique conformational configuration of tau found only in
neurodegenerative disease. PHF is a paired configuration of tau marking the transition
towards tau accumulation in the soma. (A) a significant increase in CP-13 was noted in
the prefrontal cortex following repetitive blast exposure compared to control (q = 5.54,
p<0.01), but the response was ameliorated by lipoic acid administration post-blasts (q =
3.967, p<0.05). ** = p<0.01 RB vs. CTRL. # = p<0.05 RB + LA vs. RB. (B) no
significant differences between groups were observed for MCI. (C) a significant increase
in PHF was noted in the prefrontal cortex following repetitive blast exposure compared to
control (q = 7.865, p<0.001), but was ameliorated by lipoic acid administration post-
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blasts (q = 6.703, p<0.001). *** = p<0.001 RB vs. CTRL. ### = p<0.001 RB + LA vs.
RB. CTRL = control, RB = repeat blast, LA = lipoic acid.
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Figure 6.11: Tauopathy in human chronic traumatic encephalopathy brains. Scale bar =
100µm. Tauopathy is the characteristic finding of CTE. Hyperphosphorylated tau causes
conformational changes, which facilitate the transition towards neurofibrillary tangles.
(A) a significant increase in CP-13 was seen between control and football player brains (q
= 6.406, p<0.001), and between control and wrestler brains (q = 8.695, p<0.001). *** =
p<0.001. (B) a significant increase in MCI was seen between control and football player
brains (q = 9.88, p<0.001), and between control and wrestler brains (q = 4.838 = p<0.01).
*** = p<0.001. ** = p<0.01. (C) a significant increase in PHF was seen between control
and football player brains (q = 10.58, p<0.001), and between control and wrestler brains
(q = 13.64, p<0.001). *** = p<0.001. CTRL = control, NFL = football player, WWE =
wrestler.
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Figure 6.12: Effect of repetitive blast on impulsive-like behavior using the elevated plus
maze assessment. (A) Animals exposed to repetitive blast spent more time in the open
arms compared to control (t=3.632, p<0.05). Time spent in open arm is a representation
of impulsive-like behavior in rodents. Alpha lipoic acid treatment following blast
decreased time spent in open arm compared to repetitive blast exposed animals (t=3.573,
p<0.05). * p<0.05 CTRL vs. RB. # p<0.05 RB vs. RB + LA. (B) The groups did not
differ in terms of distance traveled in the elevated plus maze.

205

!

Supplementary Figure 6.1: Schematic showing Nox4 pathway post- blast. Free iron
damages the intracellular membrane and leads to activation formation of the Nox4 and
P22phox complex. The Nox4 complex generates superoxide, which can decrease antiapoptotic markers acutely and increase pro-apoptotic markers subacutely. Ultimately, this
pathway contributes to apoptosis and neurodegeneration. Lipoic acid has potential to
target this pathway and reduce neurodegeneration following traumatic brain injury.
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Chapter Seven
Modeling chronic traumatic encephalopathy: The way forward for future discovery
This!work!is!published!in!Front Neurol. 2015 Oct 26;6:223. doi:
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ABSTRACT
Despite the extensive media coverage associated with the diagnosis of chronic
traumatic encephalopathy (CTE), our fundamental understanding of the disease
pathophysiology remains in its infancy. Only recently have scientific laboratories and
personnel begun to explore CTE pathophysiology through the use of preclinical models
of neurotrauma. Some studies have shown the ability to recapitulate some aspects of
CTE in rodent models, through the use of various neuropathologic, biochemical, and/or
behavioral assays. Many questions related to CTE development however remain
unanswered.

These include the role of impact severity, the time interval between

impacts, the age at which impacts occur, and the total number of impacts sustained.
Other important variables such as the location of impacts, character of impacts, and effect
of environment/lifestyle and genetics also warrant further study. In this work we attempt
to address some of these questions by exploring work previously completed using single
and repetitive injury paradigms. Despite some models producing some deficits similar to
CTE symptoms, it is clear that further studies are required to understand the development
of neuropathological and neurobehavioral features consistent with CTE-like features in
rodents.

Specifically, acute and chronic studies are needed that characterize the

development of tau-based pathology.
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INTRODUCTION
Corsellis described the original case series of chronic traumatic encephalopathy
(CTE) in boxers (Corsellis et al 1973). The disease consisted of brain atrophy, dilated
ventricles, a cavum septum pellucidum, and pallor of the substantia nigra. Chronic
traumatic encephalopathy was reintroduced into the medical lexicon by Dr. Bennet
Omalu in 2005 (Omalu et al 2005). Omalu described a progressive tauopathy that was
seen in the brains of deceased football players. In recent years, McKee, Goldstein, and
Stern have defined clinical and pathologic features of the disease. These include
behavioral disturbances such as impulsivity, depression, and lack of oversight (Corsellis
et al 1973, Mez et al 2013). Pathologic criteria include neurofibrillary tangles in a
perivascular distribution and within superficial cortical areas with occasional amyloid and
TDP-43 protein aggregations (Baugh et al 2014). Stern recently expanded the CTE
criteria further by describing young vs. old onset based on symptom manifestation (Stern
et al 2013). Interestingly, blast traumatic brain injury has been linked to CTE following a
single exposure, where athletes develop the disease following repetitive head injury
(Lucke-Wold et al 2014c).
CTE has been defined as a slowly progressive disease that takes years to decades
to develop, often providing a significant latent period between when the neurotrauma
occurs and when symptoms develop. A few cases involve athletes/soldiers as early as
late teen’s to early twenties (Omalu et al 2011a, Tartaglia et al 2014). The reason for the
discrepancies in age of presentation observed is currently unknown but is likely due to
the age at which impacts were sustained and the severity of the injury. Prior studies have
shown that children with TBI have inadequate development of social cognition (Ryan et
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al 2014) and that adolescents can develop post-traumatic headaches. Very rarely however
do either of these groups experience symptoms of CTE (Dubrovsky et al 2014). Early
behavioral symptoms of CTE usually do not appear until the mid-thirties, and cognitive
impairment does not begin until the early sixties (Baugh et al 2014). Recent evidence
suggests that neurotrauma may be linked to other neurodegenerative diseases such as
Alzheimer’s disease (AD) as well (Johnson et al 2010b).
CTE and AD, despite both being tauopathies, have generally been viewed as
separate diseases. Each disease has distinct clinical presentations and unique clinical risk
values. This view has gradually been changing with some reports showing that CTE can
develop within the context of AD. The relationship between these two conditions
however is poorly understood. Prior studies have indicated that TBI is a risk factor for
development of cognitive impairment and AD (Guskiewicz et al 2005), but whether the
conditions are additive or synergistic remains unclear (Weber 2007). Recent evidence
suggests that neurotrauma may both increase the likelihood of disease development and
accelerate the development of AD (Barnes et al 2014). Notably, the wealth of AD
pathology observed in preclinical neurotrauma models supports the idea of disease
acceleration (Tran et al 2011). In addition to AD, some groups have presented a possible
link between CTE and a variant of amyotrophic lateral sclerosis that has been termed
‘chronic traumatic encephalomyelopathy’ (CTEM) (McKee et al 2010). Therefore, it is
clear that neurotrauma may have many lasting deleterious consequences, including the
potential for increased risk and accelerated development of neurodegenerative diseases
such as AD, CTE, and CTEM. While the data on these studies is preliminary in nature
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and not prospective, these findings demonstrate the need for further investigation with
both preclinical models and clinical trials.
THE QUEST FOR THE IDEAL CTE MODEL
The search for ideal preclinical models to study CTE remains an area of ongoing
investigation with a relative paucity of prior studies. Of those published previously, the
majority of studies fail to recapitulate the extensive neuropathologic and neurobehavioral
aspects of injury (Goldstein et al 2012, Ojo et al 2015). Post-mortem identification of
neurofibrillary tangles are a key diagnostic marker used clinically (Baugh et al 2012).
Therefore, the development of hyperphosphorylated tau in animals following injury must
be an important component in establishing a CTE model. Tau hyperphosphorylation
appears to correlate with the emergence of neuropathologic and neuropsychiatric deficits
representative of neurotrauma related neurodegeneration (Petraglia et al 2014c). By
modeling CTE in rodents, we can better understand disease development and discover
potential therapeutic avenues. Similarly, little justification is given to injury severity,
number of impacts, interval between impacts, and age at which the impacts occur. Few
studies have also evaluated secondary mechanisms of injury. In the following sections,
we discuss the advancements and shortcomings of prior research while highlighting areas
in need of further investigation.
Proper controls to use when studying CTE
One of the challenges in creating a preclinical model for CTE is the establishment
of proper controls comparing sham to TBI animals (Weber 2007). Specifically, sham
animals must undergo the exact same procedure each day of the injury paradigm. They
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must be anesthetized for the same duration as injured animals. The age of the animal
must also be considered. Control animals should be the same age as experimental
animals at time of sacrifice. This is an important consideration in designing extended
studies with behavioral assays. Biochemical time courses also require control animals for
each time point. Numerous questions must be addressed in planning experiments while
considering the implications of each decision in terms of experimental question addressed
and potential complications (Figure 7.1).
Available tools to study CTE
One of the current weaknesses of clinical investigation of CTE is that the disease
remains a neuropathological diagnosis. Some advancement has been made in ligandbased PET imaging. The imaging was used in a cohort of patients with an extensive
history of neurotrauma, but the modality is not readily available (Small et al 2013).
Consequently, clinical observations are largely retrospective in nature and it is nearly
impossible to investigate disease onset and progression. These clinical shortcomings can
be readily addressed through the use of adequately designed preclinical models.
The first step in creating a preclinical model of CTE is to choose a model that can
be used to generate a combination of biochemical and behavioral changes post-injury
consistent with the CTE-like phenotype.

Specifically, tauopathy or a precursor of

tauopathy (tau hyperphosphorylation), must be present. The changes in tau must be
inducible in genetically unaltered animals and then must be verified with transgenic
rodents. Behavioral changes must be induced by neurotrauma. These changes should
persist or worsen at chronic time points post-injury. Assessment of behavior should
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include tests capable of evaluating behavioral symptoms reported in clinical CTE cases.
In particular, tests for cognition, depressive-like behavior, and impulsive-like behavior
should be used. Cognition can be measured using Morris water maze (MWM) whereas
depressive-like behavior can be assessed with the forced swim test or tail suspension test.
Impulsivity can be elucidated with the elevated-plus maze (EPM).
Once a model is established, biochemical, electrophysiological, and advanced
imaging techniques can be employed to assess neural injury. Biochemical mechanisms
of potential interest include those related to cell survival/death, regulation of tau
phosphorylation/dephosphorylation

(kinases/phosphatases),

bioenergetics,

and

propagation of tau-based changes. Electrophysiological studies can be performed to
identify effects of injury and CTE development both on individual synapses and larger
tracts such as the Schaffer collaterals within the hippocampus. Imaging modalities such
as magnetic resonance imaging (MRI), functional MRI (fMRI), spectroscopy (MRS), and
PET studies have the unique advantage of being able to be performed longitudinally with
multiple assessments of the same animal at different time points.

Taken together,

integration of biochemical, behavioral, electrophysiological, and imaging modalities may
provide insight into the mechanisms and time course of CTE development.

This

approach will also allow for more definitive evidence to be gathered. This evidence will
provide a stepping-stone in addressing key questions about the effect of inter-injury
interval, injury severity, and number of cumulative injuries necessary for the
development of CTE. The answers garnered from this potential work may then influence
the design of clinical trials that dictate return-to-play decisions. Baseline monitoring may
become required in sports arenas and battlefields with high incidences of neurotrauma.
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The monitoring may assist in detecting cumulative subthreshold injury levels and be used
to decrease the overall level of concussions.
IMPLICATIONS FOR MODELING CTE: RESULTS FROM PRIOR CTE
MODELING STUDIES
Perhaps one of the most promising studies, with regards to demonstrating CTElike disease in a rodent model, was performed by Luo, et al. In this study, the authors
developed a closed head model of neurotrauma utilizing an electromagnetic stereotaxic
impact device. The authors showed that enhanced force of injury or using repeat injury
increased GFAP-tagged luciferase. Intriguingly, when this same repeat injury paradigm
was applied to wild-type mice, spatial learning and memory deficits were observed 2 to 6
months after injury and were accompanied by increased hyperphosphorylated tau and
astrogliosis (Luo et al 2014a). The gliosis response in human CTE has not been well
characterized, but the findings by Luo and colleagues show that GFAP was increased
near areas of tauopathy. Similar findings have been seen by Petraglia and colleagues
who performed a rigorous investigation of the behavioral effects of both single and
repetitive closed head injury in wild-type mice (Petraglia et al 2014b). The authors found
that a single injury, in un-anesthetized animals, produced notable short-term
abnormalities in behavior similar to a post-concussive state.

Repetitive injury (42

impacts total: 6 impacts per day over 7 days) produced chronic deficits, particularly with
regards to depressive-like and risk-taking behaviors as well as spatial learning and
memory (Petraglia et al 2014b). This same group published a recent follow-up study
demonstrating the presence of hyperphosphorylated tau, a precursor of neurofibrillary
tangle (NFT) development, in repetitively injured animals (Petraglia et al 2014c). The
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model produces several of the same behavioral symptoms reported by patients suspected
of having CTE. We recently show that endoplasmic reticulum stress contributes to
tauopathy and CTE-like behavioral deficits following repeat blast injury (Lucke-Wold et
al 2015d).
Other studies, conducted by Mouzon and colleagues report both behavioral and
neuropathologic changes following repetitive neurotrauma in mice.

Specifically, 5

injuries administered 48 hours apart, produced durable cognitive deficits, learning
disabilities, diminished rotarod performance, and changes in anxiety-like behavior on
elevated-plus maze. Notably, these behavioral changes occurred in conjunction with
persistent neuroinflammatory changes and disruption of white matter integrity.

No

changes in Aβ and tau phosphorylation were seen at the chronic time points of 6 and 12
months post-neurotrauma, likely because rodents don’t naturally develop neurofibrillary
tangles (Mouzon et al 2014). Rodents do however demonstrate acute tau changes due to
phosphorylation and cleavage following injury (Huber et al 2013). Liu and colleagues
found that tau hyperphosphorylation was increased in rats acutely post-injury and triggers
caspase activation in rat cortices (Liu et al 2011). The activation of cell death can lead to
circuit dysfunction and behavioral deficits (Abisambra & Scheff 2014). Goldstein and
colleagues show that tauopathy contributes to mitochondrial dysfunction and microtubule
injury that ultimately leads to apoptosis. In this study, they found that tau modulation is a
potential avenue for therapeutic intervention (Kondo et al 2015). We recently report that
caspase activation was increased in human CTE brains near sites of neurofibrillary tangle
formation (Lucke-Wold et al 2015a).
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Other repeat-injury studies have investigated changes in tau and amyloid postinjury with the goal being to more clearly elucidate the relationship between TBI and
neurotrauma related neurodegeneration. One report showed an increase in neuronal tau
immunoreactivity (Kanayama et al 1996) and another showed elevated amyloid precursor
protein (APP) (Dobrowolska & Gibson 2005, Weber 2007) at a variety of time points
post-injury. A final study by Zhang and colleagues showed that monoacylglycerol lipase
can lead to behavioral deficits and tauopathy characteristic of a CTE-like phenotype
(Zhang et al 2015). These findings were further verified in other studies using transgenic
models of amyloidosis and tauopathy in which repetitive injury paradigms produced
elevated amyloid and tau levels with increased deposition. Single injury however failed
to produce changes above control levels (Conte et al 2004, Uryu et al 2002). Using a T44
tau Tg mouse line, Yoshiyama and colleagues sought to study dementia pugilistica (DP),
a condition sharing many features with modern day CTE, but with several key
differences.

DP by definition occurs only in boxers and has more severe gross

anatomical changes that are not always present in CTE. The Yoshiyama group found that
4 impacts per day given once a week for 4 weeks produced only modest neuropathology
with only 1 mouse demonstrating CTE or DP characteristics out of a total of 18 Tg mice
and 24 wild-type mice (Weber 2007, Yoshiyama et al 2005). The affected mouse
displayed neuropathologic changes that included heightened tau burden, the presence of
neurofibrillary tangles, and cognitive deficits (Yoshiyama et al 2005). While it remains
unclear why only one mouse developed such pathology, neuropathological findings from
this one animal demonstrated that iron deposition was increased and associated with
blood-brain barrier disruption. Iron deposition, associated with degradation of heme,
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activates oxidative stress-related pathways. Importantly, this oxidative stress is then
associated with accelerated neurofibrillary tangle formation in these perivascular locales
(Yoshiyama et al 2005).
Notably, even single injury paradigms have been shown to produce tauopathy in a
variety of injury models including blast (Goldstein et al 2012), fluid percussion (Hawkins
et al 2013), and controlled cortical impact, findings consistent with prior clinical reports
(Begum et al 2014, Rubenstein et al 2014). Goldstein and colleagues demonstrated that
tauopathy following single blast injury was associated with hippocampal-dependent
learning and memory deficits at subacute and chronic time points. These changes were
also associated with electrophysiological alterations in long-term potentiation (Goldstein
et al 2012). Therefore, even a single mild to moderate injury may induce
neurodegeneration and neurological deficits leading to impaired cognition and disrupted
synaptic transmission (Goldstein et al 2012). Single injury has also been shown to
contribute to blood brain barrier disruption (Glushakova et al 2014). This is a significant
finding considering the numerous concussive and subconcussive injuries occurring in
athletics and on the battlefield. Other studies using single injury models have also
demonstrated activation of numerous pathological processes and behavioral changes
associated with neurodegeneration. Modeling neurotrauma related neurodegeneration is a
key component in the search for a model of CTE (Logsdon et al 2014, Lucke-Wold et al
2014a, Smith et al 1995). While the importance of repeat injury in CTE modeling cannot
be overstated, some single injury studies have led to advances in the ability to detect
phospho-tau in serum at weeks to months post-injury. These advances indicate the
potential role of biomarkers in monitoring and understanding disease pathophysiology
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(Rubenstein et al 2014). The development of animal based models that exhibit similar
characteristics of CTE will afford researchers the opportunity to characterize the acute
and chronic effects of injury on the phosphorylation of tau in controlled experimental
conditions. In vitro models may even be beneficial in elucidating changes at the cellular
level (Zander et al 2015). Evaluating imaging modalities, potential biomarkers, such as
phosphorylated tau, and proposed therapeutics in a controlled context will promote
advancement towards clinical applications and could be instrumental for monitoring and
understanding disease pathophysiology in the future.
IMPLICATIONS FOR MODELING CTE: LEARNING FROM PAST
SHORTCOMINGS WITH TBI MODELS
Despite these notable advancements in CTE modeling as outlined above, the vast
majority of repeat injury studies fail to address the role of injury severity, inter-injury
interval, and the total number of impacts needed to reproduce a CTE-like state
(Goddeyne et al 2015, Prins et al 2010). Most studies simply describe features of TBI
without relating the findings to neurodegeneration (Loane & Kumar 2015). Furthermore,
because CTE is a neuropathologic diagnosis, any study claiming to serve as a model of
CTE must demonstrate the hallmark neuropathologic changes (tau hyperphosphorylation
and neurofibrillary tangles) and show that these changes persist at delayed time points
and coexist with behavioral deficits. Few studies have looked at amyloid, tau, or TDP43
accumulation following injury.
One of the most common omissions from repetitive injury paradigms is the lack
of consideration for inter-injury interval.

Work by Longhi and colleagues directly
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explored this issue, demonstrating that in a mouse model of closed-head injury (CHI),
mice had a period of vulnerability estimated between 3 and 5 days where the effect of
injuries was additive and produced deficits in cognition. When the inter-injury interval
was lengthened to 7 days, these deficits were not present (Longhi et al 2005). While the
focus of that study was elucidating differences in the inter-injury interval, other groups
employing a repeat injury paradigm should consider how the inter-injury interval may
relate to their findings. Inter-interval design will be an important consideration in
developing CTE models. Attempting to provide a clinical context for these decisions
would be desirable, with the interval between severe concussive-type impacts ideally
being longer than that between mild subconcussive-type impacts. This would expand
scientific insight for “return-to-play” guidelines that require players to be asymptomatic
following a diagnosed concussion prior to returning to contact sports. These types of
questions have generally not been considered in preclinical work, with most studies using
brief inter-injury intervals, often ranging from minutes to 24 hours with poor justification
for timing (Creeley et al 2004, Genovese et al 2013, Klemenhagen et al 2013, Petraglia et
al 2014b, Shitaka et al 2011, Wang et al 2014).
Another important limitation related to interpretation of injury severity and
neuropathologic outcome, is the sensitivity of detecting neuropathology using current
scientific approaches.

Shitaka and colleagues demonstrated previously that silver

staining was more reliable for detecting axonal injury and pathology in comparison to
routine histological analysis, assessment of neuronal cell loss, and amyloid precursor
protein (APP) immunohistochemistry (Shitaka et al 2011).

It may be increasingly

important, particularly in studies of repetitive subconcussive impacts, to utilize measures
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of high sensitivity for injury detection. Silver staining, which has been shown repeatedly
to exhibit a higher degree of sensitivity in detecting axonal injury than many
immunohistochemical techniques; electron microscopy; or other markers with these
characteristics may prove promising (Shitaka et al 2011). It has not yet been determined
if neurofibrillary tangles accumulate around sites of axonal shearing.
KEY QUESTIONS GOING FORWARD
Improving experimental models will enhance the quest for developing therapeutic
agents that can be used to prevent and treat CTE. The search for a model of CTE raises a
number of questions that are important clinically. These questions include issues such as
length of the inter-injury interval, the number and severity of impacts, and the age at time
of impacts, as well as the mechanism of impact, the gender of the patient, and what role
genetic predisposition may play in the development of neurodegenerative disease
following neurotrauma. Another important question that must be addressed is does a
history of neurotrauma and potential presence of CTE accelerate the development of
Alzheimer’s disease?

Furthermore, how can the period of susceptibility following

neurotrauma be identified most readily? In the following sections we attempt to address
these questions based upon available evidence. We also provide suggestions for handling
shortcomings going forward. Studies upon which these sections are based are referenced
in Tables 7.1-7 for quick reference.
Inter-injury interval
The effect of inter-injury interval on outcome following TBI has only recently been
investigated. Studies have explored a variety of intervals ranging from 2 minutes apart
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(in vitro) to a few hours (in vivo) to as long as 30 days apart (in vivo). Using a novel
approach assessing vasoreactivity in TBI, Fujita and colleagues demonstrated that
administration of seemingly mild injuries at brief intervals (3 hours apart) produced
dramatic declines in vasoreactivity and axonal pathology. When the inter-injury interval
was lengthened to 5 hours, the magnitude of these changes was diminished substantially
with complete dissolution of changes in both pathology and vasoreactivity at 10 hours
(Fujita et al 2012).
Other studies that have investigated longer inter-injury intervals have identified
periods of susceptibility following an initial impact at periods ranging from 24 hours to a
few weeks (Bolton & Saatman 2014, Mannix et al 2013, Meehan et al 2012, Weil et al
2014). Bolton and colleagues demonstrated with a CHI model that a single impact
produced extensive gliosis bilaterally in the hippocampi and entorhinal cortices. Repeat
injury after 24 hours produced a more severe injury consisting of hemorrhage in the
entorhinal cortices as well as heightened measures of neurodegeneration, gliosis, and
neuroinflammation (Bolton & Saatman 2014). When the experimental paradigm was
changed such that impacts were given with a 48-hour inter-injury interval, the
histopathology resembled that of a single impact suggesting enhanced susceptibility when
a second impact was administered within 24 hours (Bolton & Saatman 2014).
Mannix and colleagues performed one of the most rigorous investigations of the
effect of inter-injury interval on outcomes associated with TBI. These studies included
measures of both cognition and neuropathology related to the development of
neurodegenerative diseases such as CTE and AD. In this study, the investigators showed
that animals who received daily or weekly injuries with weight-drop had persistent
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cognitive deficits up to 1 year post-injury (Mannix et al 2013). This was in contrast to
when animals were injured biweekly or monthly, which failed to produce deficits at such
a chronic time point (Mannix et al 2013). Notably, the cognitive deficits seen in the
daily- and weekly-injured animals did not correlate with elevations in tau
phosphorylation or amyloid-β when measured by ELISA nor brain volume loss when
measured by MRI (Mannix et al 2013). This finding may indicate that in addition to
inter-interval time, injury severity must be considered. Tauopathy is essential for
modeling CTE therefore an appropriate inter-injury interval might be best characterized
in transgenic animals. Weight drop produces variable injury based on the height of the
drop. A more severe TBI can produce cognitive deficits but may not be representative of
the concussive and subconcussive injuries associated with CTE. A mild TBI with a
transgenic animal will likely produce the most relevant deficits.
Meehan and colleagues performed a similar study with primarily behavioral
assays. The investigators subjected mice to a CHI via weight-drop for a total of 5
impacts at various intervals.

These intervals included daily, weekly, and monthly

intervals. Mice receiving 5 impacts total at daily or weekly intervals were impaired in the
MWM compared to sham animals (Meehan et al 2012). This was not the case when
injuries were delivered at monthly intervals, as these animals exhibited no impairment in
the MWM (Meehan et al 2012). Interestingly, at one month post-injury, the daily- or
weekly-injured animals still exhibited deficits in the MWM and this deficit persisted in
daily-injured animals out to 1 year (Meehan et al 2012). This finding may represent why
football lineman who experience daily subconcussive injuries appear more likely to
develop CTE based on the clinical cases reported. It is still necessary to establish if
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tauopathy is the driving mechanism behind behavior. The findings confirm and expand
upon the inter-interval studies completed by Longhi and colleagues (Longhi et al 2005).
Longhi reported that shorter inter-interval injuries produce worse outcomes, which is in
agreement with the Mannix and Meehan findings. These studies were consistent with
findings in higher phylogenetic species as well, specifically piglets.

Friess and

colleagues showed that a 24-hour inter-injury interval produced more severe deficits and
higher mortality rates than when the interval was extended to 7 days (Friess et al 2009).
Finally, Kanayama and colleagues demonstrated a graded response in locomotor activity.
Both shorter inter-injury intervals as well as greater number of total injuries were
associated with worse outcome (Kanayama et al 1996).
Weil and colleagues explored the effect of altering the inter-injury interval in
relation to recovery from TBI. They used a clear clinical-minded approach and utilization
of metabolic imaging (PET). This group showed that injuries separated by only 3 days
were associated with worse neuropathology and an inability to mount the typical
hypermetabolic response with regards to glucose utilization following TBI. This worse
outcome was not seen following either a single injury or repeat injuries with an extended
inter-injury interval of 20 days (Weil et al 2014). Similarly, a brief inter-injury interval
of 3 days was associated with elevated IL-1β and TNFα gene expression when compared
with other experimental groups (Weil et al 2014).
The longest interval between injuries used in preclinical studies, to the best
knowledge of the authors, was 30 days. The additional injury had no additive effect on
anxiety (EPM), depression (FST), and cognitive function (MWM) when compared to
animals receiving only one injury (Mychasiuk et al 2014). These findings indicate that
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either the window of vulnerability following the first injury was avoided or that the
response to the first injury may protect the animal from subsequent injuries, a concept
known as preconditioning (Mychasiuk et al 2014). The progression towards tauopathy
was not well characterized in this work.
In vitro studies have shown similar findings to the in vivo studies described above.
Shorter inter-injury intervals between mechanical stretching resulted in an elevation in S100β protein release and increased cellular permeability identified with propidium iodide
staining (Weber 2007). Similarly, a ‘subthreshold’ level of stretch did not produce any
overt cellular damage or death when repeated at 1-hour intervals but did cause neuronal
loss and neuron-specific enolase (NSE) release when performed at incredibly short
intervals (every 2 minutes) (Slemmer & Weber 2005, Weber 2007). Remarkably, this
rapid and repetitive ‘subthreshold’ stretch that produced changes in neurons, failed to
produce an increase in S-100β protein release, indicating a differential response between
neurons and glia to neurotrauma severity and interval (Slemmer & Weber 2005, Weber
2007).
In contrast to the above studies, one group showed that repeat injury, when
administered in different anatomical locations within the brain, failed to result in
heightened damage when an inter-injury interval was 3 days. It did however increase
tissue vulnerability with a 7-day interval as evident by increased hemorrhage (Donovan et
al 2012, Donovan et al 2014). The authors of the study therefore argue that the period of
susceptibility likely depends on not only the time interval between injuries, but also the
anatomic location of injury (Donovan et al 2012, Donovan et al 2014). Importantly, this
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study utilized an open injury model (controlled cortical impact), a scenario that is only
seen in a subset of clinical neurotraumas.
In summary, these studies demonstrate a period of vulnerability following initial
injury in which sustaining a second brain injury may result in an additive effect. Additive
injury is not clearly apparent when the brain is allowed a more extensive recovery period.
Interestingly, this vulnerability may not solely be due to initial axonal pathology but may
also be the result of cerebrovascular reactivity and the inability to utilize glucose
effectively (Fujita et al 2012, Weil et al 2014). This concept of a varied cellular response
to TBI is consistent with findings from in vitro studies that demonstrate a varied response
amongst glia and neurons (Slemmer & Weber 2005, Slemmer et al 2004, Weber 2007).
Number of impacts
The prevailing theory for ‘mild’ neurotrauma is that repetitive injuries are
associated with more short- and long-term detrimental effects than a single injury alone
(Bolton & Saatman 2014, Laurer et al 2001, Mouzon et al 2012). This concept has been
applied regardless of injury severity (concussive versus subconcussive) with emerging
evidence indicating that even subthreshold impacts are cumulatively detrimental (Bailes
et al 2013, Fujita et al 2012). In this section we explore the effect of repeat injury
through analysis of studies employing both repeat and single injury paradigms.
One of these studies, conducted by Mouzon and colleagues, showed that when
rodents are exposed to 5 total injuries with an interval of 48 hours, these animals exhibit
both impaired learning and memory at extended time points (Mouzon et al 2014). These
findings are in contrast to single injured animals that display only learning deficits but no
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retention impairment at the same time points (Mouzon et al 2014). This study closely
parallels the clinical findings documented by Guskiewicz and colleagues in which former
athletes with a history of repetitive concussions experience memory-related issues at a
rate 5 times higher than those without a history of concussion (Guskiewicz et al 2005,
Mouzon et al 2014).
Other work that investigated various iterations of impacts (0, 1, 3, 5, and 10)
demonstrated that while a single injury does not produce deficits in MWM performance
in comparison to sham-injured animals, repetitive injury does in fact produce deficits and
these deficits may exhibit a dose-dependent relationship. When mice were given 10
concussive weight-drop injuries, those in which the weight was dropped from a height of
42 inches performed worse than those injured from a height of 38 inches. Therefore, this
work demonstrates the potential for both injury number and injury severity in
contributing to neurological dysfunction (Meehan et al 2012).

Luo and colleagues

utilized a GFAP-driven luciferase mouse line and a repetitive closed head injury model to
investigate cumulative decline. The investigators showed that there appeared to be a
linear increase in GFAP luminescence from 1 to 3 injuries but that this response appeared
to reach a plateau by 5 injuries (Luo et al 2014a). In addition to the increase in GFAP
fluorescence with repetitive injuries, mice receiving three injuries demonstrated less
freezing time than sham animals in both cued and contextual fear conditioning (Luo et al
2014a). This was in contrast to single injury animals that did not differ from shaminjured animals in cued or contextual memory (Luo et al 2014a). Consequently, this data
demonstrates that an increase in injury number is associated with an increasing severity
of injury markers (based on protein expression of GFAP) as well as functional deficits
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(fear conditioning). Others employing both single and repeat injury paradigms have
shown that while single injury may not induce pathological findings, repeat injury, of the
same severity, does. This was particularly notable in work by Uryu and colleagues in
which repetitive injury produced an increase in Aβ deposition in Tg2576 animals,
whereas no increase was observed in single injury paradigms in these same animals
(Uryu et al 2002). Likewise, Kanayama and colleagues demonstrated that repeat injury
paradigms induced tau hyperphosphorylation, a precursor to NFT formation, in
conditions such as CTE and AD (Kanayama et al 1996).
The observed findings in closed-head, repeat injury models, were also consistent
with those found in open-head injury using a craniectomy and controlled cortical impact.
In work by Donovan and colleagues, the investigators showed that repeat injury induces
progressive and evolving changes that are not observed in single injury paradigms
(Donovan et al 2014). The basis of many of the memory and cognitive changes following
repeat TBI, may be explained by electrophysiological alterations in synaptic
transmission. In work by Aungst and colleagues, repetitive TBI was found to prevent the
induction of long-term potentiation (LTP) 28-days post-injury due to alterations in the
NMDA receptor. This is in stark contrast to single injury paradigms that revealed the
ability to induce LTP in both hemispheres, with the contralateral hemisphere exhibiting
less LTP than the ipsilateral hemisphere.
neurotransmission

following

repeat

injury

The impairments in excitatory
were

accompanied

by

extensive

neuroinflammation and neurodegeneration as well as behavioral/functional impairments
(Aungst et al 2014b). Specifically, repeat injury produced deficits more severe than
single injury when measured at one-week intervals out to a month. Importantly, even
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single injury produced deficits at chronic time points post-injury when compared to sham
animals, indicating long-term effects of TBI (Aungst et al 2014b).
Povlishock and colleagues expanded the concept of subthreshold injury. In these
studies, the investigators showed that administering a single weight-drop injury from 1.0
m resulted in neither axonal nor microvascular change. With repeat injury of short interinjury intervals (hours), significant axonal and microvascular pathology was observed
(Fujita et al 2012).

This work was the first to assess microvascular reactivity to

acetylcholine (ACh) following repetitive subthreshold brain injury.

This work

demonstrates the clear danger of subthreshold impacts when sustained in a repeated and
rapid fashion. It also illustrates the role of the microvasculature in neuronal injury,
showing that the neurovascular unit is essential for neuronal homeostasis.
Importantly, work regarding the number of impacts has been extended higher up
the phylogenetic tree to rabbits and piglets (Olsson et al 1971, Raghupathi et al 2004). In
rabbits, repeated loading with loads of up to 1.5 atm failed to produce an additive
concussive response over a single load.

A multi-loading paradigm at higher loads

however caused respiratory arrest (Olsson et al 1971). In piglets, multiple less severe
injuries induced neuropathological findings similar to a severe load based on the density
of injured axons as well as number and distribution of foci (Raghupathi et al 2004).
In vitro studies have reported similar findings to the in vivo studies. Weber and
colleagues applied a mild stretch to hippocampal neuronal cultures that produced lowgrade injury when applied at a single time. When this injury was repeated, the cells
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exhibited cumulative damage with two injuries inducing an increase in neuron-specific
enolase (NSE) (Slemmer & Weber 2005, Slemmer et al 2004, Weber 2007).
Notably, the group led by Mychasiuk and colleagues provides evidence contrary
to the widely held belief that an increased number of impacts are associated with
detrimental findings on behavioral or histological measures. With a 30-day inter-injury
interval, rodents receiving multiple injuries performed similar to single-injury animals on
measures of anxiety, depression, and cognitive ability. Therefore, they propose that
receiving head injury at an early age may prime the brain to be less susceptible to the
effects of a later neurotrauma, a theory known as ‘pre-conditioning’ (Mychasiuk et al
2014).

DeRoss, et al also showed that while one concussive impact resulted in

diminished performance in 85% of animals, less deviation was seen with subsequent
impacts. The number of impacts has an inverse relationship with animal performance in
the water maze (DeRoss et al 2002). Again, the mechanism behind these findings is not
entirely clear as those animals sustaining multiple injuries also received additional
exposure to the water maze, allowing for enhanced training/learning of the maze (DeRoss
et al 2002). Therefore, while repetitively injured animals did better than single-injured
animals in the maze, this is likely a product of increased training rather than a protective
response but this cannot be said with absolute certainty.
Severity of impacts
The effect of injury severity on likelihood of neurodegenerative disease
development is not entirely clear, although some clinical reports indicate that more severe
injury results in a greater predisposition for AD development (Plassman et al 2000, Uryu
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et al 2002). What is known from preclinical studies using an array of animal models is
that there is a dose-dependent increase in neural injury markers and cognitive deficits
with more severe injury (Budde et al 2013, DeFord et al 2002, Long et al 2009, Luo et al
2014a, Manley et al 2006, Turner et al 2013). Similarly, repetitive ‘mild’ injuries may
produce a phenotype more consistent with a single more severe injury (DeFord et al
2002).
How ‘mild’ TBI contributes to the likelihood of developing CTE remains unclear.
Emerging evidence from preclinical studies raises concern about lasting effects of
subthreshold injuries when sustained in a rapid and repetitive fashion. These repetitive
injuries contribute to vascular reactivity and subsequent axonal degeneration in vivo
(Fujita et al 2012). Some studies suggest that severity of injury may dictate the rest
period required to minimize cumulative cognitive deficits, although further studies are
required to validate these findings (Meehan et al 2012).
Similarly, preclinical studies, even those in which only a mild force is imparted to
a thinned cranium, indicate that a substantive inflammatory response is produced quickly
after injury (Roth et al 2014). This response is associated with heightened vascular
permeability, also seen clinically, as well as microglial response (Roth et al 2014). It is
these mechanisms, both primary and secondary, that may contribute to neurodegenerative
disease post-neurotrauma.
In vitro studies may be of further use in addressing the role of injury severity,
particularly in subconcussive/subthreshold-type studies, as levels of injury and
subsequent cellular responses can be monitored rapidly and performed over a greater
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number of iterations at a lower cost in comparison to in vivo studies. In fact, a number of
injury paradigms and mechanisms have been investigated successfully in this manner
including fluid pulse-induced shear stress, repetitive stretching, and other mechanical
deformation procedures, both in vitro and ex vivo (LaPlaca & Thibault 1998, Morrison et
al 2006, Mukhin et al 1998, Sieg et al 1999, Slemmer & Weber 2005, Slemmer et al
2004). The in vitro shearing studies found a significant amount of axonal beading and
glial death (LaPlaca et al 2005).
Age at time of impacts
Age is the biggest risk factor for the development of neurodegenerative disease
and has been associated with poor outcomes following TBI in a variety of clinical and
preclinical reports (Anderson et al 2009, Hamm et al 1991, Hoane et al 2004, Maughan et
al 2000, Mehan & Strauss 2012, Timaru-Kast et al 2012, Turner et al 2012c, Turner et al
2014, Wali et al 2011). Similarly, neurotrauma has been associated with an increased
risk of neurodegenerative disease development with regards to AD (Magnoni & Brody
2010, Plassman et al 2000, Sivanandam & Thakur 2012, Van Den Heuvel et al 2007), PD
(Bower et al 2003), and CTE (Gavett et al 2011a, Goldstein et al 2012, McKee et al 2010,
Montenigro et al 2014, Omalu 2014, Omalu et al 2011a, Omalu et al 2011b, Omalu et al
2010a, Omalu et al 2006, Omalu et al 2005, Omalu et al 2010b, Omalu et al 2010c, Stern
et al 2013). One of the primary questions currently in the field is how the age at which
the patient sustains the neurotrauma pertains to the development, or lack thereof, of CTE.
Similar findings have been observed in preclinical studies.

Mychasiuk and

colleagues showed that TBI during brain development leads to worse outcomes than TBI
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affecting the mature brain (Mychasiuk et al 2015). Preclinical work has also shown that
young animals experience less edema than middle-aged animals following TBI (Kasturi
& Stein 2009). The increased edema is associated with an increase in lesion size in aged
rodents experiencing TBI (Kumar et al 2013). TBI in aged rodents is also more likely to
increase sensorimotor and cognitive decline (Hoane et al 2004). TBI in youth may
ultimately be more detrimental for social development, whereas severe injury in the
elderly results in rapid cognitive decline due to increased edema and therefore, lesion
size. In regards to human TBI, it is unclear if the elderly would have a more progressive
form of the disease similar to rodent studies or if the disease would develop in the normal
manner. It is also important to consider that males <35 years old are the most likely to
have repetitive TBIs, a group associated with heavy participation in sports and now the
military (Theadom et al 2014). Future preclinical studies should therefore continue to
investigate TBI secondary mechanisms in both young and aged animals with particular
attention paid to addressing repetitive injury paradigms and the development of CTE-like
features, both behaviorally and biochemically.
Mechanism of impact
CTE has been diagnosed in athletes sustaining direct impacts as a result of
participation in warfare, football, wrestling, and soccer (Gavett et al 2011a, Goldstein et
al 2012, McKee et al 2010, Montenigro et al 2014, Omalu 2014, Omalu et al 2011a,
Omalu et al 2011b, Omalu et al 2010a, Omalu et al 2006, Omalu et al 2005, Omalu et al
2010b, Omalu et al 2010c, Stern et al 2013). The mechanism of injury is different
between blast and athletic concussions, but how these mechanisms relate to injury
progression remains to be elucidated. For blast, primary to quaternary injury must be
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considered (Kobeissy et al 2013). Other important questions include what is the influence
of linear versus rotational impacts? What is the effect of direct impacts such as a football
tackle versus indirect impacts such as primary blast exposure? Furthermore, how can
comparisons most accurately be made across these various impacts? Are accelerometers
and recording systems (such as the HITS system) the best method for understanding and
comparing these impacts?

What role does high-speed videography and subsequent

kinematic analysis play? Each of these questions remains to be answered and may
provide further insight into understanding the role that impact type plays in CTE
development.
Biochemical mechanisms
Interestingly, glymphatic clearance has recently been shown to play a role in
injury progression. Iliff and colleagues showed increased tauopathy accumulation in
aquaporin knock-out mice following traumatic brain injury due to disrupted glymphatic
clearance (Iliff et al 2014). It has yet to be determined how the primary injury mechanism
causes the disruption to glymphatic channels. Cernak proposed an interesting theory
about low-frequency stress waves transmitting kinetic energy through tissue (Cernak
2015). This mechanism may account for the dysfunction of the aquaporin channels. The
energy transfer may also injure other cellular components such as axons or vessels.
Chodobski and colleagues have shown that kinetic transfer of energy can account for
blood brain barrier disruption (Chodobski et al 2011). Blood brain barrier disruption postinjury can trigger increased neuroinflammation. Agoston and colleagues showed that
blast traumatic brain injury, in particular, causes persistent neuroinflammation, which
leads to behavioral deficits (Kovesdi et al 2012). The neuroinflammation can also
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contribute to post-traumatic epilepsy and tauopathy (Salazar & Grafman 2015).
Investigating how tauopathy spreads is a topic warranting further investigation (Koliatsos
& Xu 2015). Furthermore, Kobeissy and colleagues highlight in their recent review that
underlying neuronal damage can cause lasting neuropsychiatric deficits such as postconcussion syndrome and post-traumatic stress disorder (Kobeissy et al 2013).
Role of genetics
Genetics and lifestyle choices may play a role in likelihood of sustaining a TBI
and also the outcome following a TBI. Little to no evidence currently exists regarding
lifestyle choices associated with TBI and only recently has genetic contribution to CTE
been addressed. Specifically, it is well known in the human literature that the APOε4
allele is associated with worse outcome following TBI (Ponsford et al 2011). APOε4 and
APOε3 have also been implicated in the development of both CTE and AD (Saulle &
Greenwald 2012, Weber 2007). The mechanism by which APOε4 worsens outcome
following TBI is poorly defined (Mannix et al 2013), but targeted replacement of the
allele in mice has allowed focused research into cholesterol metabolism and may lead to
insights in the field of traumatic brain injury and subsequent neurodegeneration
(Laskowitz & Dawson 2014). Notably, a study by Maroon and colleagues recently
demonstrated that there was no significant difference between ApoE4 carriers in a
population of patients afflicted with CTE when compared to the general population,
suggesting that perhaps ApoE may not represent a significant risk factor for CTE
development, even in individuals exposed to neurotrauma (Maroon et al 2015).
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Other genetic influences have also been observed but are currently limited to
preclinical evidence. Rare genetic alterations such as mutation of the CACNA1A calcium
subunit gene have also been shown to lead to poor TBI outcomes in human patients (Kors
et al 2001). Recent pre-clinical studies have shed light on other potential genetic factors
that may influence TBI outcomes. Decreases in micro RNA 23a and 27a increase
apoptosis following TBI in rodents (Sabirzhanov et al 2014).

Deficient caveolin

expression can exacerbate neuroinflammation post-TBI (Niesman et al 2014).

The

knock-in mouse APP696swe has accelerated deposition of Aβ following TBI
(Yoshiyama et al 2005). Emerging evidence also suggests dysfunctional mitochondrial
genes following TBI such as Fas, Apaf1, and Chp. Interestingly, these genes become
more dysfunctional and mutated with time after mild TBI (Sharma et al 2012). TBI can
also induce DNA fragmentation leading to an upregulation of p53, a critical regulator of
cell cycle (Lu et al 2000). On the other hand, upregulation of insulin growth factor
expression prior to TBI is associated with neuroprotection (Carlson et al 2014).
Similarly, genetic regulation of aquaporin 4 channels can reduce edema formation
following TBI in rodent models (Ke et al 2001). Surprisingly, disruption or the PARP1
gene offers protection against TBI hypoxia (Hagberg et al 2004). Studying genetic risk
factors for TBI is an area of growing importance and requires further investigation.
Understanding factors that lead to increased or decreased TBI severity may also allow the
development of novel pharmaceutics for the prevention of neurodegenerative disease.
An emerging area is the role of epigenetic modulation following TBI. Epigenetic
markers are now being used preliminarily to predict recovery following injury (Lipsky &
Lin 2015). VandeVord and colleagues show enhanced methylation of DNA in the rat
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hippocampus following blast traumatic brain injury (Bailey et al 2015a). These epigenetic
changes are mediated by HDACs and DNMTs (Bailey et al 2015b). Interestingly, the
methylation changes are cumulative with repetitive injury (Haghighi et al 2015). HDAC
has been shown to contribute to GSK3β activation, which is a known tau kinase. When
HDAC is inhibited white matter damage is reduced (Wang et al 2015). Epigenetic
regulation has been tied to the development of post-traumatic stress disorder clinically
(Almli et al 2015). Targeting epigenetic regulation may therefore be a viable target in
preventing tauopathy and behavioral deficits following traumatic brain injury.
Influence of gender
The influence of gender on outcome after TBI remains controversial, particularly
in light of the few cases of CTE diagnosed in women. Some studies claim that females
have better outcomes following neural injury (Bramlett & Dietrich 2001) while others
report no change (Bruce-Keller et al 2007, Kadyan et al 2004), or worse outcome (Farace
& Alves 2000a). Estrogen treatment has shown improved outcomes in rodent models of
neural injury (Jia et al 2009, Li et al 2011, Simpkins et al 1997, Suzuki et al 2007),
including TBI (Day et al 2013, Gatson et al 2012).

Female rodents exhibit better

outcomes after neural injury as evidenced by increased neurotrophin production (Gatson
et al 2012), decreased neuroinflammation (Brown et al 2009), and better performance on
motor tasks (Wagner et al 2004b). Clinical evidence shows that female patients exhibit
lower oxidative damage after TBI (Wagner et al 2004a), which could be the result of a
higher estrogen circulation following injury. Gender differences should be considered
when conducting clinical trials for TBI therapy.
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Interestingly, Dixon and colleagues found that TBI in female humans reduces
estradiol in the CSF (Garringer et al 2013). The reduction of estradiol may have unique
long-term effects because it is not yet known if this is transient or permanent. The limited
amount of data about women with TBI has restricted the comparisons of injury between
genders (Bell & Pepping 2001). The majority of traumatic brain injuries in women are
subdural hematomas from falls. Elderly women with subdural hematomas tend to fair
worse than the general TBI population as a whole (Farace & Alves 2000b). Menopause
may therefore dampen the neuroprotective physiologic properties mediated by estrogen
post-injury. TBI in elderly women is also linked with earlier onset Alzheimer’s disease
(Nemetz et al 1999). Hormonal changes may also be a contributing factor to CTE, but
this has yet to be verified. It is clear based on the limited pre-clinical and clinical data that
further investigation into the gender differences surrounding TBI outcome is warranted.
Effect of environment
Another area of investigation required for elucidation of factors influencing the
likelihood and/or severity of CTE development following neurotrauma includes the effect
of environment.

Areas of particular interest include social support, diet, use of

supplements, and use of drugs or anabolic steroids.
Good social support has been shown to decrease the likelihood of developing a
postconcussional disorder following acute head injury (McCauley et al 2001). Strong
family support is linked to better outcomes (Khan et al 2003). Another important feature
of environment is diet. While the effect of diet is well understood with regards to general
health, there are limited studies relating diet and mental health, particularly in the context

237

!
of traumatic brain injury. A preclinical study conducted by Mychasiuk and colleagues
showed that high-fat diet in conjunction with TBI resulted in cumulative deficits on
assessments of motor function, short-term working memory, and produced depressivelike effects compared to animals with normal diet and TBI (Mychasiuk et al 2014).
Similarly, administration of dietary supplements such as Vitamin E and DHA have been
shown to improve outcomes from TBI in numerous studies (Bailes & Patel 2014, Conte
et al 2004, Mills et al 2011a, Mills et al 2011b, Wu et al 2004). The suggestion has been
made previously, based on evidence that some cases of diagnosed CTE occurred in
former athletes with a history of anabolic steroid use, that anabolic steroid use may
predispose these athletes to CTE development.

While this question has not been

completely resolved in terms of studying markers of CTE, preliminary studies found no
difference in amyloid precursor protein (APP) expression post-TBI regardless of when
anabolic steroids were used (Mills et al 2012).
Preconditioning
Any neural injury model has the potential to be complicated by the concept of
preconditioning. Preconditioning at the most basic levels refers to neuroprotection for a
given injury induced by a prior stimulus/injury. The concept of preconditioning has been
well documented in a variety of neural injury models ranging from ischemic stroke to
TBI (Weber 2007). Initial stimuli that serve a protective effect in a subsequent injury
include but are not limited to brief periods of ischemia, chronic exposure to moderate
heat or heat acclimation, and subthreshold or mild injury (Weber 2007). The proposed
mechanism is that neuronal antioxidant machinery is upregulated with subthreshold
injury thereby increasing the cells ability to respond to free radical production during
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subsequent injuries (Hu et al 2008) Whether preconditioning serves a protective
phenomenon in the development of CTE is unclear, but the general clinical consensus is
that any brain injury no matter how small may be detrimental long-term, minimizing any
potential benefit of the preconditioning phenomenon (Bailes et al 2013, Talavage et al
2014). This is in contrast to preclinical literature demonstrating that sustaining repetitive
mild injury prior to a single severe injury protects the animal from the most deleterious
effects of the severe injury (Allen et al 2000). In other words, animals receiving
repetitive mild injury prior to a severe injury do better than animals receiving a single
severe injury (Allen et al 2000). Similar findings have been observed in vitro in which
subthreshold stretch prevented more deleterious injury when a threshold stimulus was
given (Slemmer & Weber 2005). The concept of preconditioning versus additive injury
is captured pictorially in figure 7.2.
SUMMARY
In conclusion, understanding CTE as a disease remains in its infancy and current
studies remain largely speculative in nature without prospective clinical investigation.
The required clinical studies to advance the field mandate extensive financial resources
and time. Preclinical studies represent the most promising mechanism for studying many
of the basic biologic questions about CTE, as discussed above. While these studies are
continuing to evolve, numerous groups have reported exciting findings. Better modeling
has allowed more extensive biochemical and behavioral characteristics to be defined.
Now that our laboratory and others have established CTE models, options for
translational investigation of CTE pathophysiology abound. In this work we discussed
numerous avenues for addressing translational questions, namely the role of 1) inter239
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injury interval, 2) number of impacts, 3) impact severity, 4) age at time of impacts, 5)
mechanism of impact, 6) genetics, 7) gender, and 8) effect of environment on the
development of CTE. We also highlighted some of the challenges of CTE modeling and
specific requirements for successful models. By improving our understanding about CTE
mechanisms, we believe that significant strides can be made not only in understanding
CTE but also potentially developing prevention and therapeutic-related approaches. A
companion manuscript describes our collective experience in modeling CTE, both
neuropathologically and behaviorally.
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Figure 7.1: Methodological challenges associated with repeat injury in comparison to
single injury paradigms include balancing equal age at time of exposure versus age at
sacrifice. Two possibilities are shown depending on the variable the experimenter wants
to control in future work.
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Figure 7.2: Schematic representation of factors influencing injury outcomes, particularly
in repetitive injury paradigms. Initial evidence indicates that longer inter-injury intervals,
less severe initial injury, a younger age, and female gender may serve as protective
effects in repeat paradigms. In contrast, shorter intervals, increased severity, older age,
and male gender may be associated with worse outcomes.
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Table 7.1: A collection of studies that propose to model CTE. The majority of the studies
represent both neuropathologic and behavioral deficits. Tauopathy, behavioral changes,
and worse cognitive performance are hallmarks.
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Table 7.2: A collection of studies utilizing blast-induced neurotrauma models are
summarized here. These studies employed both single and repeat-injury paradigms with
experimental endpoints investigating both neurobehavioral changes and injury
pathophysiology. Notably, the referenced studies, consistent with most blast literature,
have been conducted within the past 5 years, indicating that blast pathophysiology is
probably the least well understood of any mechanism of neurotrauma.
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Table 7.3: Selected studies using a conventional weight-drop model similar to the
Marmarou or impact-acceleration injury models utilized both single and repeat-injury
paradigms.
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Table 7.4: Modification of the more traditional controlled cortical impact device has
resulted in the ability to develop highly reproducible neurotrauma in preclinical models.
Consequently, all of the selected studies demonstrate the implementation of repeat-injury
paradigms, often in the investigation of CTE-like neurodegeneration and neurobehavioral
changes.
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Table 7.5: Selected studies of interest requiring craniotomy for administration of fluidpercussion injury, controlled cortical impact, or open-head weight-drop.
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Table 7.6: Less conventional models of neurotrauma due to species utilized, injury
mechanism, and/or equipment adaptations. Of particular interest is the study by Petraglia
and colleagues that administered single or repetitive impacts in unanesthetized animals.
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Table 7.7: Selected in vivo or ex vivo studies of neurotrauma.
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Chapter Eight
Final Discussion
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SUMMARY
Traumatic brain injury continues to be a daunting challenge with few available
clinical treatment options. Repetitive concussions have been linked to chronic symptoms
such as impulsivity, cognitive decline, and motor dysfunction. In order to advance
forward towards the development of novel treatments that can prevent these debilitating
symptoms it will be imperative to elucidate the mechanisms that link acute injury to
chronic neurodegeneration. We have investigated in this dissertation several of these
mechanisms that might contribute to disease progression. In particular, we examined
blood brain barrier disruption and the role of protein kinase C activity, endoplasmic
reticulum stress and tauopathy, and NADPH oxidative stress and neuronal plasma
membrane damage. Once these mechanisms are more fully understood and shown to be
similarly upregulated in humans, it will be possible to design targeted therapeutics that
can both prevent degenerative changes and slow the progression of chronic traumatic
encephalopathy.
The pharmacologic compounds investigated in this dissertation target broad
secondary injury cascades. Bryostatin was used historically as a chemotherapy agent with
cytotoxic properties. Recent pre-clinical findings have shown its potential for modulating
protein kinase C isozymes within the brain and preventing neuronal injury expansion. We
showed it has neuroprotective benefits at the blood brain barrier. Docosahexaenoic acid
has been shown to stabilize neuronal membranes, prevent axonal degeneration, and
reduce endoplasmic reticulum stress. The multiple therapeutic targets and cost-effective
nature of this supplement make it an ideal candidate for clinical trials. We were able to
show that it successfully prevented cognitive decline when given after injury in our
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rodent model. Furthermore, lipoic acid is known to readily cross the blood brain barrier
and target oxidative stress. We showed that it was effective at reducing NADPH
oxidative stress within the neuronal membrane. Further work is needed to determine if it
also can prevent mitochondrial related oxidative stress.
FUTURE DIRECTIONS
Going forward, it will be necessary to utilize the expertise of multi-disciplinary
teams. In this dissertation, we highlighted a project that was performed in conjunction
with an astronautical engineer and physicist. The collaboration led to an enhanced
understanding of the wave mechanisms and how the wave dynamics may be directly
causing injury. Similarly, we partnered with Anthony Petraglia, MD to compare two
proposed models of chronic traumatic encephalopathy. The collaborative nature of these
projects will continue to propel the field further and allow a broader appreciation of
different types of TBIs.
We are currently working with a PhD in mechanical engineering for developing a
strategic approach for handling concussion. In the first component, we are investigating
strategies for early detection of concussion such as measurements of successive impacts
and rotational acceleration. In the second component, we are working on the development
of early diagnosis of concussion by blood-based biomarkers. In the third component, we
are developing new preventative equipment such as neck sheaths and re-designed
helmets. Finally, we will develop a brain health supplement regimen that can be used to
prevent cognitive decline following injury.
As mentioned in chapter 7, several unanswered questions are still looming in
regards to understanding chronic traumatic encephalopathy development and progression.
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While animal models can give us valuable data about secondary injury cascades, they fail
to address the more complex questions regarding genetic predisposition, the association
with comorbidities, and the number of impacts or intensity of impacts necessary to push
the brain beyond a certain damage threshold. It will be necessary for further human
epidemiologic studies to be performed in order to map the progression of the disease.
These prospective studies can be used to gather better information about disease
prevalence and incidence. The number of concussions is on the rise and the topic of
degenerative brain changes is of great importance. This dissertation adds a small but
informative piece to the puzzle for our overall understanding degenerative changes
following neurotrauma. Future work will investigate how the acute secondary injury
cascades work together to contribute to persistent neuroinflammation. Targeting
neuroinflammation may be the ideal target for reducing behavioral deficits following
injury.
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(2014) Aging, the Metabolic Syndrome, and Ischemic Stroke: Redefining the
Approach for Studying the Blood Brain Barrier in a Complex Neurological
Disease. Pharmacology and the Blood Brain Barrier: Targeting CNS Disorders.
Advances in Pharmacology. 71:411-49.
Nguyen, L. Lucke-Wold, B.P., Mookerjee, S., Kaushal, N., and Matsumoto, R.R.
(2016) Sigma-1 receptors and neurodegenerative diseases: Towards a hypothesis
of sigma-1 receptors as amplifiers of neurodegeneration and neuroprotection.
Advances in Experimental Medicine and Biology. Springer. In press
Logsdon, A.F., Lucke-Wold, B.P., Rosen, C.L., and Huber, J.D. (2016) Aging and
Cerebrovascular Dysfunction. Primer on Cerebrovascular Diseases. Academic
Press. In press

Accepted Journal Articles:
1. Lucke-Wold, B.P. (2011). Where to Draw the Line: the Balance Between
Research and Medicine. The International Undergraduate Journal for Service
Learning, Leadership, and Social Change. 1:11-29.
2. Lucke-Wold, B.P. (2011). The Varied Uses of Conditioned Place Preference in
Behavioral Neuroscience Research: An Investigation of Alcohol Administration
in Model Organisms. Impulse: Premier Undergraduate Journal for Neuroscience
Research. 11:1-9.
3. Turner, R.C., Lucke-Wold, B.P., Robson, M.J., Omalu, B.I., Petraglia, A.L., and
Bailes, J.E. (2012) Repetitive Traumatic Brain Injury and Development of
Chronic Traumatic Encephalopathy: A Potential Role for Biomarkers in
Diagnosis, Prognosis, and Treatment? Frontiers in Neurology: Frontiers in
Neurotrauma. 3:186
4. Lucke-Wold, B.P., Turner, R.C., Lucke-Wold, A.N., Rosen, C.L., and Huber,
J.D. (2012). Age and the Metabolic Syndrome as Risk Factors for Ischemic
Stroke: Improving Preclinical Models of Ischemic Stroke. Yale Journal of
Biology and Medicine. 85(4):523-39.
5. Turner R.C., Lucke-Wold, B.P., Lucke-Wold, A.N., Elliott, A.S., Logsdon, A.F.,
Rosen, C.L., Huber, J.D. (2013) Neuroprotection for Ischemic Stroke: Moving
Past Shortcomings and Identifying Promising Directions. International Journal of
Molecular Science. 14(1):1890-917.
6. Turner, R.C., VanGilder, R.L., Naser, Z.J., Lucke-Wold, B.P., Bailes, J.E.,
Matsumoto, R.R., Huber, J.D., Rosen, C.L. (2014) Elucidating the Severity of
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Preclinical Traumatic Brain Injury Models: A Role for Functional Assessment?
Neurosurgery. 74(4):382-94.
7. Lucke-Wold, B.P., Turner, R.C., Logsdon, A.F., Bailes, J.E., Huber, J.D., Rosen,
C.L. (2014) Linking Traumatic Brain Injury to Chronic Traumatic
Encephalopathy: Identification of Potential Mechanisms Leading to
Neurofibrillary Tangle Development. Journal of Neurotrauma. 31(13):1129-38.
8. Lucke-Wold, B.P., Turner, R.C., Logsdon, A.F., Nguyen, L., DiPasquale, K.,
Huber, J.D., Rosen, C.L. (2014) Metabolic Syndrome and its Profound Effect on
the Development of Ischemic Stroke. American Medical Student Research
Journal. 1(1):29-38.
9. Lucke-Wold, B.P. (2014) Finding Balance: Running Through the Journey of
Medical School. American College of Physicians: Impact. 5(14):epub
10. Tan, Z., Li, X., Turner, R.C., Logsdon, A.F., Lucke-Wold, B.P., DiPasquale, K.,
Chen, R., Huber, J.D., Rosen, C.L. (2014) Combination treatment of r- tPA and
apyrase reduces mortality rate and hemorrhagic transformation 6h after ischemic
stroke in aged female rats. European Journal of Pharmacology. 738:368-73.
11. Lucke-Wold, B.P., Turner, R.C., Logsdon, A.F., Simpkins, J.W., Alkon, D.L.,
Smith, K.E., Chen, Y., Tan, Z., Huber, J.D., Rosen, C.L. (2014) Common
Mechanisms of Alzheimer’s disease and Ischemic Stroke: the Role of Protein
Kinase C in the Progression of Age-related Neurodegeneration. Journal of
Alzheimer’s Disease. 43(3):711-24.
12. Logsdon, A.F., Lucke-Wold, B.P., Rosen, C.L., Huber, J.D. (2014) Disparity
among Neural Injury Models and the Unfolded Protein Response. Journal of
Neurological Disorders and Stroke. 2(5):1083.
13. Lucke-Wold, B.P., Logsdon, A.F., Smith, K.E., Turner, R.C., Alkon, D.L., Tan,
Z., Naser, Z.J., Knotts, C.M., Huber, J.D., Rosen C.L. (2014) Bryostatin-1
Restores Blood Brain Barrier Integrity following Blast-Induced Traumatic Brain
Injury. Journal of Molecular Neurobiology. 52:1119-34
14. Logsdon, A.F., Turner, R.C., Lucke-Wold, B.P., Robson, M.J., Naser, Z.J.,
Smith, K.E., Matsumoto, R.R., Huber, J.D., and Rosen, C.L. (2014) Altering
endoplasmic reticulum stress in a model of blast-induced traumatic brain injury
controls cellular fate and ameliorates neuropsychiatric symptoms. Frontiers in
Cellular Neuroscience. 8:421
15. Nguyen, L., Lucke-Wold, B.P., Mookerjee, S.A., Cavendish, J.Z., Robson, M.J.,
Scandinaro, A.L., Matsumoto, R.R. (2014) Role of Sigma-1 Receptors in
Neurodegenerative Diseases. Journal of Pharmacological Sciences. 127(1):17-29
16. Logsdon, A.F.*, Lucke-Wold, B.P.*, Huber, J.D., Rosen, C.L., Simpkins, J.W.
(2015) Role of Microvascular Disruption in Brain Damage from Traumatic Brain
Injury. Comprehensive Physiology. 5(3): 1147-60
17. Bonasso, P., Lucke-Wold, B.P., Jacob, G. (2015) Osteonecrosis of
interphalangeal joint of thumb two months after rattlesnake bite. Hand Surgery.
20(2): 330-332
18. Bonasso, P., Lucke-Wold, B.P., Reed, Z., Bozek, J., Cottrell, S. (2015)
Investigating the Impact of Preparation Strategies on USMLE Step 1
Performance. MedEdPublish. 4:5

288

!
19. Lucke-Wold, B.P., Turner, R.C., Logsdon, A.F., Nguyen, L., Bailes, J.E., Lee,
J.M., Robson, M.J., Omalu, B.I., Smith, K.E., Huber, J.D., Rosen, C.L. (2015)
Endoplasmic Reticulum Stress Implicated in Chronic Traumatic Encephalopathy.
Journal of Neurosurgery. 18: 1-16
20. Lucke-Wold, B.P., Smith, K.E., Nguyen, L., Turner, R.C., Logsdon, A.F.,
Jackson, G.J., Huber, J.D., Rosen, C.L., Miller, D.B. (2015) Sleep Disruption and
the Sequelae Associated with Traumatic Brain Injury. Neuroscience and
Biobehavioral Reviews. 55: 68-77
21. Lucke-Wold, B.P., Bonasso, P.C., Turner, R., Cassim, R. (2015)
Adenocarcinoma of the Cecum with Rare Splenic Metastasis. West Virginia
Medical Journal. Accepted
22. Tan, Z.*, Lucke-Wold, B.P.*, Logsdon, A.F., Turner, R.C., Tan, C. Li, X.,
Hongpaison, J., Alkon, D.L., Simpkins, J.W., Rosen, C.L., Huber J.D. (2015)
Bryostatin Extends tPA Time Window to 6 Hours Following Middle Cerebral
Artery Occlusion in Aged Female Rats. European Journal of Pharmacology.
764:404-412
23. Bailes, J.E., Turner, R.C., Lucke-Wold, B.P., Patel, V. Lee, J.M. (2015) Chronic
Traumatic Encephalopathy: Is it Real? The Relationship Between Neurotrauma
and Neurodegeneration. Neurosurgery. 1:15-24
24. Lucke-Wold, B.P., Naser, Z., Logsdon, A.F., Turner, R.C., Smith, K.E., Robson,
M.J., Bailes, J.E., Lee, J.M. Rosen, C.L., Huber, J.D. (2015) Amelioration of
NADPH-Mediated Stress Reduces Cell Death following Blast-induced Traumatic
Brain Injury. Translational Research. 166:509-528
25. Bonasso, P., Lucke-Wold, B.P., Riffon, M., Long, D., Wilson, A., Knight, J.
(2015) The Effect of Sporting Events on Medical Transport Time at a Level 1
Trauma Center: a Retrospective Cohort Study. West Virginia Medical Journal.
Accepted.
26. Lucke-Wold, B.P., Nguyen, L., Turner, R.C., Logsdon, A.F., Chen, Y., Smith,
K.E. Huber, J.D., Matsumoto, R. Rosen, C.L., Tucker, E. Richter, E. (2015)
Traumatic Brain Injury and Epilepsy: Underlying Mechanisms Leading to
Seizure. Seizure: European Journal of Epilepsy. 33: 13-23
27. Turner, R.C., Lucke-Wold, B.P., Logsdon, A.F., Robson, M.J., Lee, J.M., Bailes,
J.E., Dashnaw, M.L., Huber, J.D., Petraglia, A.L., Rosen, C.L. (2015) The Quest
to Model Chronic Traumatic Encephalopathy: The Way Forward for Future
Discovery. Frontiers in Neurotrauma. 6:222
28. Turner, R.C.*, Lucke-Wold, B.P.*, Logsdon, A.F.*, Robson, M.J., Dashnaw,
M.L., Huang, J.H., Smith, K.E., Huber, J.D., Rosen, C.L., Petraglia, A.L. (2015)
Modeling Chronic Traumatic Encephalopathy: A Multiple Model & Injury
Paradigm Experience. Frontiers in Neurotrauma. 6:223
29. Nguyen, L., Thomas, K.L., Lucke-Wold, B.P., Cavendish, J.Z., Crowe, M.S.,
Matsumoto, R.R. (2016) Dextromethorphan: An update on its utility for
neurological and neuropsychiatric disorders. Pharmacology and Therapeutics.
[Epub]
Current Submissions
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1. Logsdon, A. Lucke-Wold, B.P., Nguyen, L., Matsumoto, R., Turner, R.C.,
Rosen, C.L., Huber, J.D. (2015) Salubrinal reduces markers of neuroinflammation
and improves outcome in a rodent model of traumatic brain injury. Experimental
Neurology. Under Review
2. Lucke-Wold, B.P., Bonasso, P. Cassim, R. (2015) Primary Colon
Adenocarcinoma and Primary Rectal Carcinoma with Metastatic Disease to the
Left Axilla. American Journal of Surgery. Under Review
3. Lucke-Wold, B.P., Phillips, M., Turner, R.C., Logsdon, A.F., Smith, K.E.,
Huber, J.D., Rosen, C.L., Regele, J. (2015) Elucidating the Role of Compression
Waves and Impact Duration for Generating mild Traumatic Brain Injury in Rats.
Brain Injury. Under Review
4. Turner, R.C., Lucke-Wold, B.P., Hwang, R., Underwood, B.D. (2015) Lung
Cancer Metastasis Presenting as a Solitary Skull Mass: A Case Report and
Review of the Literature. Neurological Medicine. Under Review
5. Bonasso, P., Lucke-Wold, B.P., Jacob, G. (2015) Re-fracture of Distal Radius in
the Setting of Trauma. Medical Student Research Journal. Under Review
6. Turner, R.C., Lucke-Wold, B.P., Robson, M.J., Lee, J.M., Lee, J.M., Bailes, J.E.
(2015) Alzheimer’s disease and Chronic Traumatic Encephalopathy: Distinct but
Possibly Overlapping Disease Entities. Brain Injury. Under Review.
7. Katsevman, G., Turner, R., Lucke-Wold, B.P., Sedney, C., Bhatia, S. (2016)
Osteopathia Striata with Cranial Sclerosis (OSCS): Review of the Literature &
Case Report Demonstrating Challenges of Posterior Cervico-thoracic Fusion after
Trauma. Acta Neurochirurgica. Under Review
8. Lucke-Wold, B.P.*, Turner, R.C., Josiah, D., Bhatia, S. (2016) Effect of Age and
Anticoagulation on the Natural History of Acute Convexity Subdural Hematomas.
Turkish Neurosurgery. Under Review
9. Turner, R.C., Lucke-Wold, B.P., Josiah, D., Gonzalez, J., Tarabishy, A.R.,
Bhatia, S. (2016). Stereotactic radiosurgery planning based on time-resolved CTA
for arteriovenous malformation: A case report and review of the literature.
Stereotactic and Functional Neurosurgery. Under Review
10. Ciporen, J., Lucke-Wold, B.P., Mendez, G., Cameron, W. (2016). Managing
cavernous carotid surgical complications endoscopically: A simulated costeffective and reproducible training opportunity. Journal of Neurosurgery. Under
Review
11. Ciporen, J., Lucke-Wold, B.P., Dogan, A., Cetas, J., Cameron, W.E. (2016).
Dual endoscopic endonasal transphenoidal and precaruncular transorbital
approaches for clipping the cavernous carotid artery: A cadaveric simulation.
Skull Base. Under Review
12. Ciporen, J.N., Lucke-Wold, B.P., Dogan, A., Cetas, J., Cameron, W. (2016).
Endoscopic endonasal transclival approach vs dual transorbital port technique for
clip application to the posterior circulation: A cadaveric anatomic and cerebral
circulation simulation study. Skull Base. Under Review.
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1. Logsdon, A.F., Turner, R.C., Tan, Z., DiPasquale, K., Lucke-Wold, B.P., Rosen,
C.L., Huber, J.D. (2012) Alterations to the JAK2/STAT3 signaling pathway may
affect ER stress levels in the aged rat stroke model. WVU Center for
Neuroscience Annual Retreat.
2. Tan, Z., Li, X., Turner, R.C., Logsdon, A., Lucke-Wold, B.P., DiPasquale, K.,
Chen, R., Rosen, C.L., Huber, J.D. (2012) Combination treatment of r-tPA and
APT 102 reduces cerebral infarct volume, improves neurological deficit score and
prevents hemorrhagic transformation in embolic stroke in aged female rats. WVU
Center for Neuroscience Annual Retreat.
3. Lucke-Wold, B.P., Turner, R.C., DiPasquale, K., Rosen, C.L., Huber, J.D. (2012)
Pressure Wave: a Membrane-Rupture Induced Model of Traumatic Brain Injury.
WVU Center for Neuroscience Annual Retreat.
4. Lucke-Wold, B.P., Bonasso, P., Riffon, M., Long, D., Wilson, A., Knight, J.
(2013) County Roads Take Me Home: Population Surge and its Effect on a Rural
Trauma Center. American Medical Association National Meeting.
5. Lucke-Wold, B.P., Logsdon, A.F., Turner, R.C., Huber, J.D., Rosen, C.L. (2014)
Linking Acute Neurotrauma to Chronic Traumatic Encephalopathy: the Role of
the ER Stress Response. WVU Van Liere Research Day.
6. Logsdon, A.F., Turner, R.C., Lucke-Wold, B.P., Robson, M.J., Naser, Z.J., Tan,
Z., Matsumoto, R.R., Rosen, C.L., and Huber, J.D. (2014). Altering endoplasmic
reticulum stress attenuates neural injury markers following blast-induced
traumatic brain injury in male rats. WVU Van Liere Research Day.
7. Lucke-Wold, B.P., Logsdon, A.F., Turner, R.C., Huber, J.D., Rosen, C.L. (2014)
PERK-mediated ER Stress: Linking Acute Blast-induced Neurotrauma with Taudependent Neurodegeneration. American College of Physicians National Meeting.
8. Lucke-Wold, B.P., Logsdon, A.F., Turner, R.C., Bailes, J.E., Lee, J., Huber, J.D.,
Rosen, C.L. (2014) PERK-mediated ER Stress: Linking Acute Blast-induced
Traumatic Brain Injury with Chronic Traumatic Encephalopathy. American
Physician Scientist Association.
9. Logsdon, A.F., Hernandez, A., Tan, C., Lucke-Wold, B.P., Turner, R.C., Tan, Z.,
Bibb, J.A., Rosen, C.L., Huber, J.D. (2014). Calcium-dependent mechanisms
resulting from blast-induced traumatic brain injury are linked to tau
hyperphosphorylation. Barriers of the CNS: Gordon Research Conference.
10. Lucke-Wold, B.P., Logsdon, A.F., Turner, R.C., Bailes, J.E., Lee, J., Huber, J.D.,
Rosen, C.L. (2014) Connecting Acute Neurotrauma to Chronic Traumatic
Encephalopathy: the Role of the ER Stress Response. National Neurotrauma
Society Meeting.
11. Lucke-Wold, B.P., Logsdon, A.F., Smith, K., Turner, R.C., Alkon, D., Huber,
J.D., Rosen, C.L. (2014) Bryostatin Restores Blood Brain Barrier Integrity
following Blast Injury. WVU Neuroscience Retreat.
12. Lucke-Wold, B.P., Naser, Z., Logsdon, A.F., Turner, R.C., Bailes, J.E., Lee, J.,
Huber, J.D., Rosen, C.L. (2014) Targeting NADPH-mediated Stress to Prevent
Apoptosis following Blast Traumatic Brain Injury. Appalachian Regional Cell
Conference.
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13. Lucke-Wold, B.P., Naser, Z., Logsdon, A.F., Turner, R.C., Bailes, J.E., Lee, J.,
Huber, J.D., Rosen, C.L. (2015) Elucidating the Role of Oxidative Stress in Blast
Injury. WVU Van Liere.
14. Lucke-Wold, B.P., Naser, Z., Logsdon, A.F., Turner, R.C., Bailes, J.E., Lee, J.,
Huber, J.D., Rosen, C.L. (2015) Reducing Oxidative Stress Following Acute
Neurotrauma Improves Behavior. ASPET Experimental Biology.
15. Lucke-Wold, B.P., Logsdon A.F., Turner, R.C., Naser, Z., Bailes, J.E., Lee, J.
Rosen C.L. (2015) Elucidating the Underpinnings of Neurotrauma Related
Neurodegeneration ACTS: AFMR Translational Science.
16. Lucke-Wold, B.P., Logsdon A.F., Turner, R.C., Naser, Z., Bailes, J.E., Lee, J.,
Rosen C.L. (2015) Amelioration of NADPH-mediated Stress Reduces Cell Death
following Blast Traumatic Brain Injury. Central Society of Clinical and
Translational Research
17. Lucke-Wold, B.P., Logsdon A.F., Turner, R.C., Naser, Z., Bailes, J.E., Lee, J.,
Rosen C.L. (2015). Lipoic Acid: the Anti-Oxidant for Neurotrauma. American
Society of Clinical Investigation.
18. Lucke-Wold, B.P., Logsdon A.F., Turner, R.C., Naser, Z., Bailes, J.E., Lee, J.,
Rosen C.L. (2015). Finding Treatments for Athletes and Soldiers Experiencing
Brain Injury. American College of Physicians.
19. Lucke-Wold, B.P., Xu, S., Logsdon, A.F., Rosen, C.L., He, P. (2015) Targeting
Endothelial Cell Transcellular Diapedesis: Src Dependent Activation of ICAM-1.
American Association of Pharmaceutical Sciences Research Day. West Virginia
University.
20. Lucke-Wold, B.P., Turner, R., Dashnaw, M., Lee, J., Rosen, C., Petraglia, A.
(2015) Modeling Chronic Neurodegeneration Following Neurotrauma: A MultiModel Experience. National Neurotrauma Meeting.
21. Lucke-Wold, B.P., Logsdon, A.F., Mohammad, A., Adkins, C., Ren, X.,
Lockman, P., Simpkins, J., Rosen, C. (2015) Stroke and Alzheimer’s Disease:
Shared Vascular Mechanisms. WV Rural Health Meeting.
22. Lucke-Wold, B.P. Logsdon, A., Turner, R.C., Lockman, P., Simpkins, J., Rosen,
C. (2015) Novel Approach for Concussion Treatment: Protein Kinase C and the
Blood Brain Barrier. American Association of Pharmaceutical Sciences Meeting.
23. Lucke-Wold, B.P. Logsdon, A.F., Mohammad, A., Adkins, C., Ren, X.,
Lockman, P., Simpkins, J., Rosen, C. (2015) Understanding the Vascular Interrelationship Between Stroke and Alzheimer’s Disease. Future Tox 2015
Washington, D.C.
24. Ciporen, J., Lucke-Wold, B., Mendez, G., Cua, D.J., Chen, A., Banerjee, A.,
Akins, P.T., Balough, B. (2016) Single Staged Resections and 3D Reconstructions
of the Nasion/Glabella/Medial Orbital Wall/Frontal Sinus and Bone: Long-Term
Outcome and Review of the Literature. North American Skull Base Conference.
25. Lucke-Wold, B.P., Ciporen, J., Cetas, J., Dogan, A., Cameron, W. (2016) Dual
Endoscopic Endonasal Transphenoidal and Precaruncular Transorbital
Approaches for Clipping of the Cavernous Carotid Artery-Enhanced Degrees of
Freedom: A Cadaveric Cerebral Perfusion Simulation. North American Skull
Base Conference.
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26. Lucke-Wold, B.P., Logsdon, A., Mohammad, A., Adkins, C., Ren, X., Simpkins,
J., Lockman, P., Rosen, C. (2016) The Vascular Inter-relationship between Stroke
and Alzheimer’s disease. International Stroke Conference.
Oral Presentations:
1. Lucke-Wold, B.P. (2011) Embarking on New Paths in the World of
Metallacarborane Chemistry. Thesis Defense Baylor University.
2. Lucke-Wold, B.P. (2012) Ethanol, Zebrafish, and Conditioned Place Preference.
Meeting of Behavioral and Biomedical Researchers WVU.
3. Lucke-Wold, B.P., Logsdon, A.F., Turner, R.C., Tan, Z., Huber, J.D., Rosen,
C.L. (2013) PERK-mediated ER Stress: Linking Acute Blast-Induced
Neurotrauma with Tau-dependent Neurodegeneration. American College of
Physicians WV Meeting.
4. Lucke-Wold, B.P. (2013) Blast Exposure Induces PTSD Related Traits in a Rat
Model. Meeting of Behavioral and Biomedical Researchers WVU.
5. Lucke-Wold, B.P., Tan, Z., Huber, J.D., Rosen, C.L. (2013) The Effect of
Bryostatin on Blood Brain Barrier Disruption and Hemorrhagic Transformation.
American Association of Pharmaceutical Sciences Regional Meeting.
6. Lucke-Wold, B.P. (2014) The ER Stress Response: Linking acute traumatic brain
injury to chronic tau-dependent neurodegeneration. Neurological Surgery Society
of the Virginias Meeting.
7. Lucke-Wold, B.P. (2014) Linking Acute Neurotrauma to Chronic Traumatic
Encephalopathy: the Role of the ER Stress Response. Van Liere
8. Lucke-Wold, B.P. (2014) The ER Stress Response: A Bridge Between Acute
Neurotrauma and Chronic Neurodegeneration. Synapse Meeting.
9. Lucke-Wold, B.P. (2014) Bryostatin Restores Blood Brain Barrier Integrity
following Blast-Induced Traumatic Brain Injury. WVU Neuroscience Retreat.
10. Lucke-Wold, B.P. (2014) Blast!induced Traumatic Brain Injury, Oxidative
Stress, and Apoptosis: the Beneficial Effects of Alpha Lipoic Acid. American
College of Physicians WV Scientific Meeting.
11. Lucke-Wold, B.P. (2014) Amelioration of NADPH-Mediated Stress Reduces
Cell Death following Blast Traumatic Brain Injury. American Association of
Pharmaceutical Sciences Pittsburgh Meeting.
12. Lucke-Wold, B.P. (2014) The Effects of Sporting Events on Trauma Transport
Time at a Level 1 Trauma Center. Meeting of Behavioral and Biomedical
Researchers WVU.
13. Lucke-Wold, B.P. (2015) Ameliorating NADPH-stress reduces cell death
following blast traumatic brain injury. Neurological Surgery Society of the
Virginias Meeting.
14. Lucke-Wold, B.P. (2015) The Case for Medical Marijuana in Epilepsy. West
Virginia University Neuroscience Blitz.
15. Lucke-Wold, B.P. (2015) Elucidating the Underpinnings of Neurotrauma-related
Neurodegeneration. ACTS:AFMR Translational Science
16. Lucke-Wold, B.P. (2015) Progressive Tauopathy: Understanding NeurotraumaRelated Neurodegeneration. Alzheimer’s Association International Conference.
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17. Lucke-Wold, B.P., Logsdon, A.F., Mohammad, A., Adkins, C., Ren, X.,
Lockman, P., Simpkins, J., Rosen, C. (2015) Stroke and Alzheimer’s Disease:
Shared Vascular Mechanisms. WV ACP Scientific Meeting.
18. Lucke-Wold, B.P. (2015) Tackling Neural Injury: the Importance of Team
Science. WVU Neuroscience Research Forum.
19. Lucke-Wold, B.P., Logsdon, A.F., Mohammad, A., Adkins, C. Lockman, P.,
Rosen, C.L. (2015) Targeting Trauma-induced Blood Brain Barrier Disruption: an
Innovative Approach for Treating Concussion. Appalachian Regional Cell
Conference.
20. Lucke-Wold, B.P., Ciporen, J., Cetas, J., Dogan, A., Cameron, W. (2016)
Endoscopic Endonasal Transclival Approach vs Dual Transorbital Port Technique
for Clip Application to the Posterior Circulation: an Anatomic and Cadaveric
Cerebral Perfusion Simulation Study. North American Skull Base Society
Meeting.
Invited Talks
1. Lucke-Wold, B.P. & Turner, R.C. (2014) Modeling Blast-induced Traumatic
Brain Injury & Solving the Chronic Traumatic Encephalopathy Crisis.
NorthShore Health System.
2. Lucke-Wold, B.P. & Logsdon, A.F. (2015) Investigating Pathophysiologic
Mechanisms of Traumatic Brain Injury and Neurodegeneration. NorthShore
Health System.
Online Forums
1. Lucke-Wold, B.P. (2016) Novel Approach for Concussion Treatment: Protein
Kinase C and the Blood Brain Barrier. AAPS Best Abstract Presentations.

Funding
•
•
•
•
•
•

West Virginia University Research Funding and Development Grant Coinvestigator 2013: $17000
West Virginia University Distinguished Doctoral Fellowship 2014: $5000 and
2015: $5000
American Medical Association Foundation Seed Grant 2015: $2500
American Foundation of Pharmaceutical Education Pre-doctoral Fellowship 2015:
$10000 and 2016: $10000
Neurosurgery Research and Education Foundation Medical Student Summer
Research Fellowship 2015: $2500
Sigma Xi Grants in Aid of Research 2016: $500

Professional Meetings:

294

!
•
•
•
•
•
•
•
•
•
•
•
•

Neurological Surgery Society of the Virginias Meeting, Greenbrier, WV, 2014,
2015
American Physician Scientist Association Institutional Representative Annual
Meeting Chicago, IL, 2014, 2015
National Neurotrauma Society Meeting 2014, 2015
American College of Physicians National Meeting 2014, 2015
Experimental Biology Meeting 2015, 2016
American Association of Neurological Surgeons National Meeting 2015, 2016
American Federation for Medical Research Eastern 2015, and Central 2015
NINDS/AUPN/ANA/CNS Combining Clinical and Research Careers in
Neuroscience Symposium 2015
Alzheimer’s Association International Conference 2015
American Association of Pharmaceutical Sciences 2015
FutureTOX 2015
North American Skull Base Society 2016

Professional Service:
•
•
•
•
•

Poster Judging – Undergraduate scholars at the WVU Neuroscience Retreat
Nu Rho Psi National Council – Honor Society for Neuroscience
Neuroscience Breakthrough Blitz- Speaker Committee
Diabetes Health Coach – School of Public Health
Blind Reviewer – Compass Clinical Trial

Certification
•
•

NIH Stroke Scale (1/17/16)
Modified Rankin Scale Test (1/17/16)

Editorial:
•
•
•

Reviewer, Molecular Neurobiology
Reviewer, NeuroReport
Reviewer, PlosOne

Teaching:
•
•
•

West Virginia University Graduate Neuroanatomy: Teaching Assistant and
Discussion Leader (Spring 2015)
West Virginia University Graduate Journal Club: Ran Sessions on Neuroscience
Articles (Fall 2015)
West Virginia University Introductory Psychology: Taught Lectures on Hormones
and Behavior (Fall 2015)
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Professional Development:
•
•

NIH Grant Writing Workshop (Fall 2015)
NIH Ethical and Regulatory Aspects of Clinical Research (Fall 2015)

Laboratory Experience:

•

•

•

Honors Thesis: Metallacarborane research under the direction of Dr. Bruce Hodson
and Dr. Gordon Stone at Baylor University. My Thesis Project involved four newly
synthesized metallacarborane compounds. I used simple Schlenk line procedures,
nuclear magnetic imaging, spectroscopy, and chromatography tubes to execute most
of the experiments I conducted. After a substantial yield of the synthesized
compound had been collected, I ran the compound through a series of reactions. I
also conducted a thorough examination of structure through crystallography
procedures. The work was published by Lambert Academic Publishing. (Spring
2008-2011)
Dissertation Work: Utilizing a blast traumatic brain injury model we investigated
blood brain barrier disruption, axonal shearing, endoplasmic reticulum stress
activation, NADPH activity, and iron mediated toxicity. Areas of interest include
chronic traumatic encephalopathy, tauopathy, blast traumatic brain injury, and
neurodegeneration. In addition to mechanistic investigation, we looked for
therapeutic agents targeting the aforementioned pathways. We likewise investigated
blood brain barrier disruption in ischemic stroke looking at the relationship between
Alzheimer’s disease and ischemic infarct.
Past Laboratory Work:
1. Neuroanatomy vascular perfusions with endoscopic skull based surgery using
cadaveric models. Perfusion simulation model and microfil injections to map
intracranial vasculature. Oregon Health & Science University. (Summer 2015)
2. Neuroscience research rotation focused on Alzheimer’s disease and Post
Traumatic Stress Disorder using rabbit eye blink conditioning under the
direction of Dr. Schreurs at Blanchette Rockefeller Neurosciences Institute.
(Summer 2011)
3. Neuroscience research focused on Conditioned Place Preference for alcohol
under the direction of Dr. Diaz-Granados at Baylor University. Review article
published in Impulse: Premier Undergraduate Journal for Neuroscience
Research (Fall 2010-Spring 2011)
4. Immunology research focused on the mechanism of neddylation in specific
regards to rheumatism and Alzheimer’s disease. I also looked at the role of the
experimental drug MLN4924 on IL-2 production in a 2B411 cell line under
the direction of Dr. Dragone at National Jewish Health in Denver, CO.
Presented my work in a laboratory presentation at the end of the summer.
(Summer 2010)
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5. Immunology research focused on malignant melanoma and the mechanism of
toll ligand receptors under the direction of Dr. Karen Newell-Rogers and Dr.
Josh Cabrera at University of Colorado, Colorado Springs. (Summer 2009)

Memberships:
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

Alpha Lambda Delta Honor Society (Inducted Spring 2008)
National Society Collegiate Scholars (Inducted Spring 2008)
Delta Epsilon Iota Honor Society (Inducted Fall 2008)
Alpha Epsilon Delta Pre-medical Honor Society (Inducted Spring 2009)
Golden Key Honor Society (Inducted Fall 2009)
Nu Rho Psi- Neuroscience Honor Society (Inducted Spring 2010)
Alpha Chi Honor Society (Inducted Spring 2010)
Omicron Delta Kappa Circle of Leaders (Inducted Spring 2010)
American Medical Association (Fall 2011 to present)
American Medical Student Association (Fall 2011 to present)
American Physician Scientist Association (Spring 2014 to present)
American Association of Pharmaceutical Sciences (Spring 2014 to present)
American Academy of Neurology (Spring 2014 to present)
National Neurotrauma Society (Spring 2014 to present)
American Society for Pharmacology and Experimental Therapeutics (Fall 2014 to
present)
American Heart Association (Spring 2015 to present)
American Association of Neurological Surgeons (Spring 2015 to present)
American College of Surgeons (Spring 2015 to present)
American Chemistry Society Division of Medicinal Chemistry (Spring 2015 to
present)
Sigma Xi Research Society Full Member (Spring 2015 to present)
American Federation of Medical Research Member (Spring 2015 to present)
American Society of Cell Biology (Spring 2015 to present)
Society of Toxicology (Spring 2015 to present)
Microcirculatory Society (Fall 2015 to present)

Achievements and Awards:
College
•
•
•
•
•
•
•
•

Congressional Award Gold Medalist (Summer 2007)
LeadAmerica Advanced Medicine and Healthcare (Summer 2008)
William Carey Crane Scholar (Fall 2008)
Integrity Scholar of National Society of Collegiate Scholars (Spring 2008)
Summer Surgery Experience Fellow-University of Cincinnati (Summer 2009)
Intercollegiate Studies Institute-Honors Program Fellow (Summer 2009)
Founder’s Scholarship-Baylor University (Fall 2009)
Cullen Trust Symposium on Translational Research (Spring 2010)
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• Who’s Who Among American College Students (Spring 2010)
• President’s Volunteer Service Award (Spring 2010)
• Scholar of Promise (Spring 2010)
• Earhart Foundation Scholarship-The Philadelphia Society (Fall 2010)
• Goodrich Foundation Scholarship-The Philadelphia Society (Spring 2011)
• Most Outstanding Neuroscience Senior (Spring 2011)
MD/PhD Program
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

John E. Pescott Award for Academic Excellence (Spring 2012)
1st Place Oral Presentation American College of Physicians Scientific Meeting
(Fall 2013)
1st Place Oral Presentation American Association of Pharmaceutical Sciences
Regional Meeting (Fall 2013)
1st Place Oral Presentation Neurological Surgery Society of Virginias Meeting.
The Crutchfield, Gage, and Thomson Award. (Spring 2014)
Behavioral and Biomedical Sciences Research Scholarship (Spring 2014)
American Physician Scientist Association Travel Award (Spring 2014)
2nd Place Van Liere Oral Presentation (Spring 2014)
Synapse Travel Award (Spring 2014)
American Association of Clinical Investigation Travel Award (Spring 2014)
Neurotrauma Travel Award (Summer 2014)
WVU Innovator Award Finalist (Fall 2014)
1st Place Oral Presentation American College of Physicians Scientific Meeting
(Fall 2014)
1st Place Oral Presentation American Association of Pharmaceutical Sciences
Regional Meeting (Fall 2014)
1st Place Poster Presentation Appalachian Regional Cell Conference (Fall 2014)
American Society of Pharmacology and Experimental Therapeutics Travel Award
(Spring 2015)
American Society of Pharmacology and Experimental Therapeutics Best Abstract
Competition (Spring 2015)
Central Society for Clinical and Translational Research Travel Award (Spring
2015)
Behavioral and Biomedical Sciences Research Scholarship (Spring 2015)
American Federation of Medical Research Scholar (Spring 2015)
Burroughs-Wellcome Fund Trainee Travel Award Translational Science Meeting
(Spring 2015)
1st Place Poster Competition National American College of Physicians Meeting
(Spring 2015)
Alzheimer’s Association International Conference Travel Fellowship (Summer
2015)
Cranial Trauma Research Award American Association of Neurological
Surgeons/Congress of Neurological Surgeons Section on Neurotrauma and
Critical Care (Summer 2015)
American Association of Pharmaceutical Science Biotec Graduate Student
Research Award (Fall 2015)
WV Rural Health Conference Travel Award (Fall 2015)
298

!
•
•
•
•
•

Society of Toxicology Future Tox Silver Award (Fall 2015)
American College of Physicians Research Meeting 2nd Place (Fall 2015)
Washington Fellow’s Program American Society of Pharmacology and
Experimental Therapeutics (2015/2016)
American Association of Neurological Surgeons Medical Student Summer
Research Fellowship Award (Spring 2016)
American Society of Pharmacology and Experimental Therapeutics Travel Award
and Best Abstract Award (Spring 2016)

Business:
•

Co-founder of Wright Wold Scientific, LLC. Provisional patent filed.

Leadership:
College
Kappa Kappa Psi National Honorary Band Fraternity: Corresponding Secretary
(2008-2009) and President (2009-2010). We organized and hosted the national
convention while I was president.
• Baylor Neuroscience Society: Historian (2008-2009) and Vice President (20092011). We introduced students to the field of neuroscience through a speaker
series and volunteer work at the local Alzheimer’s care facility.
• Nu Rho Psi: Vice President (2010-2011) and Regional Vice President (20112014). Through this neuroscience honor society, we started an endowment to fund
travel awards for students in order for students to present at national conferences.
• Delta Epsilon Iota: Treasurer (2009-2010) and President (2010-2011). Our
chapter won chapter of the year, and I was awarded most outstanding chapter
president for our campus projects focused on career development and networking.
• American Medical Student Association: Treasurer (2008-2010) and Vice
President (2010-2011). We hosted a speaker series, organized a medical service
trip, and sent members to the national convention.
• Alpha Epsilon Delta pre-med honor society: Treasurer (2009-2010). Through
fundraising, we raised $3,000 for our organizational activities.
• National Society of Collegiate Scholars: President (2009-2011) and National
Leadership Council (2010-2011). We were named a gold star chapter for our
focus on community service, professional development, and campus involvement.
MD/PhD Program
•

•
•

Academic Council WVU School of Medicine (2011-2013). We were student
advocates for our class and presented academic concerns to the professors and
associate deans.
American Medical Student Association: Vice President (2012-2013). We hosted
an equipment sale for students, and hosted a forum to expose students to different
specialties.
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•
•
•

•

•
•

Students for Global Health: Vice President (2012-2013). We hosted global health
week featuring several well-known keynote speakers. The week long activities
increased exposure about global health concerns campus wide.
Student Interest Group in Surgery: Committee Leader (2012-2013). We hosted a
speaker’s series regarding the different subspecialties of surgery and sponsored a
suturing workshop.
Neuroscience Graduate Student Organization: Committee Chair (2014-2015). I
worked closely with the academic steering committee to select high quality and
engaging speakers for the neuroscience seminar series. Vice President (20152016). As vice president, I helped grow the organization and expand its influence
around campus.
American Association of Pharmaceutical Sciences: Treasurer (2014-2015). I
orchestrated fundraising activities and managed a several thousand-dollar budget.
President (2015-2016). We sponsored a regional meeting, participated in
community service endeavors, and had multiple networking events.
American Physician Scientist Association: Partnerships Committee (2015-2016).
I orchestrated new partnerships for MD/PhD students with the American
Association of Neurological Surgeons and American College of Physicians.
American Foundation of Pharmaceutical Education: Development Committee
(2016-2017). Interacted with Pharmaceutical company leaders and investors to
provide sustainable funding for the AFPE pre-doctoral fellowships.

Extracurricular:
College
• Baylor University Golden Wave Marching Band (2007-2009)
• Baylor University Concert Band (2008-2010)
• Intramural Soccer and Basketball (2007-2010)
• 1st place Great Brazos Relay long distance run (Fall 2009)
• Age-division Champion Miracle Match 5K (Fall 2008)
MD/PhD Program
•
•
•
•
•

September Stride 5K (2011)
Run For Cover 5K, Jim Dunn 5mile Run, Ruckus Pittsburgh, Weekly Yoga
Classes, Racket ball, and Turkey Trot 5K (2012)
WVU Indoor Triathlon, Run For Cover 5K, 2nd Place Color Run, Decker’s Creek
Half Marathon, Ruckus, Age-division Champion Gene’s run (2013).
2nd Place Cooper’s Rock Run, 3rd Place Wild Warrior Challenge, State 10k race,
Decker’s Creek Half Marathon, Jim Dunn 5mile Run, Turkey Trot 5K (2014)
Technology Park Veteran’s 5k age group winner, Decker’s Creek Half Marathon,
Bark in the Park 5k, Akron Blue Half Marathon, Marathon on the Mountain Half
Marathon (2015)

Other Life Experience:
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•
•
•
•
•
•
•
•
•

Worked at Angry Squirrel Tree Company (2005-2006) and Rocky Mountain
Landscaping (2006-2007)
CPR and First Aid Certified through the American Heart Association (2010-2012)
Renewed (2011-2013)
All-State Track Athlete (2007)
Canoed from Eli, Minnesota into Canada (2004), Backpacked in the Wemuniche
Wilderness of Durango, CO (2005), Snowshoed in Cooper’s Rock State Park,
WV (2014)
Worked at Nuremberg YMCA in Germany during the World Cup (2006)
Visited 48 of the 50 United States
Zip-Lined through the jungle in Costa Rica (2010), kayaked in bioluminescent
bay in Puerto Rico (2014), and took a river cruise through Hungary, Slovakia,
Austria, and Germany (2016)
Climbed Pikes Peak, Mt. Sherman, Mt. Lincoln, Mt. Democrat, and Mt. Bros in
Colorado (2010)
Honeymooned in Iceland (2011): went deep-sea fishing, hiked along waterfalls
and geysers, and visited the world-renowned Blue Lagoon.

Service:
College
100+ hours of volunteer work at the GI Lab of Memorial Hospital North in
Colorado Springs, CO (2008-2010)
• 60+ hours of volunteer work in Emergency Room at Hillcrest Hospital in Waco,
TX (2009-2010)
• 100+ hours mentoring under-privileged youth at Antioch Community Center
(2007-2008)
• 30+ hours of volunteer work at Wesley Woods Alzheimer Care Center (20082010)
• Two medical service trips to Belize and Mexico. In Belize, we worked in Mayan
villages providing medical care via a make-shift clinic, triage, and pharmacy
under the direction of two United States physicians. We also gathered population
data for the Red Cross. In Mexico, we worked with a local physician to provide
medical care for villagers in the mountains of central Mexico. (Spring 2009 and
Spring 2010 respectively)
• Civic engagement project at J.H. Hines elementary school in poverty stricken East
Waco. I set up a tutoring program and parent involvement day, raised money
through box tops for education, and recruited physicians to do annual check-ups
for the students. (2010-2011)
MD/PhD
•

•

30+ hours Mushroom Leader: Mushroom is the homeless outreach at WVU
School of Medicine. We pass out food, water, and clothes and do basic medical
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•
•
•
•

work under the supervision of licensed physicians. Street Rounds are every other
Thursday evening. (2011-2013)
20+ hours volunteer work at S.A.F.E. Clinic: Student run clinic for underinsured
in Morgantown and surrounding area. (2011-2014)
Guest Presenter WVU Neuroscience Research Day: I interacted with
undergraduate students, presented my research, and encouraged pursuit of further
education. (Spring 2015)
Panel Participant WVU Neuroscience Career Development Session: I served on a
panel for undergraduate neuroscience students to help encourage the pursuit of
medical or graduate degrees training in neuroscience. (Spring 2015)
100+ hours Diabetes Health Coach: taught sessions in the local community to
foster diabetes prevention and enhance knowledge about diabetes. Was mentored
and supervised by Dr. Ranjita Misra in the School of Public Health. (2015-2016)
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